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ABSTRACT 
William Daniel Mackay: Novel Applications of DonorAcceptor Cyclopropanes and 
Dearomatization towards the Expedient Synthesis of Highly Substituted Carbocycles 
(Under the direction of Jeffrey S. Johnson) 
I.  Lewis Acid Catalyzed (3+2)-Annulations of DonorAcceptor Cyclopropanes and 
Ynamides. 
 
The Sc(OTf)3-catalyzed (3+2)-annulation of donoracceptor cyclopropanes and ynamides is 
described, providing the corresponding cyclopentene sulfonamides in good to excellent yield. 
Deprotection and hydrolysis of the resulting cyclopentenesulfonamides delivers 2,3-substituted 
cyclopentanones with high diastereoselectivity.  
 
II. Kinetic Separation and Asymmetric Reactions of Norcaradiene Cycloadducts: 
Facilitated Access via H2O-Accelerated Cycloaddition. 
 
We exploit the Buchner reaction to access 1,2-disubstituted cyclohexadiene synthons 
(norcaradienes), which participate in H2O-accelerated cycloaddition with dienophiles to provide 
cyclopropyl-fused [2.2.2]-bicyclooctene derivatives in good yields. Regioisomeric mixtures can 
be kinetically separated exploiting different reaction rates in DielsAlder reactions.  meso-
DielsAlder products may be enantioselectively desymmetrized, providing highly substituted 
cyclohexanes with up to seven contiguous stereocenters.  
iv 
 
 
 
III. The Development of Regioisomerically Enriched Buchner Products for Use as 
Cyclohexadienyl Synthetic Intermediates. 
 
We have investigated two conceptual methods to generate highly regioisomerically 
enriched norcaradienyl intermediates through arene cyclopropanation. Intermolecular Buchner 
reaction of aryl diazoacetates under either thermolysis or silver(I) catalysis provide expedient 
routes to single regioisomeric norcaradienes, in some cases favoring the least sterically 
encumbered site of cyclopropanation. Intramolecular Buchner reaction of benzyl 
cyanodiazoacetates allow for the site-selective cyclopropanation of the tethered arene, and the 
installation of an activated cyclopropane for downstream functionalization. Both methods generate 
norcaradienes that are amenable to further transformations to generate highly stereochemically 
complex carbocyclic products.  
 
 
 
 
 
 
 
 
 
 
 
 
  
v 
 
 
 
 
 
 
ACKNOWLEDGEMENTS 
 
First of all, I would like to thank my family who has helped me develop as an individual 
over the years. I could not have completed this program without the love and support of all my 
family members. 
I would especially like to thank my wife, Kelsey, whose sacrifices for me have allowed me 
to develop professionally and individually. For all of the days that we only spent just one or two 
waking hours together, for all of the vacations that were only taken in our minds, for all of the time 
you have spent without a dog: these moments will not be forgotten. My love for you increases each 
day, and despite the hardships that you were put through these past four years, know that when I 
saw you each night, all of my stress from the day subsided, and your smile made everything better. 
I could not have been as successful in my time here without you.  
I would also like to thank all of the Johnson group members—past and present—who have 
assisted in my training, through assistance with revising manuscripts and presentations, through 
helping me prepare for my preliminary candidacy exam, and through sharing knowledge, catalysts, 
and reagents. I would like to provide special mention to the following former members for their 
contributions to my development: Dung Do: for his patience and mentorship as I began my 
graduate studies, and for telling me why all of my ideas during my first year were terrible, and 
teaching me better ways to think about solving problems. Robert Sharpe: for healthy discussions 
about chemistry, Disney, and college football, and who provided an excellent role model for what 
kind of chemist that I should strive to become. Guy Goodman: for always being willing to discuss 
anything, and for being the group historian, and also for allowing me to share the Clemson football 
vi 
 
experience at Death Valley with you. Lexi Akeyson: for being a hard-working undergraduate 
mentee who helped me develop as a teacher and a mentor, and allowing me the proud moment of 
listening to you effectively talk about the silver Buchner project for the presentation to your class.  
Last, I would like to express my sincere gratitude to my PI, Jeff Johnson. Thank you for 
affording me the opportunity to learn and develop under your tutelage. Throughout the synthetic 
community, your name garners respect for your work, and through my time in your group I have 
found that that respect is well-deserved for your creativity, industriousness, and continuation to 
support your students to become the best that they can. Your leadership has allowed me to see the 
world in new and unique ways. You have given me the freedom explore non-conventional 
reactivity and the opportunity to address challenging and significant problems in organic 
chemistry, and for that I am forever grateful. I could not have chosen a better advisor for my time 
in graduate school. 
  
vii 
 
 
 
 
 
 
Dear Kelsey: 
 
For all the sacrifices that have been made. 
For all the time that has been shared. 
For all the compassionate love that is had.  
For the promising future yet to unfold. 
For all the good times and bad. 
Forever, for you. 
 
  
viii 
 
 
 
 
 
 
TABLE OF CONTENTS 
LIST OF TABLES................................................................................................................. .........xi 
LIST OF FIGURES............................................................................................................... .......xii 
LIST OF SCHEMES............................................................................................................. ......xiii 
LIST OF ABBREVIATIONS AND SYMBOLS.................................................................. .......xvi 
CHAPTER ONE LEWIS ACID CATALYZED (3+2)-ANNULATIONS OF DONORACCEPTOR 
CYCLOPROPANES AND YNAMIDES......................................................... ..........1 
   
1.1 Introduction.................................................................................................................... ..........1 
1.2 Background.................................................................................................................... ..........1 
 1.2.1 Introduction and History of DonorAcceptor Cyclopropanes....................... ..........1 
 1.2.2 Utility of Ynamides in Cycloaddition Reactions........................................... ..........4 
1.3 Results and Discussion................................................................................................... ..........5 
 1.3.1 Initial Reaction Design and Optimization...................................................... ..........5 
 1.3.2 Substrate Scope of the Reaction..................................................................... ..........6 
 1.3.3 Generation of Enantioenriched Cyclopentenesulfonamides.......................... ..........8 
 1.3.4 Deprotection and Hydrolysis of Cyclopentenesulfonamide Intermediates.... ........10 
 1.3.5 Unexpected Byproduct from Ynamide Hydrolysis........................................ ........12 
 1.3.6 Investigation of the “Interrupted” (3+2)-Annulation..................................... ........14 
1.4 Conclusions................................................................................................................ ........16 
1.5 Experimental Details.................................................................................................. ........17 
1.6 References.................................................................................................................. ........39 
CHAPTER TWO KINETIC SEPARATION AND ASYMMETRIC REACTIONS OF 
NORCARADIENE CYCLOADDUCTS: FACILITATED ACCESS VIA H2O-
ACCELERATED CYCLOADDITION........................................................... ........41 
ix 
 
   
2.1 Introduction.................................................................................................................... ........41 
2.2 Background.................................................................................................................... ........42 
 2.2.1 Importance and Application of Dearomatization in Synthesis....................... ........42 
 2.2.2 The Buchner Reaction.................................................................................... ........43 
 2.2.3 Factors Influencing the Norcaradiene/Cycloheptatriene Equilibrium............ ........44 
 2.2.4 Comparison between the Intra- and Intermolecular Buchner Reaction......... ........46 
2.3 Results and Discussion................................................................................................... ........48 
 2.3.1 Initial Reaction Design................................................................................... ........48 
 2.3.2 Substrate Scope of the Intermolecular Buchner Reaction.............................. ........49 
 2.3.3 Substrate Scope of the Rh2(TFA)4 Catalyzed Buchner Reaction.................. ........50 
 2.3.4 Rationale for the Observed Regioselectivity in the  
Intermolecular Buchner Reaction................................................................... ........51 
    
 2.3.5 Isomerization of Norcaradienes by Ring Walking......................................... ........53 
 2.3.6 Further Functionalization of Buchner Products in Cycloaddition Reactions. ........57 
 2.3.7 Investigations into the Kinetic Separation of Regioisomeric Mixtures.......... ........59 
 2.3.8 Optimized Multistep Route to Regioisomerically  
Enriched Buchner Products............................................................................ .......60 
    
 2.3.9 Desymmetrization of meso-[2.2.2]-Bicycles.................................................. ........62 
2.4 Conclusions.................................................................................................................... ........64 
2.5  Experimental Details...................................................................................................... ........65 
2.6 References...................................................................................................................... ........97 
CHAPTER THREE THE DEVELOPMENT OF REGIOISOMERICALLY ENRICHED BUCHNER 
PRODUCTS FOR USE AS CYCLOHEXADIENYL SYNTHETIC 
INTERMEDIATES.................................................................................... ......100 
   
3.1 Introduction.................................................................................................................... ......100 
3.2 Background.................................................................................................................... ......101 
x 
 
 3.2.1 Poor Regioselectivity of Buchner Reactions Using Diazoacetates................ ......101 
 3.2.2 Controlling Regio- and Enantioselectivity of Intramolecular  
Buchner Reactions......................................................................................... ......102 
    
3.3 Results and Discussion................................................................................................... ......104 
 3.3.1 The Reactivity of Various Diazo Substitution Patterns  
towards the Buchner Reaction........................................................................ ......104 
    
 3.3.2 Iron Porphyrin Catalyzed Buchner Reaction.................................................. ......104 
 3.3.3 Thermolysis of Phenyl Diazoacetates............................................................ ......106 
 3.3.4 Functionalization of Norcaradienes through Cycloaddition Reactions.......... ......107 
 3.3.5 Non-Cycloaddition Transformations of Norcaradiene................................... ......108 
 3.3.6 Silver(I)-Catalyzed Buchner Reaction........................................................... ......109 
 3.3.7 Ligand Screening for the Silver(I) Buchner Reaction.................................... ......110 
 3.3.8 AgPF6 Catalyzed Regioselective Intermolecular Buchner Reaction.............. ......112 
 3.3.9 Efforts towards an Enantioselective Silver Buchner Reaction....................... ......114 
 3.3.10 Functionalization of Regioisomerically Enriched Norcaradienes.................. ......116 
 3.3.11 Benefits of an Intramolecular Buchner Reaction............................................ ......116 
 3.3.12 Initial Investigations into an Intramolecular Buchner Reaction..................... ......117 
 3.3.13 Development of an Expedient Route to Cyano Diazoacetates....................... ......119 
 3.3.14 Substrate Scope of Intramolecular Buchner Reaction 
of Cyano Diazoacetates................................................................................. ......119 
    
 3.3.15 Further Functionalization of Fused Norcaradienes........................................ ......121 
3.4 Conclusions.................................................................................................................... ......123 
3.5 Experimental Details...................................................................................................... ......124 
3.6 References...................................................................................................................... ......148 
  
xi 
 
LIST OF TABLES 
Table 1-1 Substrate Scope................................................................................................. .......7 
Table 1-2 Tosyl Reduction and Hydrolysis....................................................................... .....11 
Table 1-3 Lewis Acid Screen to Suppress Amide Byproduct........................................... .....14 
Table 2-1 Optimization of the Buchner Reaction.............................................................. .....49 
Table 2-2 Substrate Scope of the Rh2(TFA)4 Catalyzed Buchner Reaction..................... .....50 
Table 2-3 Ring Walk Promoter Screen.............................................................................. .....55 
Table 2-4 Isomerization of Regioisomeric Buchner Products by I2.................................. .....56 
Table 2-5 Rate Enhancement on the DielsAlder Reactions of 2.1 on Water.................. .....57 
Table 2-6 Optimized Kinetic Separation via Buchner/DielsAlder Reaction Sequence... .....61 
Table 3-1 Catalyst Screen for Intermolecular Buchner Reaction of p-Xylene.................. ...106 
Table 3-2 Ligand Screening in Ag(I)-Catalyzed Buchner Reaction of p-Xylene............. ...111 
Table 3-3 Substrate Scope of AgPF6-Catalyzed Buchner Reaction of p-Xylene.............. ...114 
Table 3-4 Substrate Scope of Intramolecular Buchner Reaction  
under Microwave Heating................................................................................. ...120 
  
  
  
  
xii 
 
LIST OF FIGURES 
Figure 2-1 Kinetic Separation of 2.12 Using Maleic Anhydride on Water........................ ....78 
  
xiii 
 
LIST OF SCHEMES 
Scheme 1-1 DonorAcceptor Cyclopropanes as 1,3-Dipole Synthons................................ ......2 
Scheme 1-2 Base-Promoted (3+2)-Annulations of DonorAcceptor Cyclopropanes.......... ......2 
Scheme 1-3 Lewis-Acid Promoted (3+2)-Annulation with Cyclohexene Alkylidenes........ ......3 
Scheme 1-4 (3+2)-Annulation Reactions using Enol- and Ynolsilanes................................ ......4 
Scheme 1-5 Resonance Structures of Ynamides................................................................... ......4 
Scheme 1-6 Selected Examples of Regioselective (n+2)-Annulation Reactions  
of Ynamides...................................................................................................... ......5 
   
Scheme 1-7 Proposed (3+2)-Annulation of DonorAcceptor Cyclopropanes  
and Ynamides.................................................................................................... ......6 
   
Scheme 1-8 DyKAT of DA Cyclopropanes and Aldehydes.............................................. ......9 
Scheme 1-9 Attempted DyKAT of DA Cyclopropanes and Ynamides............................. ....10 
Scheme 1-10 Chirality Transfer of Enantioenriched DA Cyclopropane.............................. ....10 
Scheme 1-11 Lewis Acid Promoted Ynamide Hydrolysis...................................................... ....12 
Scheme 1-12 Plausible Mechanism for Hydrolysis of Ynamides using Lewis  
Acidic Conditions.............................................................................................. ....12 
   
Scheme 1-13 “Interrupted” (3+2)-Annulation of Phthalimido DA Cyclopropane  
and Ynamide..................................................................................................... ....15 
   
Scheme 1-14 “Interrupted” (3+2)-Annulation of Indolyl DA Cyclopropane and Ynamide. ....15 
Scheme 1-15 “Interrupted” (3+2)-Annulation Using Acetate Trap........................................ ....16 
Scheme 2-1 Rapid Complexity-Building of Dearomatized 1,2-Disubstituted 
Cyclohexadienes............................................................................................... ....42 
   
Scheme 2-2 Selected Example of Oxidative Dearomatization of Phenols in Synthesis....... ....42 
Scheme 2-3 Other Selected Arene Dearomatization Reactions............................................ ....43 
Scheme 2-4 Seminal Investigations into Benzene Cyclopropanation................................... ....44 
Scheme 2-5 Influences of Substitution at C1-C6 on the NCD/CHT Equilibrium................ ....45 
Scheme 2-6 Frontier Molecular Orbital Analysis of C7 Substitution to  
NCD/CHT Equilibrium..................................................................................... ....46 
xiv 
 
Scheme 2-7 Inherent Challenges Using Norcaradienes as Synthetic Intermediates............. ....46 
Scheme 2-8 Selected Examples of Intramolecular Buchner Reactions................................. ....47 
Scheme 2-9 Proposed Functionalization of Buchner Products............................................. ....48 
Scheme 2-10 Steric Effects on the Regioselectivity of the Intramolecular Buchner Reaction. ....51 
Scheme 2-11 Electronic Effects on the Regioselectivity of the Intramolecular  
Buchner Reaction.............................................................................................. ....53 
   
Scheme 2-12 Isomerization of Regioisomeric Mixture upon Prolonged Storage................... ....54 
Scheme 2-13 Proposed Biradical Mechanism for Norcaradiene Ring Walk........................... ....54 
Scheme 2-14 Rationale for Regioisomeric Distribution in Ring Walk Isomerizations........... ....56 
Scheme 2-15 DielsAlder of 2.1 with PTAD......................................................................... ....58 
Scheme 2-16 Photosensitized Singlet Oxygen DielsAlder Reaction of 2.1.......................... ....59 
Scheme 2-17 Kinetic Separation of Chromatographically Inseparable Regioisomers............ ....60 
Scheme 2-18 DielsAlder Reaction of 1-Methoxy-CHT 2.16c.............................................. ....62 
Scheme 2-19 Anhydride Desymmetrization Using Cinchona Alkaloids................................ ....63 
Scheme 2-20 Cyclopropane Ring-Opening of Desymmetrized Mono-Acid 2.44a................. ....63 
Scheme 2-21 Desymmetrization of meso-bis-Carbamate 2.48............................................... ....64 
Scheme 3-1 Controlling the Intermolecular Buchner Reaction through Steric Effects......... ..101 
Scheme 3-2 Divergent Carbenoid Reactivity upon Variation of the Catalyst...................... ..102 
Scheme 3-3 Controlling the Intramolecular Buchner Reaction through  
Appropriately Sized Tethers.............................................................................. ..103 
   
Scheme 3-4 Enantioselective Intramolecular Buchner Reaction/[3,3]-Rearrangement........ ..103 
Scheme 3-5 The Shortcomings of Different Diazo Classes in Intermolecular  
Buchner Reactions............................................................................................ ..104 
   
Scheme 3-6 Fe(TPP)Cl-Catalyzed Intermolecular Buchner Reaction of p-Xylene.............. ..105 
Scheme 3-7 Thermolysis of Methyl Phenyl Diazoacetate in p-Xylene................................. ..107 
Scheme 3-8 Diels–Alder Reactions of Norcaradiene 3.14.................................................... ..107 
xv 
 
Scheme 3-9 Access to syn-1,4-Diol 3.19 from meso-Norcaradiene 3.14.............................. ..108 
Scheme 3-10 Dihydroxylation of meso-Norcaradiene 3.14.................................................... ..108 
Scheme 3-11 Allylic Bromination and Kornblum Oxidation of meso-Norcaradiene............. ..109 
Scheme 3-12 Dihydrobenzofuran Synthesis from meso-Norcaradiene................................... ..109 
Scheme 3-13 AgSbF6 Catalyzed Intermolecular Buchner Reaction of p-Xylene................... ..110 
Scheme 3-14 Norcaradiene Instability to Methyl Phenyldiazoacetate and AgPF6................. ..112 
Scheme 3-15 Plausible Radical Cation Mechanism for Rearomatization of 3.14................... ..113 
Scheme 3-16 AgSTRIP Catalyzed Enantioselective Buchner Reaction................................. ..115 
Scheme 3-17 Dual Catalytic Hydrogen Bond Donor/Silver(I) Catalytic System................... ..115 
Scheme 3-18 Selective Reduction and Diels–Alder of 3.38b.................................................. ..116 
Scheme 3-19 Benefits of Using an Intramolecular Buchner Reaction.................................... ..117 
Scheme 3-20 Intramolecular Buchner Attempts with Diazoacetates and Malonates............. ..117 
Scheme 3-21 Non-Isolable Silyl Esters................................................................................... ..118 
Scheme 3-22 Donor-Acceptor Diazo Compounds for Intramolecular Buchner Reactions..... ..118 
Scheme 3-23 Expedient Route to Benzyl Cyano Diazoacetates............................................. ..119 
Scheme 3-24 Erosion of Regioselectivity via Zwitterionic Intermediates.............................. ..121 
Scheme 3-25 Diels–Alder Cycloaddition of 3.55b and N-Benzylmaleimide.......................... ..122 
Scheme 3-26 Dynamic Kinetic Resolution of Fused Norcaradiene 3.55b.............................. ..122 
Scheme 3-27 DMDO Epoxidation of Fused Norcaradiene 3.55b........................................... ..123 
  
xvi 
 
LIST OF ABBREVIATIONS AND SYMBOLS 
°C degrees Centigrade 
(TsNH)2 bis-toluenesulfonylhydrazine 
[a]D specific rotation 
13C NMR carbon nuclear magnetic resonance 
1H NMR proton  nuclear magnetic resonance 
2,3-(CH2O2)Ph piperonyl 
2-OMePh 2-methoxyphenyl 
3,5-CF3-C6H3 3,5-bis-(1,1,1-trifluoromethyl)phenyl 
4-ClPh 4-chlorophenyl 
4-MePh 4-methylphenyl 
4-NMe2Ph 4-N,N-dimethylaminophenyl 
4-OMePh 4-methoxyphenyl 
Å Angstrom 
A1,3 strain allylic 1,3-strain 
Ac acetyl 
Ac2O acetic anhydride 
acc acceptor 
Ad adamantyl 
Ag silver 
AgPF6 silver(I) hexafluorophosphate 
AgSbF6 silver(I) hexafluoroantimonate 
AgSTRIP silver(I)((1r,5aS,10r)-1,10-bis(2,4,6-triisopropylphenyl)-4,5,6,7-
tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-12-olate 
12-oxide) 
AIBN azobisisobutyronitrile 
xvii 
 
Al aluminum 
Al(OiPr)3 aluminium isopropoxide 
AlCl3 aluminum trichloride 
Ar aryl 
B boron 
B(OMe)3 trimethyl borate 
BBr3 boron tribromide 
BF4
- tetrafluoroborate 
Bn benzyl 
Br bromine 
br s broad singlet 
Bu butyl 
Bu3SnH tributyltin hydride 
C carbon 
c concentration 
C10H8 naphthalene 
C5H11 n-pentyl 
C6H13 n-hexyl 
C6H6 benzene 
C8H17 n-octyl 
Ca calcium 
CaH2 calcium hydride 
calcd calculated 
CAM ceric ammonium molybdate 
CCl3 1,1,1-trichloromethyl 
xviii 
 
CCl4 carbon tetrachloride 
CD3OD methanol-D4 
CDCl3 chloroform-D 
Celite diatomaceous earth 
CF3 1,1,1-trifluoromethyl 
CH2(OMe)2 dimethoxymethane 
CH2Cl2 methylene chloride 
CHCl3 chloroform 
CHT cycloheptatriene 
Cl chlorine 
Cl3CCOCCl3 hexachloroacetone 
cm-1 wavenumbers 
CN nitrile 
Co cobalt 
CO2 carbon dioxide 
CO2Ad adamantyl ester 
CO2Bn benzyl ester 
CO2C8H17 n-octyl ester 
CO2Et ethyl ester 
CO2Me methyl ester 
CoCp2 cobaltocene 
CONHTs N-(toluenesulfonyl) amide 
Cp cyclopentadienyl 
Cu copper 
Cu(hfacac)2 cuprous hexafluoroacetoacetonate 
xix 
 
CuCl2 cuprous chloride 
CuSO4 cuprous sulfate 
CuSO4•5H2O cuprous sulfate pentahydrate 
δ chemical shift 
Δ heat 
d days 
d doublet 
D deuterium 
D–A donor-acceptor 
dba dibenzylidene acetone 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene 
DCE 1,2-dichloroethane 
dd doublet of doublets 
ddd doublet of doublet of doublets 
dddd doublet of doublet of doublet of doublets 
decomp decomposition 
DKR dynamic kinetic resolution 
dm decimeter 
DMAD dimethylacetylene dicarboxylate 
DMAP 4-dimethylaminopyridine 
DMDO dimethyldioxirane 
DMSO dimethylsulfoxide 
don donor 
dq doublet of quartets 
dr diastereomeric ratio 
xx 
 
dt doublet of triplets 
DyKAT dynamic kinetic asymmetric transformation 
EDA ethyl diazoacetate 
EDG electron donating group 
equiv equivalents 
er enantiomeric ratio 
ESI+ electrospray ionization 
Et ethyl 
Et2O diethyl ether 
Et3N triethylamine 
EtAlCl2 ethyl dichloroaluminate 
etc. et cetera 
EtOAc ethyl acetate 
EtOH ethanol 
EWG electron withdrawing group 
F fluorine 
Fe iron 
Fe(TPP)Cl 5,10,15,20-tetraphenyl-21H,23H-porphine iron(III) chloride 
FeCl2 ferrous chloride 
FeCl3 ferric chloride 
FeI2 ferrous iodide 
FeSO4•7H2O ferrous sulfate heptahydrate 
FT Fourier transform 
gem geminal 
h hours 
xxi 
 
H hydrogen 
H+ proton or generic acid source 
H2 dihydrogen 
H2O water 
H2SO4 sulfuric acid 
H3N(l) liquid ammonia 
HCl hydrochloric acid 
HF hydrogen fluoride 
Hf hafnium 
Hf(OTf)4 hafnium(IV) trifluoromethanesulfonate 
Hg mercury 
HOMO highest occupied molecular orbital 
HPLC high performance liquid chromatography 
HRMS high resolution mass spectrometry 
hν electromagnetic irradiation 
Hz Hertz 
I iodine 
I2 diiodide 
iPr isopropyl 
IR infrared 
J coupling constant 
K potassium 
K2CO3 potassium carbonate 
Ka dissociation constant 
kcal kilocalories 
xxii 
 
KMnO4 potassium permanganate 
KOH potassium hydroxide 
L ligand 
LA Lewis acid 
LiAlH4 lithium aluminum hydride 
LiBH4 lithium borohydride 
LiEt3BH lithium triethylborohydride (Super Hydride) 
LiSPh lithium thiophenolate 
LRMS low resolution mass spectrometry 
LUMO lowest unoccupied molecular orbital 
M molar 
m multiplet 
m meta 
M+H protonated molecular ion 
mAU milli-absorbance units 
Me methyl 
Me2AlCl dimethyl chloroaluminate 
Me3NO trimethylamine N-oxide 
MeCN acetonitrile 
MeMgBr methyl magnesium bromide 
MeMgI methyl magnesium iodide 
MeNH2 methylamine 
MeOH methanol 
Mg magnesium 
mg milligram 
xxiii 
 
MgI2 magnesium iodide 
μL microliter 
μm micrometers 
μwave microwave 
MgSO4 magnesium sulfate 
M–H deprotonated molecular ion 
MHz megahertz 
min minute 
mL milliliters 
mm millimeters 
mmol millimoles 
Mn manganese 
mol mole 
mp melting point 
N nitrogen 
N2 diazo 
N2 dinitrogen 
N3 azide 
Na sodium 
Na2CO3 sodium carbonate 
Na2S2O3 sodium thiosulfate 
Na2SO4 sodium sulfate 
NaCl sodium chloride 
NaHCO3 sodium bicarbonate 
NaIO4 sodium periodate 
xxiv 
 
NBS N-bromosuccinimide 
NCD norcaradiene 
NH4Cl ammonium chloride 
NMO morpholine N-oxide 
NMR nuclear magnetic resonance 
NO2 nitro 
nOe nuclear Overhauser effect 
nOesy nuclear Overhauser effect spectroscopy 
O oxygen 
o ortho 
O2 dioxygen 
o-C6H4 1,2-disubstituted benzene 
OPiv pivalate 
Os osmium 
OsO4 osmium(VIII) tetraoxide 
OTf trifluoromethane sulfonate 
Oxone® potassium peroxymonosulfate 
P phosphorus 
p para 
P. putida Pseudomonas putida 
Pb lead 
Pb(OAc)4 lead tetraacetate 
Pd palladium 
Pd2(dba)3•CHCl3 bis-palladium-tris-dibenzylideneacetone chloroform adduct 
pdt product 
xxv 
 
PF6
- hexafluorophosphate 
Ph phenyl 
PhMe toluene 
PIDA diacetoxy iodobenzene 
PIFA di(trifluoroacetoxy)iodobenzene 
pKa -ln(dissociation constant) 
PMP 4-methoxyphenyl 
p-NO2-C6H4 4-nitro-phenyl 
PPh3 triphenyl phosphine 
ppm parts per million 
PTAD 4-phenyl-1,2,4-triazoline-3,5-dione 
pybox pyridine bis-oxazolidine 
qt quintet 
quant. quantitative 
R radical 
Rf retention factor 
Rh rhodium 
Rh2(esp)2 bis[rhodium(a,a,a',a'-tetramethyl-1,3-benzenedipropionate)] 
Rh2(OAc)4 rhodium acetate 
Rh2(oct)4 rhodium octanoate 
Rh2(Opiv)4 rhodium pivalate 
Rh2(S-PTTL)4 rhodium N-phthaloyl-(S)-tert-leucinate 
Rh2(TFA)4 rhodium trifluoroacetate 
rr regioisomeric ratio 
rt room temperature 
xxvi 
 
RT retention time 
Ru(byp)3Cl2 tris(bipyridine)ruthenium(II) chloride 
rxn reaction 
s seconds 
S sulfur 
s singlet 
salen N,N′-Ethylenebis(salicylimine) 
Sb antimony 
SbCl6N(4-Br-C6H4)3 tris(4-bromophenyl)ammoniumyl hexachloroantimonate 
Sc scandium 
Sc(OTf)3 scandium(III) trifluoromethane sulfonate 
SFC supercritical fluid chromatography 
Si silicon 
Sn tin 
SnCl4 tin(IV) chloride 
SO3•pyridine sulfur trioxide pyridine complex 
t triplet 
TBDPS tert-butyl diphenylsilyl 
TBDPSCl tert-butyl diphenylsilyl chloride 
TBS tert-butyl dimethylsilyl 
tBu tert-butyl 
tBuOH tert-butanol 
tBuOK potassium tert-butoxide 
td triplet of doublets 
temp temperature 
xxvii 
 
TEMPO 2,2,6,6-tetramethylpiperidin-1-yl)oxidanyl 
TES triethylsilyl 
TfOH 1,1,1-trifluoromethanesulfonic acid 
THF tetrahydrofuran 
Ti titanium 
Ti(OiPr)4 titanium(IV) isopropoxide 
TiCl4 titanium(IV) chloride 
TIPS triisopropylsilyl 
TLC thin layer chromatography 
TMS trimethylsilyl 
TPP 5,10,15,20-tetraphenyl-21H,23H-porphyrin 
Ts toluene sulfonyl (tosyl) 
TsCl toluene sulfonylchloride 
TsNCO toluene sulfonyl isocyanate 
tt triplet of triplets 
UV ultraviolet 
W Watts 
w/w weight per weight 
Y yttrium 
Y(OiPr)3 yttrium(III) isopropoxide 
Yb ytterbium 
Yb(OTf)3 ytterbium(III) trifluoromethanesulfonate 
 
  
 1 
 
 
 
 
 
CHAPTER ONE: 
LEWIS ACID CATALYZED (3+2)-ANNULATIONS OF DONORACCEPTOR CYCLOPROPANES AND 
YNAMIDES *
 
 
1.1 Introduction 
 The rapid generation of substituted carbocyclic compounds continues to be a useful 
endeavor in organic synthesis. In this chapter, we report the use of donoracceptor cyclopropanes 
and ynamides to construct highly-substituted cyclopentene sulfonamides in high yields and 
excellent regioselectivity. Subsequently, these products were hydrolyzed to reveal 2,3-
disubstituted cyclopentenones as single diastereomers. This class of compounds is structurally 
related to prostaglandins, which possess numerous roles in biological systems. 
1.2 Background 
1.2.1 Introduction and History of DonorAcceptor Cyclopropanes 
Donoracceptor (DA) cyclopropanes continue to receive significant attention as useful 
synthetic building blocks, particularly for their ability to act as synthetic equivalents to 1,3-dipolar 
synthons in cycloaddition reactions (Scheme 1-1a).1 The deployment of these carbogenic building 
blocks has been widespread in the efficient assembly of heterocycles by (3+n)-annulation (Scheme 
1-1b, a or b ≠ carbon),2 but fewer cases have been described for carbocycle assembly (a, b = 
carbon).3-5 
  
                                                     
*Reprinted in part with permission from Mackay, W. D.; Fistikci, M.; Carris, R. M.; Johnson, J. S. 
Org. Lett. 2014, 16, 16261629. 
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Scheme 1-1. DonorAcceptor Cyclopropanes as 1,3-Dipole Synthons 
 
Notable examples of the latter include the annulation between Pd -allyl activated vinyl 
DA cyclopropanes 1.2 and electron-deficient alkenes 1.3 (Scheme 1-2a).3a,c,d Marino and Laborde 
have achieved silyloxycyclopropane ester activation of 1.5 via fluoride-induced silyl ether 
cleavage, which enabled annulation with activated alkenes to provide cyclopentenes 1.7 (Scheme 
1-2b).3b  
Scheme 1-2. Base-Promoted (3+2)-Annulations of DonorAcceptor Cyclopropanes 
 
A common embodiment of annulations involving DA cyclopropanes is the use of a 1,1-
cyclopropane diester 1.1 in conjunction with a Lewis acid activator to create an activated intimate 
ion pair (Scheme 1-1c). In the realm of Lewis acid activation of the acceptor group, Snider has 
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shown EtAlCl2 to effectively catalyze the annulation between DA cyclopropanes 1.8 and 
methylenecyclohexane derivatives 1.9,4b providing spiro-bicyclic products 1.10 with the 
regioselectivity controlled by the preferential formation of a tertiary carbocation; however, a 
mixture of isomers was observed upon annulation with internal alkenes (Scheme 1-3).  
Scheme 1-3. Lewis-Acid Promoted (3+2)-Annulation with Cyclohexene Alkylidenes 
 
Several groups have reported annulations between DA cyclopropanes 1.11 and 
enolsilanes 1.12 providing cyclopentanes 1.13; the products commonly undergo subsequent ring-
opening under the reactions conditions to provide linear products 1.14 (Scheme 1-4a).4k,n Tang 
suppressed the ring-opening pathway in the annulation between DA cyclopropanes and 
enolsilanes through the use of bulky silyl groups (TBDPS) on the enol silane 1.16 and ester groups 
(adamantyl) on the DA cyclopropane 1.15 (Scheme 1-4b).4s The use of allenyl silanes eliminates 
the potential for subsequent ring opening; however, these trials are complicated by 1,2-silyl 
migrations, providing a mixture of cyclopentane alkylidene and cyclohexene annulation 
products.4f Ready and Qi have shown ynolsilanes 1.19 to be effective annulation partners for DA 
cyclopropanes under Lewis acidic conditions, providing access to highly substituted 
cyclopentenones 1.20; however, this union was hindered by numerous challenges, including the 
instability of ynolsilanes, the requisite of cryogenic temperatures, and the use of a harsh Lewis 
acid. (Scheme 1-4c).4j  
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Scheme 1-4. (3+2)-Annulation Reactions using Enol- and Ynolsilanes  
 
1.2.2 Utility of Ynamides in Cycloaddition Reactions 
To circumvent the challenges that plague ynolsilanes, ynamides were seen as a viable 
alternative, since they are easily prepared,6 stable upon storage, and can react with a variety of 
annulation partners at ambient conditions. Ynamides have been shown to be excellent partners for 
(n+2)-annulations7 due to the high regioselectivity with which they react. This selectivity is 
typically attributed to the major zwitterionic resonance structure (Scheme 1-5). 
Scheme 1-5. Resonance Structures of Ynamides 
 
Notable examples of such regiospecific reactivity include the stepwise (2+2)-annulation of 
ynamide 1.21 and ketene 1.22 to provide cyclobutenone 1.23 (Scheme 1-6a).8 More represented 
in this class of ring-forming reactions with ynamides are the formation of five-membered 
heterocycles, such as the alkyne-azide cycloaddition to provide triazoles 1.26 (Scheme 1-6b).9 
Nitrile oxides have also been used to produce oxazoles 1.30 using terminal ynamide 1.28 (Scheme 
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1-6c).10 In all such examples outlined herein, only a single regioisomer was formed, with no 
evidence for the production of the other possible regioisomers (1.24, 1.27, 1.31), suggesting that 
the strong polarization of the alkyne, as shown in Scheme 1-5, greatly influences the reactivity of 
ynamides.  
Scheme 1-6. Selected Examples of Regioselective (n+2)-Annulation Reactions of Ynamides 
 
1.3 Results and Discussion 
1.3.1 Initial Reaction Design and Optimization 
Despite the advantageous reactivity of both DA cyclopropanes and ynamides, at the onset 
of this project, their union remained unachieved; therefore, the site-selective capture of the intimate 
ion pair from Lewis acid activation of the DA cyclopropane by ynamide “dipolarophiles” is the 
subject of this chapter (Scheme 1-7). The preparation of useful functionalized 
cyclopentenesulfonamides by these (3+2)-annulations is demonstrated. Deprotection of the 
ensulfonamide reveals 2,3-substituted cyclopentanones with high levels of diastereoselectivity. 
This strategy provides access to an important structural motif resembling products of 
diastereoselective 1,4-addition to 2-substituted cyclopentenones. 
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Scheme 1-7. Proposed (3+2)-Annulation of DonorAcceptor Cyclopropanes and Ynamides 
 
Working first with cyclopropane 1.33 and ynamide 1.45, a brief Lewis acid screen revealed 
Sc(OTf)3 to be a superior promotor for the reaction, providing complete starting material 
conversion with catalyst loadings as low as 10 mol %. The efficacy of this particular Lewis acid 
is congruent with our previously demonstrated (3+2)-annulation of DA cyclopropanes with 
aldehydes.11 Attempts to lower the catalyst loading further were met with incomplete consumption 
of 1.33 after 20 h. Two equivalents of the ynamide were required in the annulation to maximize 
product yields as ynamide hydrolysis was found to be a competitive decomposition pathway; 
investigations into this hydrolysis will be discussed later in this chapter (Section 1.3.5). 
1.3.2 Substrate Scope of the Reaction 
With the optimized conditions in hand, we began to examine the scope of the annulation 
(Table 1-1).  The reaction proceeded smoothly for a number of substrates, particularly for 
cyclopropanes bearing electron-rich aromatic groups (1.32,1.33,1.35).  This observation is in 
agreement with our previous findings that greater stabilization of the carbenium ion in the 
zwitterionic intermediate provides faster reaction rates.11 However, there is an apparent limit to 
the electron releasing ability of the donor group towards promotion of the annulation.  N,N-
dimethylaniline substituted cyclopropane 1.41 (entry 14), the most electron rich of the substrates 
tested, failed to react after 100 h, presumably due to a marked decrease in electrophilicity at the 
donor site.  This trend may also explain the yield discrepancy between the para- and ortho-
methoxyphenyl substituted cyclopropanes (entries 3 and 7).  
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Table 1-1. Substrate Scopea,b 
 
entry R1 R2 R3 pdt yield (%)
c 
1 4-MePh H (1.32) C5H11 1.47 >99 
2 4-MePh H (1.32) Ph 1.48 >99 
3 4-OMePh H (1.33) C5H11 1.49 89(86)
d 
4 4-OMePh H (1.33) Ph 1.50 >99 
5 4-OMePh Me (1.34) C5H11 1.51 64 
6 4-OMePh Me (1.34) Ph 1.52 53 
7 2-OMePh H (1.35) C5H11 1.53 >99 
8 2,3-(CH2O2)Ph H (1.36) C5H11 1.54 64 
9 2-furyl H (1.37) C5H11 1.55 46 
10 2-thienyl H (1.38) C5H11 1.56 84 
11 2-thienyl H (1.38) Ph 1.57 93 
12 (E)-CH=CHPh H (1.39) C5H11 1.58 69 
13 4-ClPh H (1.40) C5H11 1.59 NR
e 
14 4-NMe2Ph H (1.41) C5H11 1.60 NR
e 
15 Ph Me (1.42) C5H11 1.61 59(90)
f 
16 Ph C≡CH (1.43) C5H11 1.62 63 
17 Ph H (1.44) C5H11 1.63 82 
aReactions performed with 1.0 equiv of DA cyclopropane and 2.0 equiv of ynamide in dry 
CH2Cl2 (0.1 M) with 0.10 equiv Sc(OTf)3. 
bReactions were run for 18 h. cIsolated yield. dRun on 
20 mmol scale of 1.33. eNo reaction observed after 100 h. fRun with 3.0 equiv 1.45 and 0.15 equiv 
Sc(OTf)3. 
 
Decreased yields were also observed for the 2-furyl substituted cyclopropane 1.37 (entry 
9).  This iteration suffered from significant amounts of unidentified side reactions and starting 
material decomposition.  A plausible degradation pathway for 1.37 might be the competing 
Piancatelli rearrangement, which has been previously observed for furyl-substituted DA 
cyclopropanes.12 Cyclopropanes bearing a vinyl donor group proceeded in low yields (<30%) upon 
annulation with 1.45 under Lewis acidic conditions. These annulation products were unable to be 
isolated cleanly, since no conditions that were tested prevented coelution of the amide resulting 
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from the hydrolysis of 1.45 from the desired product. Alkyl-substituted cyclopropanes (R1 = Bu, 
R2 = H) failed to react with 1.45 under standard reaction conditions, even upon refluxing in DCE 
for 24 h.  
2,2-Disubstituted cyclopropanes (entries 5,6,15,16) all suffered from diminished yields 
under the standard reaction conditions, presumably due to a slower rate of annulation. Since in situ 
ynamide hydrolysis is competitive with the annulation, at extended reaction times the availability 
of the ynamide is compromised. In these cases, the addition of 3 equiv of ynamide (entry 15) 
resulted in dramatically increased yields of 1.61. The alkynyl moiety, which has been shown to be 
an effective donor for (3+2)-annulations between DA cyclopropanes and aldehydes,13 (entry 16) 
also functions as an effective donor in the annulation with ynamides, providing 1.63 in 63% yield.  
1.3.3 Generation of Enantioenriched Cyclopentenesulfonamides 
Having developed robust conditions for the generation of racemic 
cyclopentenesulfonamides, we then began to examine the feasibility of performing a dynamic 
kinetic asymmetric transformation (DyKAT)14 of racemic DA cyclopropanes and ynamides 
based on our previous work in the cases of tetrahydrofurans2h and pyrrolidines,2i in order to access 
enantioenriched products (Scheme 1-8).  
Upon coordination of the Lewis acid, the diastereomeric intimate ion pairs 1.64/1.65 
readily racemize, allowing for all of the racemic starting cyclopropane 1.33 to funnel towards a 
single tetrahydrofuran product. Applying these conditions to our system should allow for 
analogous enantiomerization of starting cyclopropane, concomitant with ring closure. 
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Scheme 1-8. DyKAT of DA Cyclopropanes and Aldehydes  
 
In the event, however, we found this tactic to be ineffective, as the reactivity of 1.33 and 
1.45 were significantly hindered by the application of the MgI2(pybox) catalyst system (Scheme 
1-9). Varying the electronic profile of the pybox ligand by introducing halogens at the 4-position 
(X = Cl, Br) had no effect on the annulation. In addition, variation of the reaction solvent or 
temperature showed no promise for increasing starting material conversion. For example, 
treatment of 1.33 with 1.45 in refluxing CCl4 for 2 d resulted in only trace degradation (<5%) of 
1.33. Notably, no degradation of the ynamide was observed. This lack of reactivity was attributed 
to unfavorable steric interactions between the chiral ligand (R = tBu) and the approaching ynamide. 
In an attempt to minimize this strain, less sterically demanding pybox ligands (R = iPr, Bn) were 
evaluated, neither of which was successful in promoting the annulation.  
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Scheme 1-9. Attempted DyKAT of DA Cyclopropanes and Ynamides 
 
Despite the complications with accessing enantioenriched products through a DyKAT 
mechanism, our group has shown previously2d,11 that enantioenriched DA cyclopropanes transfer 
chirality to their annulation products with high fidelity, undergoing complete inversion at the donor 
site stereogenic center. As shown in Scheme 1-10, this mechanistic feature was also observed in 
the case of annulation with ynamides. Stereospecific back-side capture of the intimate ion pair (eq 
3) would account for this finding.11 
Scheme 1-10. Chirality Transfer of Enantioenriched DA Cyclopropane 
 
1.3.4 Deprotection and Hydrolysis of the Cyclopentenesulfonamide Intermediates 
In an effort to provide synthetically attractive cyclopentanones from the enamide products 
1.47-1.63, the sulfonyl group was first cleaved via single electron reduction using sodium 
naphthalenide.  The resultant enamine was then hydrolyzed under acidic conditions to provide 
cyclopentanones 1.66-1.69 as single diastereomers (Table 2).   
  
11 
 
Table 1-2. Tosyl Reduction and Hydrolysisa,b 
 
The gem-diester moiety was also removed during the hydrolysis. nOesy analysis of the 
cyclopentanone products 1.66, 1.68 confirmed an anti relationship between R1 and R3 substituents. 
These 3,3-disubstituted cyclopentanones 1.68 are of particular note, as they represent an expedient 
synthesis of formal conjugate addition products of 2,3-disubsituted cyclopentenones, whose 
enantioselective synthesis via conjugate addition to enones is non-trivial.15 
Unsubstituted ynamides (R3 = H) were not tested in the annulation with DA 
cyclopropanes, since the resultant cyclopentanones that would be accessed from these substrates 
are analogous to the products of 1,4-addition to cyclopentenone or the 1,4-reduction of -
substituted cyclopentenones. There are already several excellent reports of enantioselective 
variants of these reactions.16,17 
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1.3.5 Unexpected Byproduct from Ynamide Hydrolysis 
Scheme 1-11. Lewis Acid Promoted Ynamide Hydrolysis 
 
Investigation of this reaction was a result of the first attempt at isolating 1.49, whereupon 
the amide side product 1.70 was definitively identified. Since it had been reported that ynamides 
are readily hydrolyzed in the presence of water,7 the CH2Cl2 was distilled from CaH2 and stored 
over 3 Å molecular sieves under inert atmosphere prior to use, in an attempt to minimize the 
hydrolysis from trace water in the solvent. In the subsequent trials with the freshly distilled solvent, 
ynamide hydrolysis was still observed in appreciable quantities. The inclusion of 3 Å molecular 
sieves in the reaction vessel was also ineffective at suppressing the hydrolysis. It was then proposed 
that the Lewis acid was responsible for the observed hydrolysis (Scheme 1-12). The ynamide 
would first coordinate to the Lewis acid, displacing triflate, which subsequently adds back to the 
ketene iminium intermediate 1.72, forming a hemiaminal 1.73. Replacement of the Lewis acid 
with a proton, potentially from the solvent or during work up, and decomposition of the triflate 
provides the observed amide 1.70. 
Scheme 1-12. Plausible Mechanism for Hydrolysis of Ynamides using Lewis Acidic Conditions 
 
In order to elucidate the degradation mechanism, Lewis acids with chloride counterions 
were screened, in hopes of isolating the chloro enamide products 1.75. Utilizing AlCl3, TiCl4, and 
SnCl4 to promote the annulation resulted in isolation of the chloro enamide 1.75 (Table 1-3, entries 
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6-12), confirming our suspicions. A variety of conditions and catalysts were then screened in an 
attempt to suppress the decomposition pathway, albeit with limited success (Table 1-3). All Lewis 
acids with triflate counterions caused significant accumulation of the amide byproduct 1.71 
(entries 1-5). Altering the reaction temperature offered no benefit towards formation of 1.48. The 
degradation of the ynamide out-competes the annulation at low temperatures (entry 2). Using 
toluene as the solvent also resulted in appreciable quantities of the amide 1.71 (entry 3). At lower 
catalyst loadings (entries 8-12), the annulation attenuates appreciably, leaving a majority of 1.32 
unreacted and large amounts of 1.75 relative to 1.48.  
An alternative method for the synthesis of ynamides 1.46 involves the isomerization of N-
propargylamides with alkoxide bases (i.e., tBuOK).6c As expected, those Lewis acids with alkoxide 
ligands (entries 13-16) did not cause ynamide degradation; unfortunately, however, they were also 
ineffective at promoting the annulation. Since none of the conditions screened provided complete 
suppression of the degradation pathway, we decided to carry forward with two equivalents of the 
ynamide in the annulation to maximize product yields. This was deemed an acceptable 
compromise, since the ynamide synthesis is trivial—providing good yields and easily purified—
starting from inexpensive materials (see Section 1.5 for the experimental details). 
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Table 1-3. Lewis Acid Screen to Suppress Amide Byproduct 
 
entry Lewis acid (mol %) solvent temp (°C) 1.48 : 1.71 or 1.75a 
1 Sc(OTf)3 (10) CH2Cl2 23 1 : 0.65
b 
2 Sc(OTf)3 (10) CH2Cl2 0 1 : 1.03
b 
3 Sc(OTf)3 (10) PhMe 23 1 : 4.04
b 
4 Sc(OTf)3 (10) CH2Cl2 23 1 : 0.32
b,c 
5 Yb(OTf)3 (20) CH2Cl2 23 0% 1.48, 24% 1.71
b 
6 TiCl4 (20) CH2Cl2 23 1 : 1.70
d 
7 SnCl4 (20) CH2Cl2 23 1 : 0.29
d 
8 AlCl3 (50) CH2Cl2 23 1 : 0.69
d 
9 AlCl3 (20) CH2Cl2 23 1 : 0.83
d 
10 AlCl3 (10) CH2Cl2 23 1 : 1.86
d 
11 AlCl3 (5) CH2Cl2 23 1 : 3.95
d 
12 AlCl3 (2) CH2Cl2 23 1 : 4.60
d 
13 Hf(OtBu)4 (10) CH2Cl2 23 no rxn, minor decomp
b 
14 Al(OiPr)3 (10) CH2Cl2 23 no rxn, no decomp
b 
15 Ti(OiPr)4 (10) CH2Cl2 23 no rxn, minor decomp
b 
16 Y(OiPr)3 (10) CH2Cl2 23 no rxn, minor decomp
b 
 aDetermined from crude 1H NMR. bByproduct refers to 1.71. cRun with 1.8 mmol of 1.32 (435 
mg) and 1.45 (500 mg). dByproduct refers to 1.75. 
 
1.3.6 Investigation of the “Interrupted” (3+2)-Annulation 
While screening the phthalimido-substituted DA cyclopropane 1.76, a new side product 
arose, which was identified as the “interrupted” (3+2)-annulation product 1.79, as confirmed by 
X-ray crystallography (Scheme 1-13).  
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Scheme 1-13. “Interrupted” (3+2)-Annulation of Phthalimido DA Cyclopropane and Ynamide 
 
Instead of trapping of the ketene iminium intermediate 1.77 with the malonate to yield the 
“normal” cyclopentenesulfonamide, the “interrupted” pathway proceeds via trapping with the 
phthalamide oxygen to provide the oxazine intermediate 1.78. Quenching of the resulting 
zwitterionic intermediate yields the bridged byproduct 1.79. An analogous reaction pathway was 
observed in the case of indolyl-substituted DA cyclopropane. Initial indole trapping of 
intermediate 1.80 would provide the spirocyclic intermediate 1.81. Ring expansion of 1.81 and 
subsequent restoration of aromaticity would provide the tricyclic 1.82.  
Scheme 1-14. “Interrupted” (3+2)-Annulation of Indolyl DA Cyclopropane and Ynamide 
 
Further attempts at exploiting this alternative reactive pathway proved unfruitful. Acetate-
substituted cyclopropane 1.83, provided high yields of the “normal” (3+2)-annulation product 
1.84, with only trace amounts of the “interrupted” product 1.85 (Scheme 1-15). With the limited 
scope available to this niche observation, further investigations into this transformation were not 
pursued.  
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Scheme 1-15. “Interrupted” (3+2)-Annulation Using Acetate Trap 
 
1.4 Conclusions 
In conclusion, we have shown ynamides to be suitable partners in (3+2)-annulation 
reactions with DA cyclopropanes, providing cyclopentenesulfonamide products. Though the 
steric congestion of the system prevents a DyKAT to access enantioenriched products under the 
conditions screened, the reaction was stereospecific and relayed the stereochemistry of the starting 
cyclopropane to the product with high fidelity. Subsequent deprotection and hydrolysis provided 
2,3-substituted cyclopentanone products with high stereoselectivity. This route represents a 
practical alternative to enantioselective conjugate addition reactions to cyclopentenones, 
especially for the generation of -stereogenic--quaternary cyclopentanones.  
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1.5 Experimental Details 
Methods 
Proton and carbon magnetic resonance spectra (1H NMR and 13C NMR) were recorded on 
either a Bruker model DRX 400 or 600 Spectrometer (1H NMR at 400 or 600 MHz and 13C NMR 
at 100 or 150 MHz) with solvent resonance as the internal standard (1H NMR: CDCl3 at 7.28 ppm 
and 13C NMR: CDCl3 at 77.0 ppm). 
1H NMR data are reported as follows: chemical shift, 
multiplicity (abbreviations: s = singlet, br s = broad singlet, d = doublet, dd = doublet of doublets, 
dt = doublet of triplets, t = triplet, td = triplet of doublets, tt = triplet of triplets, qt = quintet, and m 
= multiplet), coupling constant (Hz) and integration. Melting points (mp) were determined using 
a Thomas Hoover Capillary Melting Point Apparatus and are uncorrected. Infrared (IR) spectra 
were obtained using a Jasco 260 Plus Fourier Transform Infrared Spectrometer. Low resolution 
mass spectra (LRMS) were obtained using a Micromass Quattro-II triple quadrupole mass 
spectrometer in combination with an Advion NanoMate chip-based positive ion electrospray 
sample introduction system and nozzle. High resolution mass spectrometry (HRMS) was 
performed using a Thermo Scientific LTQ FT Ultra mass spectrometer S2 with direct infusion in 
the positive ion mode. Samples were prepared in methanol, plus a few drops of acetone if needed 
to dissolve the compound, and trace aqueous formic acid solution. All reported masses correspond 
to the protonated molecular ion (M+H) unless otherwise noted. Supercritical fluid chromatography 
was performed on a Berger SFC system equipped with Chiracel AD, AS, OD, and WO columns 
(φ 4.6 mm x 250 mm). Samples were eluted with SFC grade CO2 with 10% methanol with an oven 
temperature of 40 °C. All reactions were carried out under an atmosphere of nitrogen in oven-dried 
glassware with magnetic stirring unless stated otherwise. Thin layer chromatography (TLC) was 
performed on Sorbtech plastic-backed 0.20 mm silica gel 60 plates. Visualization was 
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accomplished with UV light and an aqueous ceric ammonium molybdate (CAM) solution, 
followed by heating. Flash chromatography was performed under positive air pressure using 
Siliaflash-P60 silica gel (40-63 μm) purchased from Silicycle. Unless otherwise specified, all crude 
materials were introduced to the chromatography column after dissolution in the specified eluent 
(plus a few drops dichloromethane, if required). Purification via high performance liquid 
chromatography (HPLC) was performed on a Varian Prepstar SD-1 Solvent Delivery System 
equipped with a Cyano 60 Å 6u column from Berger Instruments, using 15% ethyl acetate /hexanes 
eluent system at a flow rate of 15.00 mL/min. Yields and diastereomeric ratios (dr’s) are reported 
herein for a specific experiment and as a result may differ slightly from those found in the tables, 
which are averages of at least two experiments. 
Materials 
Nitrogen was dried by passage through anhydrous calcium sulfate with 3% cobalt chloride 
as indicator (commercial Drierite). Dichloromethane (CH2Cl2) and tetrahydrofuran (THF) were 
passed through a column of neutral alumina under nitrogen prior to use. All cyclopropanes 1.32-
1.44, 1.76, 1.80 used in this study are known compounds and were prepared according to literature 
procedures.18 The enantiomers of cyclopropane 1.44 had been resolved previously in our 
laboratory.11 Ynamide 1.45 was stored in the freezer as a solution in benzene to retain its integrity. 
The benzene was removed by rotary evaporation prior to addition into the reaction vessel. All other 
reagents and solvents were purchased from commercial sources and used as received. 
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General Procedure A for the Preparation of Ynamides (1.45, 1.46) 
 
Based on the literature procedure,6b CH2Cl2 (40 mL) was added to TsCl (1.0 equiv) in a 
125 mL round-bottomed flask and the solution was cooled to 0 °C. MeNH2 (40% in H2O, 2.2 
equiv) was added slowly, and the reaction was stirred for 1 h. The mixture was then warmed to 
room temperature and washed with brine (40 mL), water (40 mL), and brine (40 mL), and then 
dried over Na2SO4. The solvent was removed by rotary evaporation, yielding a white solid, which 
was recrystallized in 95% EtOH/H2O if impure by 
1H NMR. The product was then transferred to 
a 300 mL 3-necked flask and combined with CuCl2 (0.067 equiv) and Na2CO3 (0.67 equiv) and 
the flask was purged with O2 for 15 min. A solution of pyridine (0.67 equiv) in toluene (75 mL) 
was added to the flask via syringe and the flask was heated to 70 °C. The alkyne (0.33 equiv as a 
solution in 18 mL of toluene) was then added to the flask via syringe pump at a rate of 3.5 – 4.0 
mL/h. After complete addition of the alkyne, the reaction mixture stirred for 20 h at 70 °C. After 
cooling to room temperature, the crude mixture was filtered through a pad of Celite, concentrated 
by rotary evaporation, and purified by flash chromatography (20% EtOAc/hexanes) to provide the 
desired product, which was stored in the freezer either neat or frozen as a solution in benzene.  
N-(hept-1-yn-1-yl)-N,4-dimethylbenzenesulfonamide (1.45): The 
title compound was prepared according to General Procedure A using 
N,4-dimethylbenzenesulfonamide (2.89 g, 15.6 mmol) and 1-heptyne 
(0.68 mL, 5.2 mmol). Flash chromatography provided a yellow oil (1.23 g, 85%) that was stored 
in the freezer, frozen as a solution in benzene. Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.80 
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(d, J = 8.0 Hz, 2H), 7.37 (d, J = 8.0 Hz, 2H), 3.03 (s, 3H), 2.47 (s, 3H), 2.25 (t, J = 7.0 Hz, 2H), 
1.49 (tt, J = 7.0, 4.6 Hz, 2H), 1.33 (m, 4H), 0.91 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) 
δ 144.4, 133.2, 129.6, 127.8, 74.8, 68.7, 39.4, 30.9, 28.6, 22.2, 21.6, 18.3, 14.0; IR (thin film, cm-
1) 3033, 2953, 2932, 2860, 2253, 1597, 1364, 1173, 814, 677; TLC (20% EtOAc/hexanes) Rf = 
0.48; LRMS (ESI+) Calcd. for C15H22NO2S: 280.14, Found: 280.07. 
N,4-dimethyl-N-(phenylethynyl)benzenesulfonamide (1.46): The title 
compound was prepared according to General Procedure A using N,4-
dimethylbenzenesulfonamide (2.79 g, 15.1 mmol) and phenylacetylene 
(0.55 mL, 5.1 mmol). Flash chromatography provided a yellow solid (1.12 g, 78%) that was stored 
neat in the freezer. Analytical data: 1H NMR (600 MHz, CDCl3) δ 7.87 (m, 2H), 7.40 (m, 4H), 
7.31 (m, 3H), 3.17 (s, 3H), 2.47 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 144.8, 133.1, 131.3, 129.8, 
128.2, 127.8, 122.6, 83.9, 68.9, 39.3, 21.6 (one peak missing due to peak overlap); mp 79-81 °C; 
IR (thin film, cm-1) 3056, 2983, 2934, 2299, 2234, 1598, 1382, 1168, 964, 815; TLC (20% 
EtOAc/hexanes) Rf = 0.35; LRMS (ESI
+) Calcd. for C16H16NO2S: 286.09, Found: 286.07. 
General Procedure B for the Preparation of (3+2)-Annulation Products (1.47-1.63, 1.84), and 
the “Interrupted” (3+2)-Products (1.79, 1.82, 1.85) 
 
To an oven-dried 1 dram vial in a nitrogen-filled glovebox was added Sc(OTf)3 (9 mg, 
0.018 mmol, 0.1 equiv) and a magnetic stir bar. The vial was then fitted with a septum screw cap 
and removed from the glovebox, where the cyclopropane (0.18 mmol) and ynamide (0.36 mmol) 
were combined and added to the vial via syringe as a solution in anhydrous CH2Cl2 (1.5 mL). The 
reaction was allowed to stir for 18 h, after which the crude mixture was concentrated by rotary 
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evaporation and purified by flash chromatography to provide the desired product. In the cases 
where multiple impurities coeluted with the desired product, analytically pure samples were 
obtained using preparatory HPLC after initial subjection of the crude material to flash 
chromatography.  
Dimethyl 2-((N,4-dimethylphenyl)sulfonamido)-3-pentyl-4-(p-
methylphenyl)cyclopent-2-ene-1,1-dicarboxylate (1.47): The title 
compound was prepared according to General Procedure B using 
dimethyl 2-(p-methylphenyl)cyclopropane-1,1-dicarboxylate 1.32 (44 
mg, 0.18 mmol) and N-(hept-1-yn-1-yl)-N,4-dimethylbenzenesulfonamide 1.45 (100 mg, 0.36 
mmol). Flash chromatography (20% EtOAc/hexanes) provided a white crystalline solid (98 mg, 
quant.). Analytical data: 1H NMR (600 MHz, CDCl3) δ 7.76 (br s, 2H), 7.27 (s, 2H), 7.15 (s, 2H), 
7.09 (br s, 2H), 3.82 (br s, 3H), 3.77 (s, 3H), 3.62 (br s, 1H), 3.22 (s, 3H), 2.93 (br s, 1H), 2.58 (br 
s, 1H), 2.39 (s, 3H), 2.36 (s, 3H), 1.25-0.93 (m, 8H), 0.75 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, 
CDCl3) δ 172.5, 169.1, 152.6, 143.2, 139.4, 137.1, 136.4, 133.3, 129.4, 129.3, 127.9, 127.4, 66.2, 
53.4, 52.7, 47.1, 41.4, 37.7, 31.2, 26.9, 25.6, 22.0, 21.4, 21.0, 13.7; mp 117-119 °C; IR (thin film, 
cm-1) 2953, 2928, 2861, 1733, 1455, 1348, 1272, 1156; TLC (20% EtOAc/hexanes) Rf = 0.22; 
LRMS (ESI+) Calcd. for C29H38NO6S: 528.24, Found: 528.26. 
Dimethyl 2-((N,4-dimethylphenyl)sulfonamido)-3-phenyl-4-(p-
methylphenyl)cyclopent-2-ene-1,1-dicarboxylate (1.48): The title 
compound was prepared according to General Procedure B using dimethyl 
2-(p-methylphenyl) cyclopropane-1,1-dicarboxylate 1.32 (44 mg, 0.18 
mmol) and N,4-dimethyl-N-(phenylethynyl)benzenesulfonamide 1.46 (100 mg, 0.35 mmol). Flash 
chromatography (5% Et2O/CH2Cl2) provided a colorless oil (96 mg, quant.). Analytical data: 1H 
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NMR (400 MHz, CDCl3) δ 7.28 (m, 2H), 7.05 (m, 5H), 6.95 (m, 6H), 4.32 (dd, J = 8.8, 6.6 Hz, 
1H), 3.88 (s, 3H), 3.78 (s, 3H), 3.31 (dd, J = 13.6, 8.8 Hz, 1H), 3.20 (s, 3H), 2.55 (dd, J = 13.6, 
6.6 Hz, 1H), 2.33 (s, 3H), 2.25 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 171.3, 170.6, 150.4, 142.3, 
139.2, 136.9, 136.1, 134.5, 133.9, 129.1, 128.9, 128.1, 128.0, 127.8, 127.6, 127.1, 66.6, 53.1, 52.8, 
49.8, 41.2, 38.0, 21.3, 21.0; IR (thin film, cm-1) 3053, 3024, 2952, 2923, 1732, 1599, 1434, 1343, 
1252; TLC (5% Et2O/CH2Cl2) Rf = 0.67; LRMS (ESI
+) Calcd. for C30H32NO6S: 534.20, Found: 
534.26. 
Dimethyl 2-((N,4-dimethylphenyl)sulfonamido)-3-pentyl-4-(p-
methoxyphenyl)cyclopent-2-ene-1,1-dicarboxylate (1.49): The title 
compound was prepared according to General Procedure B using 
dimethyl 2-(p-methoxyphenyl)cyclopropane-1,1-dicarboxylate 1.33 (47 
mg, 0.18 mmol) and N-(hept-1-yn-1-yl)-N,4-dimethylbenzenesulfonamide 1.45 (100 mg, 0.36 
mmol). Flash chromatography (20% EtOAc/hexanes) provided a white crystalline solid (87 mg, 
89%). Analytical data: 1H NMR (600 MHz, CDCl3) δ 7.74 (br s, 2H), 7.25 (d, J = 7.4 Hz, 2H), 
7.08 (br s, 2H), 6.86 (d, J = 7.4 Hz, 2H), 3.80 (s, 6H), 3.75 (s, 3H), 3.60 (br s, 1H), 3.19 (s, 3H), 
2.88 (br s, 1H), 2.55 (br s, 1H), 2.37 (s, 3H), 1.25-0.91 (m, 8H), 0.73 (t, J = 7.2 Hz, 3H); 13C NMR 
(150 MHz, CDCl3) δ 172.4, 169.0, 158.4, 152.6, 143.2, 137.0, 134.4, 133.1, 129.4, 128.9, 127.3, 
113.9, 66.1, 55.1, 52.2, 46.7, 41.4, 37.7, 31.2, 26.8, 25.4, 21.9, 21.3, 13.7 (one peak missing due 
to peak overlap); mp 125-127 °C; IR (thin film, cm-1) 2953, 2930, 2861, 1732, 1611, 1513, 1456, 
1347; TLC (20% EtOAc/hexanes) Rf = 0.16; HRMS (ESI
+) Calcd. for C29H38NO7S: 544.2363, 
Found: 544.2368. 
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Dimethyl 2-((N,4-dimethylphenyl)sulfonamido)-4-(p-
methoxyphenyl)-3-phenylcyclopent-2-ene-1,1-dicarboxylate (1.50): 
The title compound was prepared according to General Procedure B using 
dimethyl 2-(p-methoxyphenyl)cyclopropane-1,1-dicarboxylate 1.33 (46 
mg, 0.18 mmol) and N,4-dimethyl-N-(phenylethynyl)benzenesulfonamide 1.46 (100 mg, 0.35 
mmol). Flash chromatography (20% EtOAc/hexanes) provided a yellow solid (97 mg, quant.). 
Analytical data: 1H NMR (600 MHz, CDCl3) δ 7.22 (m, 2H), 7.04 (m, 2H), 7.02 (m, 1H), 6.89 
(m, 6H), 6.72 (m, 2H), 4.27 (dd, J = 8.4, 6.4 Hz, 1H), 3.85 (s, 3H), 3.76 (s, 3H), 3.71 (s, 3H), 3.26 
(dd, J = 14.0, 8.4, 1H), 3.16 (s, 3H), 2.52 (dd, J = 14.0, 6.4 Hz, 1H), 2.17 (s, 3H); 13C NMR (150 
MHz, CDCl3) δ 171.3, 170.7, 158.2, 150.5, 142.4, 136.9, 134.5, 134.4, 133.8, 129.2, 128.9, 128.1, 
127.8, 127.6, 127.1, 113.8, 66.6, 55.1, 53.1, 52.8, 49.5, 41.2, 38.0, 21.3; mp 152-154 °C; IR (thin 
film, cm-1) 3055, 2999, 2952, 2838, 1733, 1611, 1513, 1435, 1342, 1250; TLC (20% 
EtOAc/hexanes) Rf = 0.08; LRMS (ESI
+) Calcd. for C30H32NO7S: 550.19, Found: 550.19. 
Dimethyl 2-((N,4-dimethylphenyl)sulfonamido)-4-(p-
methoxyphenyl)-4-methyl-3-pentylcyclopent-2-ene-1,1-
dicarboxylate (1.51): The title compound was prepared according to 
General Procedure B using dimethyl 2-(p-methoxyphenyl)-2-
methylcyclopropane-1,1-dicarboxylate 1.34 (50 mg, 0.18 mmol) and N-
(hept-1-yn-1-yl)-N,4-dimethylbenzenesulfonamide 1.45 (100 mg, 0.36 mmol). Flash 
chromatography (20% EtOAc/hexanes) provided a white amorphous solid (64 mg, 64%). 
Analytical data: 1H NMR (600 MHz, CDCl3) δ 7.78 (d, J = 7.8 Hz, 2H), 7.28 (m, 4H), 6.89 (br s, 
2H), 3.82 (s, 3H), 3.77 (s, 6H), 3.27 (s, 3H), 2.39 (s, 3H), 2.23 (br s, 1H), 1.47 (br s, 4H), 1.32-
1.14 (m, 2H), 1.01 (s, 1H), 0.93 (m, 3H), 0.77 (m, 2H), 0.69 (t, J = 7.2 Hz, 3H); 13C NMR (150 
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MHz, CDCl3) δ 173.6, 169.3, 157.9, 156.5, 143.2, 139.4, 137.8, 132.4, 129.4, 127.6, 127.3, 113.5, 
65.7, 55.2, 52.9, 52.8, 49.8, 49.7, 38.0, 32.2, 27.5, 27.2, 23.4, 21.8, 21.4, 13.8; mp 140-142 °C; IR 
(thin film, cm-1) 2951, 2930, 2871, 1733, 1609, 1512, 1457, 1345, 1252; TLC (20% 
EtOAc/hexanes) Rf = 0.15; LRMS (ESI
+) Calcd. for C30H40NO7S: 558.26, Found: 558.27. 
Dimethyl 2-((N,4-dimethylphenyl)sulfonamido)-4-(p-
methoxyphenyl)-4-methyl-3-phenylcyclopent-2-ene-1,1-dicarboxylate 
(1.52): The title compound was prepared according to General Procedure 
B using dimethyl 2-(p-methoxyphenyl)-2-methylcyclopropane-1,1-
dicarboxylate 1.34 (48 mg, 0.18 mmol) and N,4-dimethyl-N-
(phenylethynyl) benzenesulfonamide 1.46 (100 mg, 0.35 mmol). Flash chromatography (10% → 
20% EtOAc/hexanes) provided a white solid (52 mg, 53%). Analytical data: 1H NMR (600 MHz, 
CDCl3) δ 7.37 (d, J = 8.0 Hz, 2H), 7.15 (d, J = 8.0 Hz, 2H), 7.09 (tt, J = 7.5, 1.3 Hz, 1H), 6.92 (m, 
6H), 6.58 (d, J = 7.5 Hz, 2H), 3.90 (s, 3H), 3.85 (s, 3H), 3.83 (s, 3H), 3.43 (d, J = 14.4 Hz, 1H), 
3.13 (s, 3H), 2.54 (d, J = 14.4 Hz, 1H), 2.29 (s, 3H), 1.40 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 
173.1, 170.0, 158.2, 155.3, 142.4, 139.0, 137.0, 134.3, 132.3, 129.0, 128.9, 128.4, 127.6, 127.5, 
127.1, 113.6, 65.6, 55.3, 53.2, 53.0, 50.6, 49.3, 37.7, 24.1, 21.4; mp 138-140 °C; IR (thin film, 
cm-1) 3066, 2952, 2839, 1732, 1609, 1514, 1457, 1435, 1339; TLC (20% EtOAc/hexanes) Rf = 
0.13; LRMS (ESI+) Calcd. for C31H34NO7S: 564.21, Found: 564.19. 
Dimethyl 2-((N,4-dimethylphenyl)sulfonamido)-3-pentyl-4-(o-
methoxyphenyl)cyclopent-2-ene-1,1-dicarboxylate (1.53): The title 
compound was prepared according to General Procedure B using 
dimethyl 2-(o-methoxyphenyl)cyclopropane-1,1-dicarboxylate 1.35 (47 
mg, 0.18 mmol) and N-(hept-1-yn-1-yl)-N,4-dimethylbenzenesulfonamide 1.45 (100 mg, 0.36 
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mmol). Flash chromatography (20% EtOAc/hexanes) provided a white crystalline solid (99 mg, 
quant.). Analytical data: 1H NMR (600 MHz, CDCl3) δ 7.79 (br s, 2H), 7.28 (d, J = 8.2 Hz, 2H), 
7.22 (t, J = 7.8 Hz, 1H), 7.13 (br s, 1H), 6.97 (br s, 1H), 6.87 (d, J = 8.2 Hz, 1H), 4.24 (br s, 1H), 
3.82 (s, 3H), 3.77 (s, 6H), 3.21 (s, 3H), 2.93 (br s, 1H), 2.55 (br s, 1H), 2.39 (s, 3H), 1.14-0.90 (m, 
8H), 0.76 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 172.6, 169.2, 157.1, 153.1, 143.1, 
137.1, 132.6, 130.3, 129.3, 129.2, 127.8, 127.5, 120.8, 110.5, 66.3, 55.2, 52.7, 40.2, 38.8, 37.8, 
31.2, 27.2, 25.6, 22.0, 21.4, 13.7 (one peak missing due to peak overlap); mp 112-113 °C; IR (thin 
film, cm-1) 2953, 2926, 2861, 1733, 1599, 1457, 1347, 1246; TLC (20% EtOAc/hexanes) Rf = 
0.27; LRMS (ESI+) Calcd. for C29H38NO7S: 544.24, Found: 544.26. 
Dimethyl 4-(benzo[d][1,3]dioxol-4-yl)-2-((N,4-
dimethylphenyl)sulfonamido)-3-pentylcyclopent-2-ene-1,1-
dicarboxylate (1.54): The title compound was prepared according to 
General Procedure B using dimethyl 2-(benzo[d][1,3]dioxol-4-yl) 
cyclopropane-1,1-dicarboxylate 1.36 (50 mg, 0.18 mmol) and N-(hept-1-yn-1-yl)-N,4-
dimethylbenzenesulfonamide 1.45 (100 mg, 0.36 mmol). Flash chromatography (20% 
EtOAc/hexanes) provided a brown crystalline solid (64 mg, 64%). Analytical data: 1H NMR (600 
MHz, CDCl3) δ 7.77 (br s, 2H), 7.28 (d, J = 7.8 Hz, 2H), 6.76 (d, J = 8.4 Hz, 1H), 6.66 (br s, 1H), 
6.64 (d, J = 7.8 Hz, 1H), 5.95 (d, J = 8.4 Hz, 2H), 3.79 (s, 3H), 3.76 (s, 3H), 3.63 (br s, 1H), 3.19 
(s, 3H), 2.83 (br s, 1H), 2.60 (br s, 1H), 2.40 (s, 3H), 1.16-0.94 (m, 8H), 0.76 (t, J = 7.2 Hz, 3H); 
13C NMR (150 MHz, CDCl3) δ 172.4, 169.0, 152.5, 147.9, 146.4, 143.2, 137.0, 136.4, 133.4, 
129.4, 127.4, 121.2, 108.2, 108.1, 101.0, 66.1, 52.8, 52.7, 47.3, 41.4, 37.7, 31.3, 26.9, 25.6, 22.0, 
21.4, 13.8; mp 118-119 °C; IR (thin film, cm-1) 2951, 2928, 2871, 1732, 1599, 1488, 1347, 1247; 
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TLC (20% EtOAc/hexanes) Rf = 0.22; LRMS (ESI
+) Calcd. for C29H36NO8S: 558.22, Found: 
558.27. 
Dimethyl 2-((N,4-dimethylphenyl)sulfonamido)-4-(furan-2-yl)-3-
pentylcyclopent-2-ene-1,1-dicarboxylate (1.55): The title compound 
was prepared according to General Procedure B using dimethyl 2-(furan-
2-yl)cyclopropane-1,1-dicarboxylate 1.37 (87 mg, 0.39 mmol) and N-
(hept-1-yn-1-yl)-N,4-dimethylbenzenesulfonamide 1.45 (216 mg, 0.78 mmol). Flash 
chromatography (20% EtOAc/hexanes), followed by purification by HPLC (15% EtOAc/hexanes) 
provided a light brown oil (83 mg, 46%). Analytical data: 1H NMR (600 MHz, CDCl3) δ 7.78 (br 
s, 2H), 7.36 (s, 1H), 7.27 (d, J = 7.6 Hz, 2H), 6.32 (s, 1H), 6.12 (br s, 1H), 3.82 (s, 4H), 3.77 (s, 
3H), 3.18 (s, 3H), 2.45 (m, 1H), 2.41 (s, 3H), 1.63 (br s, 1H), 1.27 (br s, 2H), 1.09-0.97 (m, 6H), 
0.79 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 171.8, 168.9, 154.4, 150.8, 143.2, 141.7, 
136.8, 133.3, 129.4, 127.6, 110.2, 106.6, 65.8, 62.4, 58.0, 52.8, 40.9, 37.7, 31.5, 27.4, 26.0, 22.0, 
21.4, 13.8; IR (thin film, cm-1) 3117, 2954, 2929, 2871, 1733, 1598, 1456, 1349, 1269; TLC (20% 
EtOAc/hexanes) Rf = 0.24; LRMS (ESI
+) Calcd. for C26H34NO7S: 504.21, Found: 504.27. 
Dimethyl 2-((N,4-dimethylphenyl)sulfonamido)-3-pentyl-4-
(thiophen-2-yl)cyclopent-2-ene-1,1-dicarboxylate (1.56): The title 
compound was prepared according to General Procedure B using 
dimethyl 2-(thiophen-2-yl)cyclopropane-1,1-dicarboxylate 1.38 (43 mg, 
0.18 mmol) and N-(hept-1-yn-1-yl)-N,4-dimethylbenzenesulfonamide 1.45 (100 mg, 0.36 mmol). 
Flash chromatography (20% EtOAc/hexanes), followed by purification by HPLC (15% 
EtOAc/hexanes) provided a clear oil (78 mg, 84%). Analytical data: 1H NMR (600 MHz, CDCl3) 
δ 7.76 (br s, 2H), 7.27 (s, 2H), 7.22 (s, 1H), 6.95 (s, 1H), 6.86 (s, 1H), 4.01 (br s, 1H), 3.81 (br s, 
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3H), 3.77 (s, 3H), 3.20 (s, 3H), 3.00 (br s, 1H), 2.66 (br s, 1H), 2.40 (s, 3H), 1.21-0.94 (m, 8H), 
0.77 (br s, 3H); 13C NMR (150 MHz, CDCl3) δ 172.1, 168.7, 151.8, 145.6, 143.2, 136.8, 133.3, 
129.4, 127.5, 126.7, 125.2, 124.3, 66.0, 52.8, 42.6, 41.8, 38.4, 37.9, 31.4, 26.9, 25.9, 21.9, 21.4, 
13.7; IR (thin film, cm-1) 2953, 2929, 2861, 1733, 1456, 1434, 1349, 1270, 1156; TLC (20% 
EtOAc/hexanes) Rf = 0.19; LRMS (ESI
+) Calcd. for C26H34NO6S2: 520.19, Found: 520.25. 
Dimethyl 2-((N,4-dimethylphenyl)sulfonamido)-3-phenyl-4-
(thiophen-2-yl)cyclopent-2-ene-1,1-dicarboxylate (1.57): The title 
compound was prepared according to General Procedure B using dimethyl 
2-(thiophen-2-yl)cyclopropane-1,1-dicarboxylate 1.38 (42 mg, 0.18 
mmol) and N,4-dimethyl-N-(phenylethynyl)benzenesulfonamide 1.46 (100 mg, 0.35 mmol). Flash 
chromatography (10% → 20% EtOAc/hexanes) provided a yellow oil (85 mg, 93%). Analytical 
data: 1H NMR (600 MHz, CDCl3) δ 7.25 (d, J = 7.8 Hz, 2H), 7.10 (tt, J = 7.4, 1.2 Hz, 1H), 7.05 
(d, J = 5.4 Hz, 1H), 7.01 (t, J = 7.4 Hz, 2H), 6.97 (m, 4H), 6.79 (dd, J = 5.4, 3.6 Hz, 1H), 6.72 (d, 
J = 3.6 Hz, 1H), 4.63 (dd, J =  8.4, 5.4 Hz, 1H), 3.87 (s, 3H), 3.78 (s, 3H), 3.43 (dd, J = 13.6, 8.4 
Hz, 1H), 3.41 (s, 3H), 2.66 (dd, J = 13.6, 5.4 Hz, 1H), 2.32 (s, 3H); 13C NMR (150 MHz, CDCl3) 
δ 171.1, 170.1, 149.6, 145.2, 142.4, 136.9, 134.0, 133.9, 129.0, 128.1, 127.91, 127.88, 127.2, 
126.6, 125.4, 124.1, 66.5, 53.2, 52.9, 45.1, 41.2, 38.1, 21.4; IR (thin film, cm-1) 3059, 2951, 2859, 
1734, 1541, 1435, 1342, 1253, 1152; TLC (20% EtOAc/hexanes) Rf = 0.18; LRMS (ESI
+) Calcd. 
for C27H28NO6S2: 526.14, Found: 526.18. 
Dimethyl (E)-2-((N,4-dimethylphenyl)sulfonamido)-3-pentyl-4-
styrylcyclopent-2-ene-1,1-dicarboxylate (1.58): The title compound 
was prepared according to General Procedure B using dimethyl (E)-2-
styrylcyclopropane-1,1-dicarboxylate 1.39 (47 mg, 0.18 mmol) and N-
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(hept-1-yn-1-yl)-N,4-dimethylbenzenesulfonamide 1.45 (100 mg, 0.36 mmol). Flash 
chromatography (20% EtOAc/hexanes), followed by purification by HPLC (15% EtOAc/hexanes) 
provided a yellow oil (66 mg, 69%). Analytical data: 1H NMR (600 MHz, CDCl3) δ 7.78 (br s, 
2H), 7.38-7.33 (m, 4H), 7.31 (d, J = 7.8 Hz, 2H), 7.27 (t, J = 7.2 Hz, 1H), 6.47 (d, J = 15.6 Hz, 
1H), 6.02 (br s, 1H), 3.81 (s, 3H), 3.78 (s, 3H), 3.35 (br s, 1H), 3.18 (s, 3H), 2.81 (br s, 1H), 2.43 
(s, 3H), 1.76 (br s, 1H), 1.64 (s, 1H), 1.51 (br s, 1H), 1.35 (br s, 1H), 1.14 (br s, 3H), 1.02 (m, 2H), 
0.81 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 172.3, 169.2, 152.6, 143.2, 137.0, 136.8, 
132.9, 132.0, 130.4, 129.4, 128.6, 127.6, 127.5, 126.2, 66.1, 52.82, 52.76, 45.5, 38.5, 38.1, 31.7, 
27.4, 25.8, 22.1, 21.4, 13.9; IR (thin film, cm-1) 3029, 2953, 2926, 2866, 1733, 1653, 1457, 1348, 
1270, 1155; TLC (20% EtOAc/hexanes) Rf = 0.29; LRMS (ESI
+) Calcd. for C30H38NO6S: 540.24, 
Found: 540.31. 
Dimethyl 2-((N,4-dimethylphenyl)sulfonamido)-4-methyl-3-pentyl-
4-phenylcyclopent-2-ene-1,1-dicarboxylate (1.61): The title 
compound was prepared according to General Procedure B using 
dimethyl 2-methyl-2-phenylcyclopropane-1,1-dicarboxylate 1.42 (44 
mg, 0.18 mmol) and N-(hept-1-yn-1-yl)-N,4-dimethylbenzenesulfonamide 1.45 (100 mg, 0.36 
mmol). Flash chromatography (20% EtOAc/hexanes), followed by purification by HPLC (15% 
EtOAc/hexanes) provided a yellow oil (55 mg, 59%). Analytical data: 1H NMR (400 MHz, 
CDCl3) δ 7.79 (d, J = 7.8 Hz, 2H), 7.34 (m, 4H), 7.27 (m, 3H), 3.78 (s, 6H), 3.28 (s, 3H), 2.40 (s, 
3H), 1.61 (s, 1H), 1.52 (br s, 4H), 1.28 (br s, 1H), 1.05-0.89 (m, 5H), 0.80-0.73 (m, 2H), 0.68 (t, J 
= 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 173.6, 169.4, 156.4, 147.3, 143.2, 137.8, 132.8, 
129.5, 128.3, 127.4, 126.6, 126.3, 65.9, 52.9, 52.8, 50.3, 49.8, 38.1, 32.2, 27.6, 27.3, 23.3, 21.8, 
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21.4, 13.8; IR (thin film, cm-1) 2953, 2926, 2871, 1734, 1599, 1457, 1435, 1346, 1270; TLC (20% 
EtOAc/hexanes) Rf = 0.24; LRMS (ESI
+) Calcd. for C29H38NO6S: 528.24, Found: 528.34. 
Dimethyl 2-((N,4-dimethylphenyl)sulfonamido)-4-ethynyl-3-pentyl-
4-phenylcyclopent-2-ene-1,1-dicarboxylate (1.62): The title 
compound was prepared according to General Procedure B using 
dimethyl 2-ethynyl-2-phenylcyclopropane-1,1-dicarboxylate 1.43 (62 
mg, 0.24 mmol) and N-(hept-1-yn-1-yl)-N,4-dimethylbenzenesulfonamide 1.45 (134 mg, 0.48 
mmol). Flash chromatography (20% EtOAc/hexanes) provided a tan solid (72 mg, 56%). 
Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 8.0 Hz, 2H), 7.56 (d, J = 8.0 Hz, 2H), 
7.41 (t, J = 8.0 Hz, 2H), 7.29 (m, 3H), 3.81 (s, 3H), 3.80 (s, 3H), 3.33 (s, 3H), 2.54 (s, 1H), 2.46 
(t, J = 7.2 Hz, 1H), 2.40 (s, 3H), 1.42 (br s, 1H), 1.23 (m, 4H), 0.91 (m, 4H), 0.68 (t, J = 7.2 Hz, 
3H); 13C NMR (150 MHz, CDCl3) δ 171.8, 168.5, 151.1, 143.5, 141.6, 136.9, 135.7, 129.5, 128.4, 
127.4, 127.3, 126.9, 84.2, 74.8, 66.0, 53.1, 52.7, 50.8, 49.5, 38.0, 31.8, 27.6, 26.1, 21.7, 21.4, 13.7; 
mp 117-118 °C; IR (thin film, cm-1) 3276, 3062, 3028, 2954, 2871, 1739, 1599, 1456, 1348; TLC 
(20% EtOAc/hexanes) Rf = 0.22; LRMS (ESI
+) Calcd. for C30H36NO6S: 538.23, Found: 538.27. 
Dimethyl 2-((N,4-dimethylphenyl)sulfonamido)-3-pentyl-4-
phenylcyclopent-2-ene-1,1-dicarboxylate (1.63): The title compound 
was prepared according to General Procedure B using dimethyl 2-
phenylcyclopropane-1,1-dicarboxylate 1.44 (1.86 g, 7.9 mmol) and N-
(hept-1-yn-1-yl)-N,4-dimethylbenzenesulfonamide 1.45 (4.44 g, 15.9 mmol). Flash 
chromatography (20% EtOAc/hexanes) provided a white solid (3.91 g, 96%). Analytical data: 1H 
NMR (600 MHz, CDCl3) δ 7.74 (br s, 2H), 7.33 (s, 2H), 7.25 (s, 3H), 7.17 (s, 2H), 3.79 (br s, 3H), 
3.76 (s, 3H), 3.64 (br s, 1H), 3.20 (s, 3H), 2.92 (br s, 1H), 2.58 (br s, 1H), 2.16 (s, 3H), 1.25-0.87 
30 
 
(m, 8H), 0.72 (t, J = 7.2, 3H); 13C NMR (150 MHz, CDCl3) δ 172.3, 168.9, 152.3, 143.1, 142.4, 
136.9, 133.4, 129.3, 128.5, 127.9, 127.3, 126.8, 66.1, 53.3, 52.6, 47.4, 41.2, 37.6, 31.1, 26.8, 25.4, 
21.8, 21.2, 13.6; mp 93-94 °C; IR (thin film, cm-1) 2953, 1733, 1433, 1384, 1271, 1155, 1087, 
667; TLC (20% EtOAc/hexanes) Rf = 0.20; LRMS (ESI
+) Calcd. for C28H36NO6S: 514.23, Found: 
514.27. 
Dimethyl -2-((N,4-dimethylphenyl)sulfonamido)-6-oxo-3-pentyl-
4H,6H-4,10b-ethano[1,3]oxazino[2,3-a]isoindole-11,11-
dicarboxylate (1.79): The title compound was prepared according to 
General Procedure B using dimethyl 2-phenylcyclopropane-1,1-
dicarboxylate S1 (121 mg, 0.4 mmol) and N-(hept-1-yn-1-yl)-N,4-dimethylbenzenesulfonamide 
1.45 (224 mg, 0.8 mmol). Flash chromatography (20% to 40% EtOAc/hexanes) provided a white 
solid (156 mg, 67%). Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.79 (d, J = 7.2 Hz, 1H), 
7.56 (dt, J = 7.2, 1.2 Hz, 1H), 7.45 (t, J = 7.4 Hz, 1H), 7.38 (br s, 2H), 6.76 (br s, 2H), 4.65 (d, J = 
6.4 Hz, 1H), 3.83 (s, 3H), 3.36 (d, J = 12.8 Hz, 1H), 3.22 (s, 3H), 2.882.76 (m, 4H), 2.40 (m, 
1H), 2.24 (m, 1H), 2.16 (br s, 3H), 1.641.28 (m, 6H), 0.92 (m, 3H); 13C NMR (150 MHz, CDCl3) 
 168.1, 167.4, 161.1, 143.1, 141.0, 138.8, 134.5, 131.6, 130.2, 128.7, 127.5, 123.3, 123.1, 118.5, 
96.7, 67.2, 53.0, 52.6, 49.5, 47.9, 35.6, 31.5, 29.2, 27.1, 22.3, 21.4, 13.9 
Dimethyl 2-((4-benzyl-3-((N,4-dimethylphenyl)sulfonamido)-2-
pentyl-1,4-dihydrocyclopenta[b]indol-1-yl)methyl)malonate (1.82): 
The title compound was prepared according to General Procedure B using 
dimethyl 2-phenylcyclopropane-1,1-dicarboxylate S2 (133 mg, 0.36 
mmol) and N-(hept-1-yn-1-yl)-N,4-dimethylbenzenesulfonamide 1.45 (204 mg, 0.73 mmol). Flash 
chromatography (10% EtOAc/hexanes) provided a white solid (71 mg, 30%). Analytical data: 1H 
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NMR (600 MHz, CDCl3) δ 7.79 (d, J = 7.8 Hz, 2H), 7.27 (m, 2H), 7.18 (m, 3H), 7.07 (m, 2H), 
7.00 (m, 1H), 6.68 (m, 1H), 5.94 (d, J = 7.8 Hz, 1H), 5.43 (d, J = 16.5 Hz, 1H), 5.33 (d, J = 16.5 
Hz, 1H), 3.72 (s, 3H), 3.26 (m, 2H), 3.22 (s, 3H), 2.94 (m, 5H), 2.64 (m, 1H), 2.42 (s, 3H), 2.25 
(m, 1H), 1.58-1.28 (m, 7H), .878 (t, J = 6.6 Hz, 3H); 13C NMR (150 MHz, CDCl3)  170.03, 
169.96, 146.2, 143.2, 141.9, 139.9, 136.8, 135.8, 134.2, 129.7, 128.7, 128.1, 127.6, 126.7, 120.7, 
119.7, 119.5, 119.1, 118.9, 109.7,  52.9, 51.8, 48.2, 46.0, 40.5, 36.7, 31.6, 29.3, 27.1, 26.0, 22.4, 
21.5, 14.0. 
Dimethyl 4-acetoxy-2-((N,4-dimethylphenyl)sulfonamido)-3-
pentylcyclopent-2-ene-1,1-dicarboxylate; dimethyl 3-((N,4-
dimethylphenyl)sulfonamido)-1-methyl-4-pentyl-2,8-
dioxabicyclo[3.2.1]oct-3-ene-7,7-dicarboxylate (1.84/1.85): The 
title compound was prepared according to General Procedure B using 
dimethyl 2-phenylcyclopropane-1,1-dicarboxylate 1.83 (50 mg, 0.23 
mmol) and N-(hept-1-yn-1-yl)-N,4-dimethylbenzenesulfonamide 
1.45 (129 mg, 0.46 mmol). The ratio of isomers (~20:1 1.84/1.85) was determined by the 
resonances of the -hydroxy methine protons (shown and bolded) in the crude 1H NMR, which 
appear at 5.43 (major) and 4.87 ppm (minor). Analytical data: 1H NMR (400 MHz, CDCl3, 1.84) 
 7.84 (d, J = 8.6 Hz, 2H), 7.32 (d, J = 8.6 Hz, 2H), 5.43 (t, J = 7.4 Hz, 1H), 3.71 (s, 3H), 3.32 (s, 
3H), 2.41 (s, 3H), 2.21 (s, 3H), 1.580.74 (m, 11 H).  
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SFC analysis of (±)-1.63 
 
peak # RT (min) area (mAU×s) height (mAU) area % 
1 6.995 11943.74 390.04 49.9 
2 9.550 11993.30 249.93 50.1 
 
SFC analysis of (+)-1.63 
 
peak # RT (min) area (mAU×s) height (mAU) area % 
1 7.041 20801.28 719.69 98.2 
2 9.799 371.18 10.73 1.8 
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General Procedure C for the Preparation of Cyclopentanones (1.66-1.69) 
 
To a flame-dried 10 mL round-bottomed flask, charged with a magnetic stir bar, was added 
sodium metal (10.0 equiv) and naphthalene (4.0 equiv) under N2 atmosphere. Anhydrous THF (2 
mL) was added to the flask, which was then cooled to 0 °C and rapidly stirred for 1 h. To the 
resultant dark green solution was added the cyclopentene sulfonamide (1.0 equiv) as a solution in 
anhydrous THF (0.5 M) via syringe. After complete consumption of the starting material 
determined by TLC (4 – 18 h), the reaction was quenched with saturated aqueous NH4Cl solution 
(3 mL), and the mixture was stirred for 30 min, forming an off white precipitate. The precipitate 
was removed by filtration, and the aqueous layer was then extracted with EtOAc (2 × 15 mL). The 
combined organic layer was concentrated by rotary evaporation. To the brown residue was added 
3 M HCl (10 mL) and the mixture was heated to reflux (125 °C) for 36 – 72 h, when a white solid 
appeared in the reflux condenser. The reaction was then cooled to room temperature and the 
aqueous layer was first extracted with EtOAc (20 mL), then basified with saturated Na2CO3 
solution and further extracted with EtOAc (20 mL). The combined organic layer was washed with 
brine (30 mL), dried over Na2SO4, and concentrated by rotary evaporation. The brown oil was then 
purified by column chromatography, yielding the desired product.  
3-(p-methoxyphenyl)-2-pentylcyclopentan-1-one (1.66): The title 
compound was prepared according to General Procedure C using dimethyl 
2-((N,4-dimethylphenyl)sulfonamido)-3-pentyl-4-(p-methoxyphenyl) 
cyclopent-2-ene-1,1-dicarboxylate 1.49 (2.00 g, 3.7 mmol), naphthalene 
(1.88 g, 14.7 mmol), and sodium (0.85 g, 36.8 mmol), and 3 M HCl (50 mL). Flash 
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chromatography (20% EtOAc/hexanes) provided a dark yellow oil (0.79 g, 83%) as a single 
diastereomer. Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.20 (d, J = 6.8 Hz, 2H), 6.91 (d, J 
= 6.8 Hz, 2H), 3.82 (s, 3H), 2.97 (dt, J = 12.0, 6.0 Hz, 1H), 2.51 (m, 1H), 2.26 (m, 3H), 1.88 (m, 
1H), 1.55 (m, 2H), 1.38-1.10 (m, 6H), 0.83 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
219.2, 158.2, 134.8, 127.8, 113.8, 55.7, 54.9, 47.6, 38.1, 31.7, 30.1, 27.6, 26.1, 22.1, 13.7; IR (thin 
film, cm-1) 3434, 1735, 1646, 1514, 1246, 828; TLC (20% EtOAc/hexanes) Rf = 0.39; LRMS 
(ESI+) Calcd. for C17H25O2: 261.19, Found: 261.19. NOESY data shown below: 
 
3-(p-methoxyphenyl)-2-phenylcyclopentan-1-one (1.67): The title compound was 
prepared according to General Procedure C using dimethyl 2-((N,4-
dimethylphenyl)sulfonamido) -4- (p-methoxyphenyl) -3- phenylcyclopent-2-ene-1,1-
dicarboxylate 1.50 (77 mg, 0.14 mmol), naphthalene (72 mg, 0.56 mmol), and sodium 
(32 mg, 1.4 mmol), and 3 M HCl (10 mL). Flash chromatography (20% EtOAc/hexanes) provided 
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a brown oil (16 mg, 43%) as a single diastereomer. Analytical data: 1H NMR (600 MHz, CDCl3) 
δ 7.29 (m, 2H), 7.23 (m, 1H), 7.12 (d, J = 8.4 Hz, 2H), 7.06 (d, J = 7.2 Hz, 2H), 6.83 (d, J = 8.4 
Hz, 2H), 3.78 (s, 3H), 3.50 (td, J = 12.0, 6.0 Hz, 1H), 3.44 (d, J = 12.0 Hz, 1H), 2.75-2.67 (m, 1H), 
2.55-2.44 (m, 2H), 2.13-2.09 (m, 1H); 13C NMR (150 MHz, CDCl3) δ 216.7, 158.3, 137.1, 133.6, 
128.6, 128.5, 127.9, 126.9, 113.9, 63.0, 55.1, 49.6, 38.8, 29.6; IR (thin film, cm-1) 3243, 2928,  
2853, 2360, 2065, 1742, 1612, 1515, 1248, 1034; TLC (20% EtOAc/hexanes) Rf = 0.26; LRMS 
(ESI+) Calcd. for C18H19O2: 267.14, Found: 267.11.  
3-ethynyl-2-pentyl-3-phenylcyclopentan-1-one (1.68): The title compound 
was prepared according to General Procedure C using dimethyl 2-((N,4-
dimethylphenyl)sulfonamido) -4- ethynyl-3-pentyl-4-phenylcyclopent-2-
ene-1,1-dicarboxylate 1.62 (169 mg, 0.31 mmol), naphthalene (254 mg, 2.0 mmol), and sodium 
(114 mg, 4.9 mmol), and 3 M HCl (25 mL). Flash chromatography (10% EtOAc/hexanes) 
provided a brown oil (24 mg, 30%) as a single diastereomer. Analytical data: 1H NMR (400 MHz, 
CDCl3) δ 7.65 (m, 2H), 7.40 (m, 2H), 7.31 (tt, J = 7.2, 1.2 Hz, 1H), 2.69-2.59 (m, 1H), 2.56-2.53 
(m, 2H), 2.52 (s, 1H), 2.50-2.43 (m, 1H), 2.36-2.24 (m, 1H), 1.87-1.78 (m, 1H), 1.50-1.41 (m, 1H), 
1.28-1.20 (m, 2H), 1.16-1.05 (m, 4H), 0.77 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
217.0, 141.6, 128.5, 127.2, 126.1, 84.1, 75.5, 60.2, 49.8, 37.9, 36.2, 31.7, 27.2, 26.4, 22.2, 13.9; 
IR (thin film, cm-1) 3292, 3060, 2929, 2363, 1742, 1456, 1277, 1155, 744, 699; TLC (20% 
EtOAc/hexanes) Rf = 0.52; LRMS (ESI
+) Calcd. for C18H23O: 255.17, Found: 255.14. NOESY 
data shown below: 
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2-pentyl-3-phenylcyclopentan-1-one (1.69): The title compound was prepared 
according to General Procedure C using dimethyl 2-((N,4-
dimethylphenyl)sulfonamido)-3-pentyl-4-phenylcyclopent-2-ene-1,1-
dicarboxylate 1.63 (0.38 g, 0.7 mmol), naphthalene (0.38 g, 3.0 mmol), and sodium (0.17 g, 7.4 
mmol), and 3 M HCl (30 mL). Flash chromatography (20% EtOAc/hexanes) provided a dark 
yellow oil (70 mg, 41%) as a single diastereomer. Analytical data: 1H NMR (400 MHz, CDCl3) δ 
7.37 (t, J = 7.2 Hz, 2H), 7.31-7.26 (m, 3H), 3.04 (dt, J = 12.0, 6.4 Hz, 1H), 2.51 (dd, J = 16.4, 8.0 
Hz, 1H), 2.29 (m, 3H), 2.00-1.84 (m, 1H), 1.59-1.47 (m, 2H), 1.36-1.28 (m, 1H), 1.25-1.11 (m, 
5H), 0.82 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 219.0, 142.9, 128.4, 126.9, 126.5, 
55.5, 48.4, 38.0, 31.6, 30.0, 27.7, 26.0, 22.1, 13.7; IR (thin film, cm-1) 3496, 2957, 1735, 1652, 
1265, 737, 700; TLC (20% EtOAc/hexanes) Rf = 0.51; LRMS (ESI
+) Calcd. for C16H23O: 231.17, 
Found: 231.07. 
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General Procedure D for the Preparation of Ynamide Hydrolysis Products (1.70, 1.71, 1.75) 
 
To 1 dram vials containing the ynamide (0.15 mmol) in CH2Cl2 (1 mL) was added the 
appropriate acid (30% H2SO4/H2O or anhydrous AlCl3). The reaction was allowed to stir at room 
temperature for 4 h, or until the reaction was deemed complete by TLC analysis. In the case of the 
hydrolysis products 1.70, 1.71, the organic layer was collected, dried over Na2SO4, filtered, and 
concentrated, providing analytically pure material. In the case of enamine 1.75, the reaction was 
concentrated, and then purified by column chromatography (20% EtOAc/hexanes), yielding a 
single alkene isomer.  
N-methyl-N-tosylheptanamide (1.70): The title compound was prepared 
according to General Procedure D using N-(hept-1-yn-1-yl)-N,4-
dimethylbenzenesulfonamide 1.45 (50 mg, 0.17 mmol) and 30% H2SO4 (1 
mL). The reaction yielded a clear oil of good purity without further purification in quantitative 
yield. Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 8.2 Hz, 2H), 7.34 (d, J = 8.2 Hz, 
2H), 3.01 (s, 3H), 2.64 (t, J = 7.4 Hz, 2H), 2.44 (s, 3H), 1.57 (m, 2H), 1.25 (m, 8H), 0.857 (t, J = 
7.2 Hz, 3H). 
N-methyl-2-phenyl-N-tosylacetamide (1.71): The title compound was prepared 
according to General Procedure D using N,4-dimethyl-N-
(phenylethynyl)benzenesulfonamide 1.46 (45 mg, 0.16 mmol) and 30% H2SO4 
(1 mL). The reaction yielded a clear oil of good purity without further purification in quantitative 
yield. Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.61 (d, J = 8.2 Hz, 2H), 7.21 (m, 5H) 7.05 
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(m, 2H), 3.96 (s, 2H), 3.20 (s, 3H), 2.36 (s, 3H); LRMS (ESI+) Calcd. for C16H18NO3S: 304.10, 
Found: 304.10. 
(Z)-N-(1-chloro-2-phenylvinyl)-N,4-dimethylbenzenesulfonamide (1.75): 
The title compound was prepared according to General Procedure D using N,4-
dimethyl-N-(phenylethynyl)benzenesulfonamide 1.46 (50 mg, 0.18 mmol) and 
AlCl3 (1 equiv). Column chromatography yielded a white solid of good purity in near quantitative 
yield. Analytical data: 1H NMR (600 MHz, CDCl3) δ 7.80 (d, J = 8.1 Hz, 2H), 7.62 (d, J = 8.1 Hz, 
2H), 7.38 (m, 2H), 7.33 (m, 3H), 6.67 (s, 1H), 3.05 (s, 3H), 2.46 (s, 3H). 
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CHAPTER TWO: 
KINETIC SEPARATION AND ASYMMETRIC REACTIONS OF NORCARADIENE CYCLOADDUCTS: 
FACILITATED ACCESS VIA H2O-ACCELERATED CYCLOADDITION†
 
2.1 Introduction 
Highly-substituted cyclohexanes comprise a large subset of valuable natural and 
laboratory-prepared molecules;1 consequently, efficient assembly of these structural subunits 
remains a topic a great interest.2 The impact of cycloaddition reactions on advances in this general 
area cannot be overstated;3 however, traditional cycloaddition approaches to the preparation of 
these functionalities are often constrained to specific substitution patterns, and stereochemistry is 
dictated by the nature of the starting materials employed.4 In this chapter, we utilize simple 
benzenoids as a platform for generating highly substituted cyclohexane derivatives. By initially 
disrupting aromaticity through an intermolecular Buchner reaction, we were able to generate 
norcaradienes (or their tautomeric cycloheptatrienes), as a mixture of regioisomers in the case of 
substituted aromatic substrates. Subsequent reaction with dienophiles allowed for the kinetic 
separation of many of the regioisomeric mixtures by exploiting the rate differences of the various 
regioisomers with dienophiles, facilitated by the rate acceleration of performing the cycloaddition 
reactions “on water.” The resultant meso-cycloadducts were successfully desymmetrized, 
providing up to seven contiguous stereocenters in three steps from commercial benzene.  
  
                                                     
† Reprinted in part with permission from Mackay, W. D.; Johnson, J. S. Org. Lett. 2016, 18, 
5369. 
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2.2 Background 
2.2.1 Importance and Application of Dearomatization in Synthesis 
Despite their obvious potential in preparing substituted cyclohexanes, the direct 
manipulation of benzene derivatives in such endeavors remains an underutilized approach. As 
inexpensive commodity feedstock materials, benzene derivatives are frequently available in 
kilogram quantities and in a variety of substitution patterns.5 Furthermore, the pre-existing six-
membered ring and latent unsaturation in benzene derivatives (enabling downstream 
functionalization) could streamline the preparation of stereodefined cyclohexanes (Scheme 2-1).  
Scheme 2-1. Rapid Complexity-Building of Dearomatized 1,2-Disubstituted Cyclohexadienes 
 
Of the extant methods for complexity-building dearomatizations of benzenes, arguably the 
most widely utilized are phenol oxidations.6 Treatment of phenols with highly oxidized metals and 
halogens (i.e., Pb(OAc)4,
7 Cu(II)/O2,
8 PIDA,9 NaIO4,
10 etc.) in the presence of an external or 
pendant nucleophile allows for rapid generation of both p- and o-quinones and their derivatives. 
Application of this chemistry has been applied towards the synthesis of numerous natural products 
(Scheme 2-2).11 
Scheme 2-2. Selected Example of Oxidative Dearomatization of Phenols in Synthesis  
 
Aside from oxidative methods, reductive dearomatization (i.e., the Birch reduction) allows 
for the expedient synthesis of 1,4-dienes through the action of solvated electrons in liquid ammonia 
(Scheme 2-3a).12 Harman has pioneered stoichiometric metal complexation as a means for 
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dearomatization, whereby strongly -basic metals render aromatic rings nucleophilic (Scheme 2-
3b).13 Along these lines, -acidic metal complexation allows for facile nucleophilic attack of the 
metal-bound arene.13a,14 Enzymatic methods are to date the most effective method of generating 
enantioenriched cyclohexadiene intermediates directly from achiral aromatic substrates. The 
action of toluene dioxygenase in Pseudomonas putida allowing for the asymmetric 
dihydroxylation of toluene, is one pronounced example of such a transformation (Scheme 2-3c).15   
Scheme 2-3. Other Selected Arene Dearomatization Reactions 
 
2.2.2 The Buchner Reaction 
Of the extant methods of arene dearomatization, we were initially drawn towards direct 
benzene cyclopropanation—the Buchner reaction—that was first discovered in 1885 by the 
thermolysis of ethyl diazoacetate (EDA) in benzene.16 The products were found to be an 
inseparable mixture of cycloheptatriene (CHT) isomers that arose from successive 1,5-hydride 
shifts of the nascent cycloheptatriene 2.1 (Scheme 2-4a), formed from a 6-electrocyclization of 
the initially formed norcaradiene (NCD; Scheme 2-4b); for a brief discussion on factors that 
influence the NCD/CHT equilibrium, see section 2.2.3. It was not until the discovery of transition 
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metal catalyzed arene cyclopropanation that single CHT isomers from benzene could be isolated 
(Scheme 2-4c).17  
Scheme 2-4. Seminal Investigations into Benzene Cyclopropanation 
 
2.2.3 Factors Influencing the Norcaradiene/Cycloheptatriene Equilibrium 
The direction of the NCD/CHT equilibrium has been a matter of significant investigation, 
and some of the many factors that are influential therein are summarized in Scheme 2-5. Devoid 
of substitution, the parent system (2.2 ⇋ 2.2′) natively favors the CHT, since the latent ring strain 
of the cyclopropyl ring (~27 kcal/mol) is relieved (Scheme 2-5a).18 
This ring-opening can be disfavored by tethering the C1 and C6 carbons in 2.3, thereby 
imposing significant bond distortion in the CHT form 2.3′ (Scheme 2-5b). The NCD isomer can 
also be favored by allowing for increased conjugation, as shown in Scheme 2-5c with the inclusion 
of two fused aromatic rings in 2.4, which are rendered non-aromatic in the CHT isomer 2.4′. 
Finally, bulky substitution at the C2 and C5 positions tends to favor the NCD isomer 2.5 due to 
relief of A1,3 strain between the substituents at C1 and C2 in 2.5′ (Scheme 2-5d).18  
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Scheme 2-5. Influences of Substitution at C1-C6 on the NCD/CHT Equilibrium 
 
The most general substitution pattern that affects the NCD/CHT equilibrium predictably is 
the inclusion of a -acceptor at C7 (Scheme 2-6). Since the -orbitals of the C7 substituents 
favorably overlap with the Walsh orbitals of the cyclopropyl ring of NCDs, the identity of a -
acceptor or donor at this position greatly influences the NCD/CHT equilibrium. In the case of -
acceptors, the NCD is more favorable through stabilization of the HOMO, concommitant with 
shortening of the C1C6 bond; the same phenomenon is not observed with -acceptors (i.e., CF3). 
Likewise, in the case of -donors, the CHT is favored through stabilization of the LUMO, resulting 
in elongation of the C1C6 bond. The inclusion of two electron-acceptors at C7 provides a 
significant stabilization effect, such that the parent benzene-derived NCD is the favored isomer 
without any other substitution.18  
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Scheme 2-6. Frontier Molecular Orbital Analysis of C7 Substitution to NCD/CHT Equilibrium 
 
2.2.4 Comparison between the Intra- and Intermolecular Buchner Reaction 
Although the initial reports of benzenoid cyclopropanation were performed 
intermolecularly, to date, there are limited examples of such dearomatized compounds as viable 
synthetic intermediates. A likely explanation of this phenomenon resides in controlling the 
regioselectivity of the Buchner reaction of substituted aromatic compounds. For monosubstituted 
benzene (i.e., toluene, chlorobenzene), three regioisomeric possibilities exist for the Buchner 
product identity via cyclopropanation at each site of unsaturation (Scheme 2-7);17 this problem is 
further complicated as the substitution pattern is increased.  
Scheme 2-7. Inherent Challenges Using Norcaradienes as Synthetic Intermediates  
 
In prior art, this regiochemical preference has been biased by rendering the 
cyclopropanation intramolecular.19 Through the incorporation of a diazo moeity tethered to a 
substituted arene, the Buchner products can be obtained with high regioselectivity (Scheme 2-8). 
2-Substituted aromatic compounds 2.6 can be selectively differentiated, whereby the least 
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sterically encumbered cycloheptarienyl product 2.7 is formed (Scheme 2-8a).19a Substitution at the 
benzylic position can effect high levels of diastereoselectivity, allowing for enantioenriched CHT 
products 2.9 from readily accessible materials (Scheme 2-8b).19d Chiral rhodium(II) complexes are 
shown to enantioselectively desymmetrize symmetrically substituted aromatic compounds 2.10 
(Scheme 2-8c), although the CHT products 2.11 tended to partially racemize upon prolonged 
reaction times.19f  
Scheme 2-8. Selected Examples of Intramolecular Buchner Reactions  
 
Despite the great strides that have been made in the intramolecular Buchner reaction, there 
currently exists no general regioselective method for the analogous intermolecular reaction.20 The 
development of a regioselective intermolecular Buchner reaction would be inherently 
advantageous compared with the intramolecular reaction, since it would obviate the need for 
prefunctionalization of the aromatic substrate prior to the dearomatization reaction itself. 
Investigations into the regioselectivity issue will be addressed during the duration of this chapter 
and in Chapter Three.  
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2.3 Results and Discussion 
2.3.1 Initial Reaction Design 
As part of our ongoing studies in complexity generation via manipulation of strained 
carbocycles (see Chapter One for one such example),21 we envisioned the union of benzene 
dearomatization and cyclopropane annulation would provide expedient access to substituted 
cyclohexanes. This could be accomplished via the Buchner reaction—the (2+1)-annulation of 
carbenes with arenes—to access substituted NCDs (or their valence tautomeric CHTs).22  These 
intermediates would then be poised to participate in a variety of useful diene functionalizations 
(Scheme 2-9). 
Scheme 2-9. Proposed Functionalization of Buchner Products 
 
At least three barriers stand in the way of broader deployment of intermolecular Buchner 
adducts in synthesis: (1) the NCD products exist as a substrate-dependent equilibrating mixture of 
the NCD and the corresponding CHT adduct via electrocyclic ring opening and closure.18 
Reactions must be developed in which only the NCD (and not the CHT) reacts productively to 
give the desired product; (2) the use of NCDs as DielsAlder dienes is severely hindered by 
impractically slow reaction rates; and (3) from a practical standpoint, mixtures of isopolar 
constitutional isomers almost always present intractable separation/purification problems (vide 
supra).  
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2.3.2 Substrate Scope of the Intermolecular Buchner Reaction 
In our initial screening using benzene, Rh2(TFA)4 was quickly identified as the optimal 
catalyst to generate high yields of the CHT product 2.1, as rhodium diacetate dimers bearing 
electron-deficient ligands are reported to provide higher activity in the intermolecular Buchner 
reaction (Table 2-1, entry 1).17 Copper catalysts (entry 3) were ineffective at promoting this 
reaction.  
Table 2-1. Optimization of the Buchner Reactiona  
 
entry substrate catalyst product yield (%) rr 
1 benzene Rh2(TFA)4 
 
 
90 - 
2  Rh2(OAc)4 40
 - 
3  Cu(hfacac)2 <2
 - 
5 p-xylene Rh2(TFA)4 
 
73 70:30 
6  Rh2(OAc)4 36
 84:16 
7  Rh2(oct)4 15
 93:7 
8  Rh2(esp)2 13
 96:4 
aAll reactions were run on 1 mmol scale. Yields are 1H NMR yields and were determined by 1H 
NMR using 1,4-dimethylterephthalate as internal standard. Regioisomeric ratio (rr) was 
determined by 1H NMR of the crude reaction mixture, and is a ratio of 2.12a:2.12b. 
 
In order to investigate the role of the catalyst in the regioselectivity of the reaction, we 
focused on p-xylene as a model substrate, since only two possible regioisomers could arise 
(2.12a/b). As shown in Table 2-1, although more electron-deficient ligands provided higher yields 
in the Buchner reaction, lower rr was observed (entry 5). Conversely, using the electron-rich 
Rh2(esp)2 (entry 8), we observed excellent regioselectivity, albeit in prohibitively poor yields. 
Variation in reaction temperature, concentration, and catalyst loading were ineffective in providing 
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higher regioselectivity in the reaction. In light of these findings, we decided to use Rh2(TFA)4 
throughout our screening, with the caveat that downstream separation of the multiple regioisomers 
would be required. 
2.3.3 Substrate Scope of the Rh2(TFA)4 Catalyzed Buchner Reaction 
Upon screening a variety of substituted benzene derivatives under the standard reaction 
conditions, moderate yields were observed for a variety of electron-rich systems. Diminished 
yields were observed for electron-deficient aromatic substrates, which is expected for reactions 
with highly electrophilic rhodium carbenoids. Isolation of the CHTs was complicated by 
appreciable instability of the Buchner products towards silica gel. Significant losses were observed 
upon each iteration of silica gel chromatography, as can be seen upon comparing the 1H NMR 
yield of 2.1 and its isolated yield. Although the identity of the remaining mass balance was not 
determined, it is likely to result from rearomatization of the NCD intermediate. Therefore, in 
subsequent functionalization of the Buchner products, the crude material was carried forward 
without purification (vide infra).  
Table 2-2. Substrate Scope of the Rh2(TFA)4 Catalyzed Buchner Reaction
a 
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2.3.4 Rationale for the Observed Regioselectivity in the Intermolecular Buchner Reaction 
There were two key aspects to the factors that governed the regioselectivity of the Buchner 
reaction: steric and electronic effects. In alkyl substituted aromatic compounds, the steric effects 
seemed to govern the regioselectivity of the bond forming event. Using toluene to generate the 
cycloheptatriene mixture 2.13, the least sterically encumbered site 2.13a was the major product, 
with decreasing product yields approaching the methyl group (Scheme 2-10a). The Buchner 
reaction was so sensitive towards the steric impact of the substrates substituents such that 1,4-bis-
hydroxymethyl-substituted arenes did not undergo the Buchner reaction, regardless of the 
protecting group on the primary alcohols (Scheme 2-10b). 
Scheme 2-10. Steric Effects on the Regioselectivity of the Intramolecular Buchner Reaction 
 
At the same time, a simple steric argument was insufficient to completely describe this 
reaction, since the non-symmetrical CHT 2.12a was the major isomer using p-xylene as substrate, 
even when it appeared to arise from cyclopropanation at the more congested site.  
It has been suggested20 that there is a significant electronic component to the 
regioselectivity of this reaction. Cyclopropanation reactions involving dirhodium carboxylate 
carbenoid intermediates are thought to proceed via a concerted process; however, the bond forming 
steps are not necessarily synchronous. In the context of this reaction, the mechanism of 
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cycloaddition was reasonable to consider a concerted, asynchronous process. With that in mind, 
the first bond forming “event” should occur at the position on the aromatic substrate with the 
highest HOMO, since the intermediate carbenoid was electrophilic. Upon reaction with anisole, 
one would expect initial addition to either the ortho- or para-positions. Initial attack at the para-
position provided the major product (2.16a). Initial attack at the ortho-position, however, could 
result in either the 1,2-addition product (Scheme 2-11), providing 2.16c, or the 1,6-addition 
product to give the 2-methoxy-substituted cycloheptatriene 2.16b. Since the latter product was not 
observed, it was evident that the 1,2-addition pathway was significantly more facile than the 1,6-
pathway.  
Along these lines, using an electron-deficient aromatic substrate, such as methyl benzoate, 
should provide a statistical mixture of the 2- and 3-substituted products, owing to the lack of 
direction by initial attack at the meta-position. In the event, we observed a 56:44 ratio of 
2.19a/2.19b, which was congruent with such an analysis. 
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Scheme 2-11. Electronic Effects on the Regioselectivity of the Intramolecular Buchner Reaction 
 
 
2.3.5 Isomerization of Norcaradienes by Ring Walking 
Although the CHT products were unable to be formed as single regioisomers, their 
fluxional nature provided us with ample opportunities to address this inconvenience. In one such 
instance, upon prolonged storage (>4 months), we noticed that the regioisomeric ratio of the 
Buchner products changed over time. As shown in Scheme 2-12, p-xylene derived CHT mixture 
2.12 became slightly more enriched in CHT 2.12a over this time; similar anomalies were observed 
for the other Buchner products. Since there was no evidence of degradation/rearomatization of the 
CHT, it was reasoned that the regioisomeric mixture was isomerizing. 
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Scheme 2-12. Isomerization of Regioisomeric Mixture upon Prolonged Storage 
 
It is documented that NCDs and related compounds can isomerize via a ring-walking 
mechanism,23,24 as shown in Scheme 2-13a. Computational studies suggest that this ring walking 
proceeds through a biradical intermediate.25 This mechanism is plausible in the case of 2.12, since 
a polar mechanism would likely result in rearomatization (upon subjecting NCD diesters to Lewis 
acidic conditions, we observed complete rearomatization in under 5 min, Scheme 2-13b). 
Scheme 2-13. Proposed Biradical Mechanism for Norcaradiene Ring Walk 
 
We thought to probe the ring-walking phenomenon in hopes of quickly isomerizing the 
regioisomeric Buchner mixtures to single regioisomers. We probed a variety of Lewis acids and 
potential radical promoters for their ability to isomerize 2.12b to 2.12a some of which are included 
in Table 2-3.  
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Table 2-3. Ring Walk Promoter Screen 
 
entry promoter (x mol %) temperature (°C) time (h) 2.12a : 2.12b 
1 n/a 23 0 70 : 30 
2 n/a -20 >3000 78 : 22 
3 FeSO4•7H2O (10) 23 60 88 : 12 
4 CuSO4•5H2O (10) 23 60 80 : 20 
5 FeCl2 (10) 23 20 82 : 18 
6 FeI2 (10) 23 20 97 : 3 
7 I2 (3) 23 15 92 : 8 
8 I2 (3) 4 15 >99 : 1 
9 TEMPO (100) 23 17 >99 : 1 
 
In the case of strong Lewis acids (i.e., BBr3, FeCl3), we observed significant 
rearomatization and other degradation products. However, when employing FeI2, we observed 
near complete convergence to 2.12a. Since older bottles of FeI2 contain a significant portion of 
free I2, we found that I2 itself is competent at promoting the ring walk of 2.12, with significantly 
higher selectivity at colder temperatures. To confirm that this reaction was proceeding via a 
biradical pathway, the addition of TEMPO provided complete convergence to 2.12a upon stirring 
at room temperature overnight. While it is unclear the exact role of I2 in the rearrangement, the 
homolysis of I2 to generate I
• is a likely mechanistic step to encourage the formation of the requisite 
biradical intermediate.  
Although the isomerization of 2.12b to 2.12a was efficient, in cases where there were more 
than two regioisomeric products, the isomerization was not as clean (Table 2-4). Toluene-derived 
2.13 did not experience significant changes in the relative amounts of the respective regioisomers. 
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m-Xylene derived 2.14 saw an appreciable increase in the relative amounts of the 1,3-dimethyl 
2.14b, albeit with retention of appreciable levels of the remaining two regioisomers. Notably, 
methoxy-substituted 2.16 cleanly converted to the 1-methoxy CHT. 
Table 2-4. Isomerization of Regioisomeric Buchner Products by I2 
 
These results can be rationalized by the propensity of each regioisomer to exist as the NCD 
isomer. Since the ring walk occurs through NCD intermediates, regioisomers that readily convert 
to a NCD 2.12b will undergo the ring walk at a faster rate than those that reside primarily as a 
CHT, resulting in an accumulation of the CHT isomer 2.12a (Scheme 2-14).  
Scheme 2-14. Rationale for Regioisomeric Distribution in Ring Walk Isomerizations 
 
Incomplete isomerization to a single product was often observed in the trisubstituted CHTs 
(2.13, 2.14, 2.17, etc.). This is likely due to two of the CHTs having appreciable kinetic barriers to 
forming the requisite NCD for ring walking, resulting in multiple kinetic sinks. It may be possible 
to coerce the systems to converge to a singular product; however, practicality dictated alternative 
57 
 
methods for accessing regioisomerically enriched products (see Section 2.3.7 for one such 
discussion).  
2.3.6 Further Functionalization of Buchner Products in Cycloaddition Reactions 
In order to probe the utility of Buchner products 2.1 as viable synthetic intermediates, we 
first investigated their reactivity towards DielsAlder cycloaddition, although they are known to 
react slowly with many dienophiles.26 Central to confronting the DielsAlder reaction rate problem 
was the recognition that conventional activation modes for accelerating DielsAlder cycloaddition 
(e.g. Lewis acid catalysis) might be precluded by the tendency of the norcaradienes to 
rearomatize.18,27  
Table 2-5. Rate Enhancement on the DielsAlder Reactions of 2.1 on Water 
 
While we continued to pursue reaction conditions that would have a lower propensity 
toward cyclopropane opening (e.g. iminium ion catalysis), in a parallel investigation we discovered 
a dramatic solvent effect that renders norcaradiene cycloadditions immediately more user friendly.  
Specifically, by using saturated aqueous NaCl as the reaction solvent, the reaction of 
cycloheptatriene 2.1 with a variety of activated carbon dienophiles (Table 2-5) led to exclusive 
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reaction via the norcaradiene isomer to providing endo-DielsAlder products 2.21-2.24 as single 
diastereomers (via dienophile facial approach anti to the cyclopropyl moiety);28 the structure was 
confirmed by an X-ray diffraction study of 2.21 (see section 2.5 for Experimental Details). 
Notably, the rate enhancement was significantly less pronounced using water without the added 
salt. 
The rate increase for the aqueous DielsAlder reaction was pronounced in the room 
temperature formation of 2.21 or 2.22 using maleic anhydride or N-benzyl maleimide, 
respectively, as the dienophiles (reaction times:  2.21 – Et2O, 3 h; brine, 90 s; 2.22 – Et2O, 16 h; 
brine, 90 s). The solvent effect was especially dramatic in the case of naphthoquinone: after stirring 
at room temperature in brine for 20 h, 22% conversion to 2.23 was observed with naphthoquinone 
as the dienophile. In diethyl ether under otherwise similar conditions, only trace product formation 
was observed. Under microwave irradiation (100 °C, 1 h) in brine, 95% conversion to the 
DielsAlder product 2.23 was observed, whereas the use of ethyl acetate under the same conditions 
provided less than 2% conversion of 2.1. Related reactions using naphthoquinone are reported to 
require prolonged heating (>120 °C, 7 d) to achieve suitable conversion.29 Treating 2.1 with 
dimethyl acetylenedicarboxylate (DMAD)30 under analogous microwave conditions provided 2.24 
in 50% yield in brine, compared with trace product formation in EtOAc. The dramatic rate 
enhancements observed for these DielsAlder reactions conducted in brine is most likely a 
manifestation of the hydrophobic effect.31 
Scheme 2-15. DielsAlder of 2.1 with PTAD 
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Hetero-DielsAlder reactions also proceeded with the norcaradiene isomer of 2.1. Treating 
2.1 with 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD) in tetrahydrofuran provided complete 
conversion to the desired adduct 2.25 in under 60 s (Scheme 2-15).32 Photochemically-generated 
singlet oxygen33 smoothly afforded the endoperoxide 2.26 in 7 h; however, this product was 
challenging to isolate when the reaction was further scaled as prolonged irradiation of 2.26 resulted 
in homolysis of the OO bond and subsequent cyclization with the pendant alkene to provide the 
syn-bis-epoxide 2.27 (Scheme 2-16).34 Productive reactivity with less reactive dienophiles 
(acrylates, acroleins, fumarates, etc.) in brine or organic solvents has been elusive to date; a screen 
of Lewis acid35 or iminium36 activators was ineffective.  
Scheme 2-16. Photosensitized Singlet Oxygen DielsAlder Reaction of 2.1 
 
2.3.7 Investigations into the Kinetic Separation of Regioisomeric Mixtures 
With proof-of-concept demonstrated for selective NCD (over CHT) reactivity DielsAlder 
reactions, we turned our attention to expanding the scope of the reaction to encompass the 
regioisomerically impure substituted CHTs (Scheme 2-17). (For a description of the 
regioselectivity of the intermolecular Buchner reaction of substituted benzenes and the associated 
numbering scheme, see Section 2.5 for the Experimental Details.) In our initial screen with p-
xylene-derived 2.12a/b and maleic anhydride using brine as the reaction medium, we observed 
complete conversion of the stable NCD 2.12b in under 2 min to 2.28, while CHT 2.12a failed to 
react prior to hydrolysis of maleic anhydride (<20 min). However, when N-benzylmaleimide 
(which exhibits increased hydrolytic stability relative to maleic anhydride) was employed, full 
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conversion to both regioisomeric products to 2.30/2.31 was realized upon prolonged stirring in 
brine (16 h). In light of these results and in order to resolve both product regioisomers, we 
envisioned a kinetic separation of the two isomers via successive treatment of the 2.12a/b with 
maleic anhydride followed by N-benzylmaleimide in a one-pot procedure. While this approach 
was effective in delivering the desired orthogonal reactivity pattern, isolation of the two products 
2.28/2.31 was complicated by challenges associated with their purification. 
Scheme 2-17. Kinetic Separation of Chromatographically Inseparable Regioisomersa 
 
2.3.8 Optimized Multistep Route to Regioisomerically Enriched Buchner Products 
To address these issues, we devised a two-step procedure to facilitate isolation and 
purification of both products. Two considerations were key to this endeavor: first, given that PTAD 
reacts with 2.1 more rapidly than N-benzylmaleimide, we transitioned to using the former as the 
second dienophile in the reaction sequence.  
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Table 2-6. Optimized Kinetic Separation via Buchner/DielsAlder Reaction Sequencea  
 
Furthermore, the anhydride moieties of 2.21 could be selectively hydrolyzed in the 
presence of the urazoles 2.25 to generate diacids, which allowed for facile separation of the two 
products by an aqueous extraction (Table 2-6). We were, however, unable to isolate the diacids 
from 3-methoxy substituted cycloheptatrienes under this manifold, although the initial Diels–
Alder adducts with maleic anhydride were readily identified by 1H NMR prior to hydrolysis. The 
halo-substituted cycloheptatrienes 2.18, 2.32 were slow to react with maleic anhydride, and we 
62 
 
were only able to convert the 3-halo-substituted isomers to product using PTAD, with the other 
regioisomers being inert to the reaction conditions, even upon stirring for multiple days. 
In our screening, we observed that the rate of the reaction of the dienes corresponded well 
with the position of the CHT/NCD equilibrium. While there are many factors that influence the 
equilibrium (see Section 2.2.3),18 in the context of this manuscript,  substitution at the 1- or 6-
position shifted the equilibrium toward the CHT. Notably, electron donating substituents at this 
position greatly favored the CHT, as evidenced by the isolation of 2.43, resulting from the (4+2)-
cycloaddition of the 1-methoxy-substituted CHT isomer 2.16c (Scheme 2-18). 
Scheme 2-18. DielsAlder Reaction of 1-Methoxy-CHT 2.16c 
 
2.3.9 Desymmetrization of meso-[2.2.2]-Bicycles 
The benzene-derived norcaradiene DielsAlder adducts are meso compounds containing 
six asymmetric centers.  The viability of these products in stereoselective cyclohexane synthesis 
was explored in the context of a number of symmetry-breaking product manipulations.  First, using 
cinchona alkaloids and alcoholic nucleophiles,37 the anhydride 2.21 underwent enantiotopic group-
selective nucleophilic acyl substitution, providing hemiesters 2.44a and 2.44b in 94:6 er with 
excellent diastereoselectivity (>20:1). Either enantiomer was accessible with comparable 
selectivity via appropriate selection of cinchona alkaloid promotor. Monoacids 2.44a/b contain 
seven contiguous stereocenters—accessed from an achiral, meso-DielsAlder adduct 2.21—
obtainable in three steps from benzene (Scheme 2-19).  
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Scheme 2-19. Anhydride Desymmetrization Using Cinchona Alkaloids 
 
The hemiesters 2.44a/b were then further manipulated towards the goal of cyclopropane 
ring-opening (Scheme 2-20). Accordingly, reduction of 2.44a using LiEt3BH followed by acid-
promoted lactonization provided the cyclopropyl methanol, which could then be converted to the 
alkyl iodide 2.45 via Appel reaction. Photolysis of the alkyl iodide in the presence of Bu3SnH 
revealed a primary cyclopropylmethyl radical that rearranged rapidly to form a secondary radical 
concomitant with cyclopropane ring-opening,38 providing a regioisomeric mixture of 2.46 and 2.47 
in 93% yield (Scheme 2-20).  
Scheme 2-20. Cyclopropane Ring-Opening of Desymmetrized Mono-Acid 2.44a 
 
Finally, meso-bis-epoxide 2.27 (derived from prolonged photolysis of endoperoxide 2.26, 
vide supra) also may be converted to new chiral structures (Scheme 2-21). Reduction of 2.27 via 
treatment with MeMgI and SnBu3H to afford the resulting syn-1,4-diol.  Desymmetrization of the 
meso-diol was then accomplished in two steps via initial condensation with p-toluenesulfonyl 
isocyanate to provide the bis-carbamate 2.48 in 87% yield from 2.27. Selective π-allyl 
displacement of the enantiotopic carbamates39 under Pd(0) catalysis afforded the protected 1,2-
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syn-aminoalcohol 2.49. Extension of this methodology to enantioselective methods is well-
precedented.40  
Scheme 2-21. Desymmetrization of meso-bis-Carbamate 2.48 
 
2.4 Conclusions 
In conclusion, we have shown that inexpensive, commercially-available aromatic 
compounds may be deployed in the synthesis of complex cyclohexane derivatives in an expedient 
manner. As a means to independently isolate both regioisomers in the Buchner reaction of p-xylene 
(2.12a/b), the inseparable regioisomeric NCD/CHT mixture was kinetically resolved upon 
successive treatment with dienophiles of variable rates of reaction. Furthermore, enantioselective 
desymmetrization of meso-DielsAlder products 2.21, 2.27 enables access to up to seven 
stereocenters in a single operation from achiral materials. The present method should provide a 
new conceptual blueprint for the expedient assembly of complex carbocyclic structures. Additional 
improvements to Buchner reaction regioselectivity and further extension of CHT product 
transformations are reported in Chapter Three. 
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2.5 Experimental Details 
Methods 
Proton and carbon magnetic resonance spectra (1H NMR and 13C NMR) were recorded on 
either a Bruker model DRX 400 or 600 spectrometer (1H NMR at 400 or 600 MHz and 13C NMR 
at 100 or 150 MHz) with solvent resonance as the internal standard (1H NMR: CDCl3 at 7.28 ppm 
and 13C NMR: CDCl3 at 77.0 ppm). 
1H NMR data are reported as follows: chemical shift, 
multiplicity (abbreviations: s = singlet, br s = broad singlet, d = doublet, dd = doublet of doublets, 
ddd = doublet of doublet of doublets, dddd = doublet of doublet of doublet of doublets, dt = doublet 
of triplets, t = triplet, td = triplet of doublets, tt = triplet of triplets, qt = quintet, and m = multiplet), 
coupling constant (Hz) and integration. Melting points (mp) were determined using a Thomas 
Hoover Capillary Melting Point Apparatus and are uncorrected. Infrared (IR) spectra were 
obtained using a Jasco 260 Plus Fourier Transform Infrared Spectrometer. High resolution mass 
spectrometry (HRMS) was performed using a Thermo Scientific LTQ FT Ultra mass spectrometer 
S2 with direct infusion in either the positive or negative ion mode. Samples were prepared in HPLC 
grade methanol. All reported masses obtained in the positive ion mode correspond to the 
protonated molecular ion (M+H) unless otherwise noted, and all reported masses obtained in the 
negative ion mode correspond to the deprotonated molecular ion (M–H), unless otherwise noted. 
High performance liquid chromatography (HPLC) was performed on a Perkin Elmer Flexar® 
HPLC system equipped with a Chiracel IA column. Samples were eluted with HPLC grade 
hexanes with the indicated percentage of iPrOH with an oven temperature of 40 °C. Optical 
rotations were measured using a 2 mL cell with a 1 dm path length on a Jasco DIP 1000 digital 
polarimeter. Microwave reactions were performed using a 300 W CEM Discover System with 
internal temperature monitoring via infrared sensing, in sealed 10 mL pressure vessels with a 
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maximum ramp time of 2 min. Reactions performed “on water” were run in either conventional 
round-bottomed flasks or 1 or 5 dram vials with rapid agitation, either by vigorous manual shaking, 
or stirring (>900 rpm); we noticed no noticeable difference in the two methods. Thin layer 
chromatography (TLC) was performed on Sorbtech plastic-backed 0.20 mm silica gel 60 plates. 
Visualization was accomplished with UV light and either an aqueous ceric ammonium molybdate 
(CAM) or potassium permanganate (KMnO4) solution, followed by heating. Flash 
chromatography was performed under positive air pressure using Siliaflash-P60 silica gel (40-63 
μm) purchased from Silicycle. Unless otherwise specified, all crude materials were introduced to 
the chromatography column after dissolution in the specified eluent (plus a few drops 
dichloromethane, if required). Yields, regioisomeric ratios (rr’s) and diastereomeric ratios (dr’s) 
are reported herein for a specific experiment and as a result may differ slightly from those found 
in the tables, which are averages of at least two experiments. 
 
Materials 
Nitrogen was dried by passage through anhydrous calcium sulfate with 3% cobalt chloride 
as indicator (commercial Drierite). Ethyl diazoacetate,41 N-benzylmaleimide,42 and 4-phenyl-
1,2,4-triazoline-3,5-dione (PTAD)43 were prepared according to known literature procedures. The 
cycloheptatrienes 2.1, 2.12-2.19, 2.32 were prepared by a modified literature procedure.17,20 The 
ethyl diazoacetate was stored at room temperature as a solution (>80% w/w) in CH2Cl2 in a brown 
bottle to exclude light. Caution: While we experienced no difficulties in handling ethyl 
diazoacetate, care must be taken at all times when handling diazo compounds, as they are known 
to be explosive, especially upon heating during distillation.41 All aromatic substrates were purified 
by distillation prior to use. In all reactions run on water, solid reagents (maleic anhydride, N-
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benzylmaleimide, naphthoquinone) were ground into fine powders prior to use. All other reagents 
and solvents were purchased from commercial sources and used as received. 
General Procedure A for the Preparation of Cycloheptatrienes/Norcaradienes (2.1, 2.12-
2.19, 2.32) 
 
To a 25 mL round-bottomed flask charged with Rh2(TFA)4 (6.6 mg, 0.01 equiv), the 
aromatic substrate (20 equiv), and CH2Cl2 (2.5 mL) was added a 2.5 mL solution of ethyl 
diazoacetate (114 mg, 1 mmol) in CH2Cl2 via syringe pump addition over 3 h. After complete 
addition, the brown solution was stirred for an additional hour at room temperature, at which time 
the CH2Cl2 was removed by rotary evaporation, and the excess arene was removed and could be 
recovered by distillation under reduced pressure with gentle heating (<40 °C). Analytically pure 
material was obtained following purification by silica gel chromatography. Complete analytical 
data are reported for new compounds; only 1H NMR data are reported for known compounds. In 
cases where multiple regioisomers were formed, the isomers are listed in decreasing order of 
percent composition of the isolated mixture, and when possible, the resonances are identified for 
each isomer. The percentage shown in parentheses after identification of the regioisomer reflects 
the percent composition of that isomer in the regioisomeric mixture of the product mixture. Also 
indicated are the cases where the norcaradiene (NCD) is the predominant isomer by 1H NMR 
analysis.  
 Ethyl cyclohepta-1,3,5-triene-7-carboxylate (2.1): The title compound was 
prepared according to General Procedure A using benzene (1.78 mL, 20 mmol), 
ethyl diazoacetate (114 mg, 1 mmol), and Rh2(TFA)4 (6.6 mg, 0.01 mmol). Flash chromatography 
(10% EtOAc/hexanes) provided a clear oil (94 mg, 57%). Analytical data: 1H NMR (600 MHz, 
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CDCl3) δ 6.68 (m, 2H), 6.28 (m, 2H), 5.46 (dd, J = 9.2, 5.6 Hz, 2H), 4.28 (q, J = 7.2 Hz, 2H), 2.56 
(t, J = 5.6 Hz, 1H), 1.33 (t, J = 7.2 Hz, 3H); TLC (20% EtOAc/hexanes) Rf = 0.59.  
Ethyl 3-methylcyclohepta-1,3,5-triene-7-carboxylate (2.13): The title 
compound was prepared according to General Procedure A using toluene (2.13 
mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol), and Rh2(TFA)4 (6.6 mg, 
1 mmol). Flash chromatography (10% EtOAc/hexanes) provided a clear oil (105 
mg, 64%). Analytical data: 1H NMR (600 MHz, CDCl3) δ (2.13a, 3-Me, 60%) 
6.44 (m, 1H), 6.20 (m, 1H), 6.10 (m, 1H), 5.40 5.32 (m, 2H), 4.27 (q, J = 7.2 
Hz, 2H), 2.57 (t, J = 5.6 Hz, 1H), 2.09 (s, 3H), 1.32 (t, J = 7.2 Hz, 3H); (2.13b, 2-Me, 27%) 6.44 
(m, 2H), 6.20 (m, 1H), 5.05 (m, 1H), 4.75 (m, 1H), 4.27 (q, J = 7.2 Hz, 2H), 2.26 (t, J = 5.2 Hz, 
1H), 1.97 (s, 3H), 1.32 (t, J = 7.2 Hz, 3H); (2.13c, 1-Me, 13%) 6.55 (m, 2H), 6.24 (dd, J = 9.1, 
4.8 Hz, 1H), 6.12 (d, J = 4.2 Hz, 1H), 5.72 (dd, J = 9.1, 7.0 Hz, 1H), 5.36 (m, 1H), 4.27 (q, J = 7.2 
Hz, 2H), 2.85 (d, J = 7.0 Hz, 1H), 1.99 (s, 3H), 1.32 (t, J = 7.2 Hz, 3H); TLC (20% EtOAc/hexanes) 
Rf = 0.60. 
Ethyl 1,4-dimethylcyclohepta-1,3,5-triene-7-carboxylate (2.12): The title 
compound was prepared according to General Procedure A using p-xylene (2.47 
mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol), and Rh2(TFA)4 (6.6 mg, 
0.01 mmol). Flash chromatography (10% EtOAc/hexanes) provided a clear oil 
(115 mg, 60%). Analytical data: 1H NMR (600 MHz, CDCl3) δ (2.12a, 1,4-Me, 
70%) 6.33 (d, J = 3.2 Hz, 1H), 6.07 (d, J = 6.0 Hz, 1H), 6.01 (d, J = 3.2 Hz, 1H), 5.69 (dd, J = 
6.0, 4.4 Hz, 1H), 4.25 (q, J = 7.2 Hz, 2H), 2.89 (d, J = 4.4 Hz, 1H), 2.05, (s, 3H), 1.95 (s, 3H), 1.31 
(t, J = 7.2 Hz, 3H); (2.12b, 2,5-Me (NCD), 30%) 6.05 (s, 2H), 4.25 (q, J = 7.2 Hz, 2H), 3.79 (br 
s, 2H), 1.97 (s, 6H), 1.59 (m, 1H), 1.31 (t, J = 7.2 Hz, 3H); TLC (20% EtOAc/hexanes) Rf = 0.62. 
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Ethyl 2,4-dimethylcyclohepta-1,3,5-triene-7-carboxylate (2.14): The title 
compound was prepared according to General Procedure A using m-xylene 
(2.47 mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol), and Rh2(TFA)4 (6.6 
mg, 0.01 mmol). Flash chromatography (10% EtOAc/hexanes) provided a clear 
oil (93 mg, 48%). Analytical data: 1H NMR (600 MHz, CDCl3) δ (2.14a, 2,4-
Me, 50%) 6.16 (br s, 1H), 5.94 (br s, 1H), 4.73 (m, 1H), 4.43 (br s, 1H), 4.25 
(q, J = 7.2 Hz, 2H), 2.11 (t, J = 5.2 Hz, 1H), 1.99 (s, 3H), 1.96 (s, 3H), 1.31 (t, J = 7.2 Hz, 3H); 
(2.14b, 1,3-Me, 35%) 6.36 (d, J = 5.6 Hz, 1H), 6.14 (m, 1H), 5.96 (br s, 1H), 5.65 (dd, J = 9.2, 
6.7 Hz, 1H), 4.25 (q, J = 7.2 Hz, 2H), 2.89 (d, J = 6.7 Hz, 1H), 2.05 (s, 3H), 1.95 (s, 3H), 1.31 (t, 
J = 7.2 Hz, 3H); (2.14c, 1,5-Me, 15%) 6.44 (m, 2H), 6.01 (m, 1H), 5.47 (d, J = 6.8 Hz, 1H), 4.25 
(q, J = 7.2 Hz, 2H), 2.84 (d, J = 6.8 Hz, 1H), 1.96 (s, 3H), 1.94 (s, 3H), 1.31 (t, J = 7.2 Hz, 3H); 
TLC (20% EtOAc/hexanes) Rf = 0.62. 
Ethyl 3,4-dimethylcyclohepta-1,3,5-triene-7-carboxylate (2.50): The title 
compound was prepared according to General Procedure A using o-xylene (2.47 
mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol), and Rh2(TFA)4 (6.6 mg, 
0.01 mmol). Flash chromatography (10% EtOAc/hexanes) provided a clear oil 
(79 mg, 41%). Analytical data: 1H NMR (600 MHz, CDCl3) δ (2.50a, 3,4-Me, 
42%) 6.04 (d, J = 8.0 Hz, 2H), 4.79 (dd, J = 8.0, 5.6 Hz, 2H), 4.25 (q, J = 7.2 
Hz, 2H), 2.25 (t, J = 5.6 Hz, 1H), 1.97 (s, 6H), 1.32 (t, J = 7.2 Hz, 3H); (2.50b, 2,3-Me, 41%) 6.32 
(d, J = 6.4 Hz, 1H), 6.09 (t, J = 7.6 Hz, 1H), 5.05 (m, 1H), 4.82 (m, 1H), 4.25 (q, J = 7.2 Hz, 2H), 
2.12 (t, J = 4.8 Hz, 1H), 2.03 (s, 3H), 1.95 (s, 3H), 1.31 (t, J = 7.2 Hz, 3H); (2.50c, 1,2-Me, 17%) 
6.56 (d, J = 11.0 Hz, 1H), 6.48 (dd, J = 11.0, 5.4 Hz, 1H), 6.18 (dd, J = 9.6, 5.4 Hz, 1H), 5.77 (dd, 
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J = 9.6, 6.8 Hz, 1H), 4.25 (q, J = 7.2 Hz, 2H), 2.69 (d, J = 6.8 Hz, 1H), 1.91 (s, 3H), 1.86 (s, 3H), 
1.32 (t, J = 7.2 Hz, 3H); TLC (20% EtOAc/hexanes) Rf = 0.62.  
Ethyl 1,3,5-trimethylcyclohepta-1,3,5-triene-7-carboxylate (2.15): The title 
compound was prepared according to General Procedure A using mesitylene 
(2.78 mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol), and Rh2(TFA)4 (6.6 mg, 0.01 mmol). 
Flash chromatography (10% EtOAc/hexanes) provided a clear oil (129 mg, 62%). Analytical data: 
1H NMR (400 MHz, CDCl3) δ 6.25 (s, 1H), 5.84 (s, 1H), 5.38 (d, J = 6.8 Hz, 1H), 4.24 (q, J = 7.2 
Hz, 2H), 2.87 (d, J = 6.8 Hz, 1H), 2.01 (s, 3H), 1.93 (s, 3H), 1.90 (s, 3H), 1.30 (t, J = 7.2 Hz, 3H); 
TLC (20% EtOAc/hexanes) Rf = 0.64.  
Ethyl 3-fluorocyclohepta-1,3,5-triene-7-carboxylate (2.18): The title 
compound was prepared according to General Procedure A using fluorobenzene 
(1.88 mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol), and Rh2(TFA)4 (6.6 
mg, 0.01 mmol). Flash chromatography (10% EtOAc/hexanes) provided a clear 
oil (99 mg, 54%). Analytical data: 1H NMR (600 MHz, CDCl3) δ (2.18a, 3-F, 
67%) 6.40 (m, 1H), 6.24 (m, 2H), 5.69 (m, 1H), 5.388 (dd, J = 9.0, 5.4 Hz, 1H), 4.28 (q, J = 7.2 
Hz, 2H), 2.69 (m, 1H), 1.32 (t, J = 7.2 Hz, 3H); (2.18b, 2-F, 20%) 6.60 (ddd, J = 10.8, 6.0, 4.2 
Hz, 1H), 6.40 (m, 1H), 6.17 (dd, J = 9.6, 6.0 Hz, 1H), 5.43 (dd, J = 7.8, 6.0 Hz, 1H), 5.03 (dd, J = 
12.6, 6.0 Hz, 1H), 4.24 (q, J = 7.2 Hz, 2H), 2.69 (m, 1H), 1.30 (t, J = 7.2 Hz, 3H); (2.18c, 1-F, 
13%) 6.47 (dd, J = 11.7, 5.7 Hz, 1H), 6.34 (dd, J = 9.6, 5.7 Hz, 1H), 6.29 (ddd, J = 12.9, 11.7, 6.6 
Hz, 1H), 6.06 (dd, J = 12.9, 7.2 Hz, 1H), 5.69 (m, 1H), 4.16 (m, 2H), 3.71 (dd, J = 18.0, 7.8 Hz, 
1H), 1.24 (t, J = 7.2 Hz, 3H); TLC (20% EtOAc/hexanes) Rf = 0.54.  
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Ethyl 3-chlorocyclohepta-1,3,5-triene-7-carboxylate (2.32): The title 
compound was prepared according to General Procedure A using chlorobenzene 
(2.03 mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol), and Rh2(TFA)4 (6.6 
mg, 0.01 mmol). Flash chromatography (10% EtOAc/hexanes) provided a clear 
oil (113 mg, 57%). Analytical data: 1H NMR (600 MHz, CDCl3) δ (2.32a, 3-Cl, 
70%) 6.82 (dd, J = 6.6, 1.2 Hz, 1H), 6.26 – 6.20 (m, 2H), 5.53 (dd, J = 9.6, 6.0 Hz, 1H), 5.50 (dd, 
J = 9.6, 5.4 Hz, 1H), 4.27 (q, J = 7.2 Hz, 2H), 2.72 (dd, J = 6.0, 5.4 Hz, 1H), 1.32 (t, J = 7.2 Hz, 
3H); (2.32b, 2-Cl, 18%) 6.54 (dd, J = 10.2, 5.4 Hz, 1H), 6.50 (d, J = 10.2 Hz, 1H), 6.23 (m, 1H), 
5.21 (m, 1H), 5.18 (ddd, J = 8.4, 5.4, 1.8 Hz, 1H), 4.26 (q, J = 7.2 Hz, 2H), 2.50 (dd, J = 6.6, 5.4 
Hz, 1H), 1.32 (t, J = 7.2 Hz, 3H); (2.32c, 1-Cl, 11%) 6.61 (dd, J = 10.8, 5.4 Hz, 1H), 6.47 (d, J = 
6.0 Hz, 1H), 6.42 (dd, J = 10.8, 6.6 Hz, 1H), 6.34 (dd, J = 9.6, 6.0 Hz, 1H), 5.78 (dd, J = 9.0, 7.8 
Hz, 1H), 4.25 (q, J = 7.2 Hz, 2H), 3.48 (d, J = 7.8 Hz, 1H), 1.28 (t, J = 7.2 Hz, 3H); TLC (20% 
EtOAc/hexanes) Rf = 0.54. 
Ethyl 3-methoxycyclohepta-1,3,5-triene-7-carboxylate (2.16): The title 
compound was prepared according to General Procedure A using anisole (2.17 
mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol), and Rh2(TFA)4 (6.6 mg, 
0.01 mmol). Flash chromatography (10% EtOAc/hexanes) provided a clear oil (73 mg, 37%). 
Analytical data: 1H NMR (400 MHz, CDCl3) δ (2.16a, 3-OMe, 74%) 6.23 (m, 1H), 6.10 (dt, J = 
10.0 Hz, 1.6 Hz, 1H), 5.89 (dd, J = 6.8, 2.0 Hz, 1H), 5.65 (m, 1H), 5.29 (m, 1H), 4.27 (q, J = 7.2 
Hz, 2H), 3.69 (s, 3H), 2.71 (t, J = 5.6 Hz, 1H), 1.33 (t, J = 7.2 Hz, 3H); (2.16c, 1-OMe, 26%), 
6.49 (dd, J = 10.8, 6.6 Hz, 1H), 6.36 (dd, J = 10.8, 5.7 Hz, 1H), 6.31 (dd, J = 9.3, 5.7 Hz, 1H), 5.66 
(dd, J = 9.3, 7.2 Hz, 1H), 5.53 (d, J = 6.6 Hz, 1H), 4.27 (q, J = 7.2 Hz, 2H), 3.66 (s, 3H), 3.34 (d, 
J = 7.2 Hz, 1H), 1.33 (t, J = 7.2 Hz, 3H). TLC (20% EtOAc/hexanes) Rf = 0.51. 
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Ethyl 3-methoxy-6-methylcyclohepta-1,3,5-triene-7-carboxylate (2.17): 
The title compound was prepared according to General Procedure A using 4-
methylanisole (2.52 mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol), and 
Rh2(TFA)4 (6.6 mg, 0.01 mmol). Flash chromatography (10% EtOAc/hexanes) 
provided a clear oil (95 mg, 46%). Analytical data: 1H NMR (600 MHz, 
CDCl3) δ (2.17a, 3-OMe, 6-Me, 51%) 6.07 (d, J = 9.9 Hz, 1H), 6.01 (dd, J = 
6.6, 1.2 Hz, 1H), 5.86 (dd, J = 9.9, 7.2 Hz, 1H), 5.77 (d, J = 6.6 Hz, 1H), 4.20 (d, J = 7.2 Hz, 2H), 
3.64 (s, 3H), 2.91 (d, J = 7.2 Hz, 1H), 1.91 (s, 3H), 1.31 (t, J = 7.2 Hz, 3H); (2.17b, 1-OMe, 4-
Me, 31%) 6.24 (d, J = 6.9 Hz, 1H), 6.12 (d, J = 9.6 Hz, 1H), 5.64 (dd, J = 9.6, 7.4, 1H), 5.39 (d, 
J = 6.9 Hz, 1H), 4.20 (q, J = 7.2 Hz, 2H), 3.61 (s, 3H), 3.31 (d, J = 7.4 Hz, 1H), 2.02 (s, 3H), 1.25 
(t, J = 7.2 Hz, 3H); (2.17c, 2-OMe, 5-Me (NCD), 19%) 5.83 (br s, 1H), 5.26 (br s, 1H), 4.20 (q, 
J = 7.2 Hz, 2H), 3.62 (s, 3H), 1.95 (s, 3H), 1.29 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) 
δ (2.17a, 3-OMe, 6-Me) 172.2, 158.7, 124.9, 122.4, 122.3, 121.2, 103.9, 60.5, 54.7, 48.6, 20.0, 
14.2; (2.17b, 1-OMe, 4-Me) 170.3, 148.1, 133.2, 129.8, 124.9, 117.4, 96.7, 60.8, 56.4, 48.5, 23.6, 
14.1; IR (thin film, cm-1) 2980, 2937, 2836, 1740, 1616, 1550, 1463, 1369, 1315, 1034; TLC (20% 
EtOAc/hexanes) Rf = 0.54; HRMS (ESI
+) Calcd. for C12H16NaO3: 231.0992, Found: 231.0993.  
7-ethyl 3-methyl cyclohepta-1,3,5-triene-3,7-dicarboxylate (2.19): The 
title compound was prepared according to General Procedure A using methyl 
benzoate (2.51 mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol), and 
Rh2(TFA)4 (6.6 mg, 0.01 mmol). Flash chromatography (10% 
EtOAc/hexanes) provided a colored oil (50 mg, 23%). Analytical data: 1H NMR (400 MHz, 
CDCl3) δ (2.19a, 3-CO2Me, 57%) 7.63 (d, J = 6.0 Hz, 1H), 6.85 (d, J = 9.6 Hz, 1H), 6.42 (m, 
1H), 5.55 (ddd, J = 9.0, 5.4, 1.2 Hz, 1H), 5.34 (ddd, J = 9.0, 5.4, 1.2 Hz, 1H), 4.27 (q, J = 7.2 Hz, 
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2H), 3.85 (s, 3H), 2.42 (dd, J = 5.4, 5.4 Hz, 1H), 1.32 (t, J = 7.2 Hz, 3H); (2.19b, 2-CO2Me, 43%) 
7.19 (d, J = 10.2 Hz, 1H), 6.64 (dd, J = 10.2, 6.6 Hz, 1H), 6.39 (m, 1H), 5.72 (ddd, J = 5.4, 3.0, 
1.0 Hz, 1H), 4.82 (ddd, J = 8.4, 5.5, 3.0 Hz, 1H), 4.27 (q, J = 7.2 Hz, 2H), 3.81 (s, 3H), 2.10 (dd, 
J = 5.4, 5.4 Hz, 1H), 1.33 (t, J = 7.2 Hz, 3H). 
General Procedure B for the Buchner/DielsAlder Sequence of Benzene and Mesitylene 
 
To a 25 mL round-bottomed flask charged with Rh2(TFA)4 (6.6 mg, 0.01 equiv), the 
aromatic substrate (20 equiv), and CH2Cl2 (2.5 mL) was added a 2.5 mL solution of ethyl 
diazoacetate (114 mg, 1 mmol) in CH2Cl2 via syringe pump addition over 3 h. After complete 
addition, the brown solution was stirred for an additional hour at room temperature, at which time 
the CH2Cl2 was removed by rotary evaporation, and the excess arene was removed and could be 
recovered by distillation under reduced pressure, yielding a brown oil. The following conditions 
were employed for the appropriate dienophile: 
For maleic anhydride and N-benzylmaleimide: To the resultant oil was then added the 
dienophile (3 equiv) and saturated brine (NaCl) solution (10 mL), and the mixture was rapidly 
stirred at room temperature until the reaction was complete (2 – 30 min). The products were 
extracted with Et2O (2 × 5 mL), dried over MgSO4, filtered, concentrated, and purified by 
chromatography. For naphthoquinone: To the resultant oil was then added naphthoquinone (3 
equiv) and saturated brine (NaCl) solution (3 mL), and the mixture was heated under microwave 
irradiation (300 W, 100 °C, 1 h). Then the reaction mixture was diluted with EtOAc (25 mL), 
filtered through a short pad of activated charcoal and Celite, dried over MgSO4, filtered, 
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concentrated, and purified by chromatography. For dimethyl acetylenedicarboxylate (DMAD): 
To the resultant oil was then added DMAD (10 equiv) and saturated brine (NaCl) solution (3 mL), 
and the mixture was heated under microwave irradiation (300 W, 100 °C, 1 h). The products were 
extracted with EtOAc (2 × 10 mL), dried over Na2SO4, filtered, concentrated, and purified by 
chromatography. For 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD): To the resultant oil was then 
added PTAD (1.1 equiv) with 5 mL Et2O. After stirring for 10 min, the solvent was removed by 
rotary evaporation, and the residue was purified by chromatography. For O=O: To the resultant 
oil was added rose bengal (0.01 equiv), and the mixture was dissolved in CCl4/MeOH (20:1, 5 
mL) and cooled to 0 °C. Then a steady stream of O2 was bubbled through the solution and the 
mixture was irradiated with a Hg lamp with a Pyrex filter. After stirring for 7 – 24 h, the solvent 
was removed by rotary evaporation at room temperature, and the crude material was purified by 
chromatography.  
Ethyl -1,3-dioxo-3,3a,4,4a,5,5a,6,6a-octahydro-1H-4,6-ethenocyclopropa-
[f]isobenzofuran-5-carboxylate (2.21): The title compound was prepared according 
to General Procedure B using benzene (17.8 mL, 200 mmol), ethyl diazoacetate (1.14 
g, 10 mmol), Rh2(TFA)4 (65.8 mg, 0.1 mmol), and maleic anhydride (2.94 g, 30 mmol). Flash 
chromatography (40% EtOAc/hexanes) provided a white solid (2.32 g, 88%). Analytical data: 1H 
NMR (600 MHz, CDCl3) δ 5.97 (tt, J = 4.2, 3.6 Hz, 2H), 4.08 (q, J = 7.2 Hz, 2H), 3.57 (m, 2H), 
3.32 (tt, J = 4.2, 1.8 Hz,  2H), 1.76 (dt, J = 2.7, 2.4 Hz, 2H), 1.38 (t, J = 2.7 Hz, 1H), 1.23 (t, J = 
7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 171.7, 171.5, 129.1, 60.8, 45.2, 32.8, 20.3, 19.6, 14.1; 
mp  129130 °C; IR (thin film, cm-1) 2981, 1861, 1838, 1779, 1721, 1420, 1297, 1229, 1173, 926; 
TLC (20% EtOAc/hexanes) Rf = 0.07; HRMS (ESI
-) Calcd. for C14H13O5: 261.0768, Found: 
261.0770.  
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Ethyl -2-octyl-1,3-dioxo-1,2,3,3a,4,4a,5,5a,6,6a-decahydro-4,6-
ethenocyclopropa-[f]isoindole-5-carboxylate (2.22): The title compound was 
prepared according to General Procedure B using benzene (1.8 mL, 20 mmol), 
ethyl diazoacetate (114 mg, 1 mmol), Rh2(TFA)4 (6.6 mg, 0.01 mmol), and N-benzylmaleimide 
(234 mg, 1.25 mmol). Flash chromatography (30% EtOAc/hexanes) provided a white solid (260 
mg, 74%).  Analytical data: 1H NMR (600 MHz, CDCl3) δ 7.29 – 7.22 (m, 5H), 5.69 (t, J = 4.2 
Hz, 2H), 4.53 (s, 2H), 4.09 (q, J = 7.2 Hz, 2H), 3.50 (br s, 2H), 3.01 (br s, 2H), 1.74 (dd, J = 5.4, 
3.0 Hz, 2H), 1.35 (t, J = 3.0 Hz, 1H), 1.23 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 
177.3, 17.2, 135.6, 128.5, 128.3, 128.2, 127.6, 60.6, 44.5, 42.0, 32.8, 20.3, 19.9, 14.1; mp 172173 
°C; IR (thin film, cm-1) 2978, 1702, 1419, 1397, 1335, 1290, 1247, 1173, 1070, 910; TLC (20% 
EtOAc/hexanes) Rf = 0.08; HRMS (ESI
+) Calcd. for C21H22NO4: 352.1543, Found: 352.1564.  
Ethyl -3,8-dioxo-1a,2,2a,3,8,8a,9,9a-octahydro-1H-2,9-ethenocyclopropa-
[b]anthracene-1-carboxylate (2.23): The title compound was prepared according to 
General Procedure B using benzene (1.8 mL, 20 mmol), ethyl diazoacetate (114 mg, 
1 mmol), Rh2(TFA)4 (6.6 mg, 0.01 mmol), and naphthoquinone (474 mg, 3.0 mmol). Flash 
chromatography (20% EtOAc/hexanes) provided a brown solid (139 mg, 43%). Analytical data: 
1H NMR (600 MHz, CDCl3) δ 8.03 (dd, J = 6.0, 3.0 Hz, 2H), 7.71 (dd, J = 6.0, 3.0 Hz, 2H), 5.80 
(dd, J = 4.2, 3.9 Hz, 2H), 4.11 (q, J = 7.2 Hz, 2H), 3.76 (br s, 2H), 3.29 (s, 2H), 1.89 (dd, J = 4.8, 
3 Hz, 2H), 1.26 (t, J = 3.0 Hz, 1H), 1.26 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 196.8, 
172.9, 135.3, 134.2, 129.8, 126.9, 60.6, 49.5, 36.7, 20.6, 18.0, 14.2; mp 127128°C; IR (thin film, 
cm-1) 3065, 2980, 1717, 1678, 1592, 1418, 1274, 1161, 709; TLC (20% EtOAc/hexanes) Rf = 
0.13; HRMS (ESI-) Calcd. for C20H17O4: 321.1132, Found: 321.1144.  
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Ethyl -1,3-dioxo-2-phenyl-2,3,5a,6,6a,7-hexahydro-1H,5H-5,7-
ethenocyclopropa[d][1,2,4]triazolo[1,2-a]pyridazine-6-carboxylate (2.25): The 
title compound was prepared according to General Procedure B using benzene (1.8 
mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol), Rh2(TFA)4 (6.6 mg, 0.01 mmol), and 4-
phenyl-1,2,4-triazoline-3,5-dione (175 mg, 1.1 mmol). Flash chromatography (20% 
EtOAc/hexanes) provided a white solid (241 mg, 71%). Analytical data: 1H NMR (600 MHz, 
CDCl3) δ 7.43 (m, 4H), 7.35 (m, 1H), 6.17 (t, J = 4.2 Hz, 2H), 5.26 (m, 2H), 4.14 (q, J = 7.2 Hz, 
2H), 2.23 (m, 2H), 1.45 (t, J = 3.0 Hz, 1H), 1.26 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) 
δ 170.2, 156.4, 131.1, 129.0, 128.2, 126.0, 125.4, 61.1, 52.1, 23.5, 15.3, 14.0; mp  167168°C; IR 
(thin film, cm-1) 3066, 2982, 2937, 1770, 1715, 1503, 1407, 1319, 1235, 1177, 1048; TLC (20% 
EtOAc/hexanes) Rf = 0.08; HRMS (ESI
+) Calcd. for C18H18N3O4: 340.1292, Found: 340.1311.  
3-Ethyl-6,7-dimethyl-tricycle[3.2.2.02,4]nona-6,8-diene-3,6,7-tricarboxylate 
(2.24):  The title compound was prepared according to General Procedure B using 
benzene (1.8 mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol), Rh2(TFA)4 (6.6 
mg, 0.01 mmol), and dimethyl acetylenedicarboxylate (1.2 mL, 10 mmol). Flash chromatography 
(20% EtOAc/hexanes) provided a clear oil (178.2 mg, 58%). Analytical data: 1H NMR (600 MHz, 
CDCl3) δ 6.16 (t, J = 4.2 Hz, 2H), 4.25 (m, 2H), 4.07 (q, J = 7.2 Hz, 2H), 3.80 (s, 6H), 2.07 (dt, J 
= 2.4, 2.4 Hz, 2H), 1.76 (t, J = 2.4 Hz, 1H), 1.23 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) 
δ 170.9, 166.2, 147.1, 130.8, 60.6, 52.3, 40.6, 30.6, 26.8, 14.1; IR (thin film, cm-1) 3065, 2985, 
2953, 2844, 1714, 1637, 1601, 1278, 1061, 731; TLC (20% EtOAc/hexanes) Rf = 0.17; HRMS 
(ESI+) Calcd. for C16H19O6: 307.1176, Found: 307.1176.  
Ethyl-6,7-dioxatricyclo[3.2.2.02,4]non-8-ene-3-carboxylate (2.26): The title 
compound was prepared according to General Procedure B using benzene (1.8 mL, 20 
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mmol), ethyl diazoacetate (114 mg, 1 mmol), Rh2(TFA)4 (6.6 mg, 0.01 mmol), and rose bengal 
(10 mg, 0.01 mmol), under irradiation for 7 h. Flash chromatography (30% EtOAc/hexanes) 
provided a white solid (104 mg, 53%). Analytical data: 1H NMR (600 MHz, CDCl3) δ 6.32 (t, J = 
6.0 Hz, 2H), 4.98 (m, 2H), 4.13 (q, J = 7.2 Hz, 2H), 2.24 (m, 2H), 1.29 – 1.22 (m, 4H); 13C NMR 
(150 MHz, CDCl3) δ 171.3, 127.8, 72.0, 61.0, 21.7, 14.3, 14.1; IR (thin film, cm-1) 2984, 1724, 
1455, 1370, 1311, 1241, 1182, 1056, 877; TLC (20% EtOAc/hexanes) Rf = 0.15; HRMS (ESI
+) 
Calcd. for C10H13NaO4: 219.0628, Found: 219.0634.  
Ethyl-3,6-dioxatetracyclo[6.1.0.02,4.05,7]nonane-9-carboxylate (2.27): The title 
compound was prepared according to General Procedure B using benzene (17.8 mL, 
200 mmol), ethyl diazoacetate (1.14 g, 10 mmol), Rh2(TFA)4 (65.8 mg, 0.1 mmol), and 
rose bengal (103 mg, 0.1 mmol) under irradiation for 20 h. Flash chromatography (20% 
EtOAc/hexanes) provided a pink solid (976 mg, 49%). Analytical data: 1H NMR (600 MHz, 
CDCl3) δ 4.19 (q, J = 7.2 Hz, 2H), 3.31 (s, 4H), 2.12 (d, J = 4.4 Hz, 2H), 1.76 (t, J = 4.4 Hz, 1H), 
1.31 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 171.1, 61.0, 47.4, 47.0, 22.6, 21.2, 14.0; 
mp 8990 °C; IR (thin film, cm-1) 2987, 1718, 1455, 1372, 1311, 1184, 1059, 1005, 945; TLC 
(20% EtOAc/hexanes) Rf = 0.05; HRMS (ESI
+) Calcd. for C10H13NaO4: 219.0628, Found: 
219.0633.  
Ethyl -4,5a,7-trimethyl-2-octyl-1,3-dioxo-1,2,3,3a,4,4a,5,5a,6,6a-
decahydro-4,6-ethenocyclopropa[f]isoindole-5-carboxylate (2.51): The 
title compound was prepared according to General Procedure B using 
mesitylene (2.78 mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol), Rh2(TFA)4 (6.6 mg, 0.01 
mmol), and N-benzylmaleimide (562 mg, 3 mmol). Flash chromatography (20% EtOAc/hexanes) 
provided a white solid (210 mg, 53%). Analytical data: 1H NMR (600 MHz, CDCl3) δ 7.27 – 7.22 
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(m, 5H), 4.96 (s, 1H), 4.57 (d, J = 14.1 Hz, 1H), 4.48 (d, J = 14.1 Hz, 1H), 4.09 (q, J = 7.2 Hz, 
2H), 3.26 (dd, J = 7.5, 3.6 Hz, 1H), 2.94 (m, 1H), 2.65 (d, J = 7.5 Hz, 1H), 1.51 (s, 3H), 1.45 (d, J 
= 1.2 Hz, 3H), 1.38 (m, 2H), 1.29 (s, 3H), 1.24 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) 
δ 177.5, 176.6, 171.6, 136.8, 135.8, 128.4, 128.3, 127.6, 125.9, 60.5, 49.0, 45.2, 43.8, 41.9, 39.9, 
33.7, 24.6, 24.1, 21.5, 20.5, 14.2, 13.2; mp  134135 °C; IR (thin film, cm-1)2933, 2874, 1770, 
1698, 1397, 1327, 1180; TLC (20% EtOAc/hexanes) Rf = 0.18; HRMS (ESI
+) Calcd. for 
C21H22NO4: 394.2013, Found: 394.2036. 
Separation difficulties for 2.28/2.31  
Figure 2-1. Kinetic Separation of 2.12 Using Maleic Anhydride on Water 
Before addition of maleic anhydride to 2.12 
 
After 2 min in brine with maleic anhydride 
 
a b c 
a b c d 
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As shown in Figure 2-S1, treatment of the regioisomeric mixture 2.12 with maleic 
anhydride in brine provided complete conversion of 2.12b in under 2 min, while only trace 
conversion of 2.12a (<3%) was observed. While this analysis was feasible with any of the protons, 
the methyl peaks provided the cleanest separation. The vinyl protons in 2.12b (6.03 ppm) and 2.28 
(5.67 ppm) both overlap peaks in 2.12a. 1,4-Dimethylterephthalate was used as an internal 
standard, with the resonance at 8.11 ppm (aryl CH) set to 4.00, and the singlet at 3.96 ppm 
(CO2Me) provided internal consistency with an integration of 6.00. 
General Procedure C for the Buchner/DielsAlder/Hydrolysis Sequence 
 
To a 25 mL round-bottomed flask charged with Rh2(TFA)4 (6.6 mg, 0.01 equiv), the 
aromatic substrate (20 equiv), and CH2Cl2 (2.5 mL) was added a 2.5 mL solution of ethyl 
diazoacetate (114 mg, 1 mmol) in CH2Cl2 via syringe pump addition over 3 h. After complete 
addition, the brown solution was stirred for an additional hour at room temperature, at which time 
the CH2Cl2 was removed by rotary evaporation, and the excess arene was removed and could be 
recovered by distillation under reduced pressure. At this point the crude mixture was analyzed by 
1H NMR spectroscopy to determine yield and regioisomeric ratio, using 1,4-dimethylterephthalate 
as an internal standard. To the brown oil was added finely ground maleic anhydride (300 mg, 3 
equiv), and the neat mixture stood at room temperature for 30 min, after ensuring that the oil 
permeated the powder, after which, the mixture was dissolved in THF (5 mL) and treated with 
PTAD (1.1 equiv, relative to the regioisomers that had not reacted with maleic anhydride), and the 
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red solution was rapidly stirred for 1 h. After stirring for 1 h, brine was added (5 mL), and the 
mixture was rapidly stirred for 30 min. The products were extracted with EtOAc (2 × 10 mL), and 
washed with NaHCO3, water, and brine (1 × 10 mL ea), dried over MgSO4, filtered, and 
concentrated. The brown residue was subsequently partitioned between THF (10 mL) and 
saturated aqueous NaHCO3 solution (10 mL) and rapidly stirred for 16 h, after which time the 
mixture was extracted with EtOAc (2 × 10 mL), and the combined organic layer was washed 
sequentially with NaHCO3, water, and brine (1 × 10 mL ea), dried over Na2SO4, filtered, and 
concentrated, and then purified by chromatography, yielding the urazole. The aqueous washes 
were combined and cooled to 0 °C and acidified with conc. HCl (about 7 mL). Then the acidic 
medium was extracted with Et2O (3 × 25 mL), and the combined organic layer was dried over 
MgSO4, filtered, and concentrated. The solid residue was then triturated with CH2Cl2, and the 
white, solid diacid was collected by vacuum filtration and dried in vacuo. Note: it was necessary 
to perform a preliminary aqueous workup to remove the maleic acid resulting from the hydrolysis 
of maleic anhydride in order to maximize the yield and purity of the diacid product. Maleic acid 
was not removed in the CH2Cl2 trituration, but it could be removed via trituration with EtOAc; 
however, the diacid products had higher solubility in EtOAc, so yields were diminished without 
removing the maleic acid halfway through the synthetic route. Notably, the anhydride in the 
DielsAlder products was significantly more stable toward hydrolysis than maleic anhydride, so 
the maleic anhydride could be selectively hydrolyzed under the conditions reported. Below, in 
cases where an inseparable mixture of regioisomers were isolated, both structures are shown, and 
when possible, the resonances for both structures are identified. All spectra were recorded in 
CDCl3; however, the diacids required approx. 10 drops of CD3OD for dissolution.  
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3-(Ethoxycarbonyl)-8-methyltricyclo[3.2.2.02,4]non-8-ene-6,7-dicarboxylic 
acid (2.33): The title compound was prepared according to General Procedure C 
using toluene (2.13 mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol), 
Rh2(TFA)4 (6.6 mg, 0.01 mmol), and maleic anhydride (294 mg, 3 mmol), yielding 
a white solid (54 mg, 20%). Analytical data: 1H NMR (600 MHz, CDCl3) δ (2.33a, 
47%) 5.51 (d, J = 6.6 Hz, 1H), 4.02 (q, J = 7.2 Hz, 2H), 3.12 – 2.92 (m, 4H), 1.71 (s, 3H), 1.58 
(m, 1H), 1.36 (m, 1H), 1.19 (m, 1H), 1.18 (t, J = 7.2 Hz, 3H); (2.33b, 53%) 5.93 (t, J = 7.8 Hz, 
1H), 5.53 (d, J = 7.8 Hz, 1H), 4.02 (q, J = 7.2 Hz, 2H), 3.18 (br s, 1H), 3.12 – 2.92 (m, 2H), 1.58 
(m, 1H), 1.54 (m, 1H), 1.31 (m, 4H), 1.18 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 
(2.33a, 47%) 175.1, 175.0, 173.5, 132.6, 120.8, 60.6, 53.6, 47.1, 38.8, 33.3, 21.7, 20.7, 20.1, 18.2, 
13.9; (2.33b, 53%) 174.9, 174.6, 173.5, 136.7, 127.3, 60.6, 50.2, 47.2, 38.8, 32.3, 26.7, 21.9, 21.5, 
17.7, 13.9; mp 170172 °C; IR (thin film, cm-1) 3445, 1716, 1653, 1419, 1317, 1282, 1219, 1168; 
HRMS (ESI-) Calcd. for C15H17O6: 293.1031, Found: 293.1034.   
Ethyl-5a-methyl-1,3-dioxo-2-phenyl-2,3,5a,6,6a,7-hexahydro -1H,5H-5,7-
ethenocyclopropa[d][1,2,4]triazolo[1,2-a]pyridazine-6-carboxylate (2.34): The 
title compound was prepared according to General Procedure C using toluene (2.13 
mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol) Rh2(TFA)4 (6.6 mg, 0.01 mmol), and 4-
phenyl-1,2,4-triazoline-3,5-dione (35 mg, 0.2 mmol). Flash chromatography (20% 
EtOAc/hexanes) provided a white solid (36 mg, 8%). Analytical data: 1H NMR (600 MHz, CDCl3) 
δ 7.45 (m, 4H), 7.38 (m, 1H), 6.27 (ddd, J = 7.2, 5.1, 1.5 Hz, 1H), 6.18 (ddd, J = 7.2, 6.0, 1.2 Hz, 
1H), 5.24 (ddd, J = 5.1, 4.5, 1.2 Hz, 1H), 4.96 (dd, J = 6.0, 1.5 Hz, 1H), 4.18 (q, J = 7.2 Hz, 2H), 
2.10 (dd, J = 4.5, 3.9 Hz, 1H), 1.61 (d, J = 3.9 Hz, 1H), 1.53 (s, 3H), 1.29 (t, J = 7.2 Hz, 3H); 13C 
NMR (150 MHz, CDCl3) δ 169.7, 157.1, 156.7, 131.2, 129.1, 128.3, 126.7, 125.7, 125.5, 61.1, 
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58.7, 52.7, 28.3, 20.4, 20.3, 14.2, 12.6; mp 140–142 °C; IR (thin film, cm-1) 3065, 2982, 2932, 
1774, 1715, 1503, 1405, 1335, 1232; TLC (20% EtOAc/hexanes) Rf = 0.13; HRMS (ESI
+) Calcd. 
for C19H20N3O4: 354.1448, Found: 354.1469.   
3-(Ethoxycarbonyl)-1,5-dimethyltricyclo[3.2.2.02,4]non-8-ene-6,7-dicarboxylic 
acid (2.35): The title compound was prepared according to General Procedure C 
using p-xylene (24.6 mL, 200 mmol), ethyl diazoacetate (1.14 g, 10 mmol), 
Rh2(TFA)4 (65.8 mg, 0.1 mmol), and maleic anhydride (2.94 g, 30 mmol), yielding a white solid 
(409 mg, 14%). Analytical data: 1H NMR (600 MHz, CDCl3) δ 5.57 (s, 3H), 3.98 (q, J = 7.2 Hz, 
2H), 2.95 (s, 2H), 1.33, (d, J = 2.4 Hz, 2H), 1.31 (s, 6H), 1.30 (t, J = 2.4 Hz, 1H), 1.16 (t, J = 7.2 
Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 174.0, 173.7, 131.7, 60.6, 56.0, 38.0, 28.1, 21.7, 17.1, 
13.8; mp 188189 °C; IR (thin film, cm-1) 3420, 2967, 1716, 1417, 1306, 1243, 1163; HRMS 
(ESI-) Calcd. for C16H19O6: 307.1187, Found: 307.1191   
Ethyl- 5a,9-dimethyl-1,3-dioxo-2-phenyl-2,3,5a,6,6a,7-hexahydro-1H,5H-5,7- 
ethenocyclopropa[d][1,2,4]triazolo[1,2-a]pyridazine - 6 – carboxylate (2.36): 
The title compound was prepared according to General Procedure C using p-xylene 
(24.6 mL, 200 mmol), ethyl diazoacetate (1.14 g, 10 mmol) Rh2(TFA)4 (65.8 mg, 0.1 mmol), and 
4-phenyl-1,2,4-triazoline-3,5-dione (1.40 g, 8 mmol). Flash chromatography (20% 
EtOAc/hexanes) provided a white solid (1.85 g, 50%). Analytical data: 1H NMR (600 MHz, 
CDCl3) δ 7.46 (m, 4H), 7.37 (m, 1H), 5.83 (m, 1H), 5.00 (dd, J = 5.1, 1.8 Hz, 1H), 4.86 (d, J = 6.0 
Hz, 1H), 4.18 (q, J = 7.2 Hz, 2H), 2.05 (dd, J = 5.1, 3.6 Hz, 1H), 1.88 (d, J = 1.8 Hz, 3H), 1.53 (d, 
J = 3.6 Hz, 1H), 1.51 (s, 3H), 1.30 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 169.8, 
157.4, 156.9, 136.3, 131.3, 129.1, 128.2, 125.4, 118.5, 61.1, 59.6, 57.0, 28.0, 21.7, 20.0, 19.5, 14.2, 
12.7; mp 126127 °C; IR (thin film, cm-1) 3063, 2981, 2935, 1772, 1716, 1504, 1404, 1227, 1158; 
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TLC (20% EtOAc/hexanes) Rf = 0.13; HRMS (ESI
+) Calcd. for C20H22N3O4: 368.1605, Found: 
368.1630.   
3 - (Ethoxycarbonyl)-1,9-dimethyltricyclo[3.2.2.02,4]non- 8-ene-6,7-
dicarboxylic acid (2.37): The title compound was prepared according to General 
Procedure C using m-xylene (2.47 mL, 20 mmol), ethyl diazoacetate (114 mg, 1 
mmol), Rh2(TFA)4 (6.6 mg, 0.01 mmol), and maleic anhydride (294 mg, 3 mmol), yielding a white 
solid (57 mg, 20%).  Analytical data: 1H NMR (600 MHz, CDCl3) δ 5.15 (s, 1H), 4.01 (q, J = 7.2 
Hz, 2H), 3.05 (d, J = 9.9 Hz, 1H), 3.00 (br s, 1H), 2.90 (d, J = 9.9 Hz, 1H), 1.78 (s, 3H), 1.57 (br 
s, 1H), 1.30 (m, 1H), 1.26 (s, 3H), 1.21 – 1.15 (m, 4H); 13C NMR (150 MHz, CDCl3) δ 174.9, 
174.6, 173.7, 135.9, 125.8, 60.6, 53.5, 49.8, 38.8, 37.3, 27.9, 21.9, 21.4, 20.5, 17.7, 13.9; mp 
159160 °C; IR (thin film, cm-1) 3432, 2091, 1646, 1636, 1456, 1418, 1274, 1173; HRMS (ESI-) 
Calcd. for C16H19O6: 307.1187, Found: 307.1192   
Ethyl -5a,10-dimethyl-1,3-dioxo-2-phenyl-2,3,5a,6,6a,7-hexahydro-1H,5H-5,7 
- ethenocyclopropa[d][1,2,4]triazolo[1,2-a]pyridazine - 6 – carboxylate (2.38): 
The title compound was prepared according to General Procedure C using m-xylene 
(2.47 mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol) Rh2(TFA)4 (6.6 mg, 0.01 
mmol), and 4-phenyl-1,2,4-triazoline-3,5-dione (105 mg, 0.6 mmol). Flash 
chromatography (20% EtOAc/hexanes) provided a white solid (114 mg, 31%). 
Analytical data: 1H NMR (600 MHz, CDCl3) δ (2.38a, 74%) 7.44 (m, 4H), 7.42 (m, 1H), 5.75 (d, 
J = 5.4 Hz, 1H), 5.14 (t, J = 5.4 Hz, 1H), 4.73 (s, 1H), 4.16 (q, J = 7.2 Hz, 2H), 2.05 (m, 1H), 1.92 
(s, 3H), 1.52 (s, 3H), 1.49 (d, J = 3.6 Hz, 1H), 1.29 (t, J = 7.2 Hz, 3H); (2.38b, 26%) 7.41 (m, 1H), 
7.36 (m, 4H), 6.18 (dd, J = 7.5, 6.0 Hz, 1H), 5.99 (d, J = 7.5 Hz, 1H), 4.94 (d, J = 6.0 Hz, 1H), 
4.16 (q, J = 7.2 Hz, 2H), 2.04 (s, 3H), 1.89 (d, J = 3.6 Hz, 1H), 1.59 (d, J = 3.6 Hz, 1H), 1.52 (s, 
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3H), 1.29 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ (2.38a, 74%) 169.8, 157.3, 156.9, 
137.2, 131.2, 129.0, 128.2, 125.3, 117.7, 63.1, 61.0, 53.6, 27.7, 22.0, 20.0, 19.6, 14.2, 12.6; (2.38b, 
26%) 169.8, 155.9, 155.4, 131.4, 131.2, 129.0, 128.2, 125.7, 125.0, 62.8, 61.0, 58.0, 28.0, 27.7, 
21.8, 21.6, 14.2, 12.5; mp 110112 °C; IR (thin film, cm-1) 3064, 2980, 2934, 1771, 1716, 1504, 
1404, 1227, 1173; TLC (20% EtOAc/hexanes) Rf = 0.13; HRMS (ESI
+) Calcd. for C20H22N3O4: 
368.1605, Found: 368.1628.  
3-(Ethoxycarbonyl)-1,8-dimethyltricyclo[3.2.2.02,4]non-8-ene-6,7-
dicarboxylic acid (2.39): The title compound was prepared according to General 
Procedure C using o-xylene (2.47 mL, 20 mmol), ethyl diazoacetate (114 mg, 1 
mmol), Rh2(TFA)4 (6.6 mg, 0.01 mmol), and maleic anhydride (294 mg, 3 mmol), 
yielding a white solid (37 mg, 12%). Analytical data: 1H NMR (600 MHz, CDCl3) 
δ (2.39a, 77%) 5.58 (d, J = 6.6 Hz, 1H), 3.96 (q, J = 7.2 Hz, 2H), 3.08 (m, 1H), 2.96 (dd, J = 10.8, 
1.2 Hz, 1H), 2.87 (d, J = 10.8 Hz, 1H), 1.56 (d, J = 0.6 Hz, 3H), 1.50 (m, 1H), 1.28 (dd, J = 8.4, 
2.4 Hz, 1H), 1.25 (s, 3H), 1.161.12 (m, 4H); (2.39b, 23%) 3.96 (q, J = 7.2 Hz, 2H), 2.93 (br s, 
2H), 2.89 (br s, 2H), 1.58 (s, 6H), 1.48 (m, 2H), 1.14 (t, J = 7.2 Hz, 3H), 0.96 (t, J = 2.4 Hz, 1H); 
13C NMR (150 MHz, CDCl3) δ (2.39a, 77%) 174.8, 174.5, 173.7, 137.9, 121.2, 60.5, 53.8, 41.0, 
32.0, 26.9, 21.9, 20.0, 18.1, 17.5, 16.8, 13.8; (2.39b, 23%) 175.0, 173.7, 127.4, 60.5, 47.0, 39.3, 
21.6, 18.2, 13.8; mp  120121°C; IR (thin film, cm-1); 3420, 1716, 1698, 1652, 1540, 1276, 1174; 
HRMS (ESI-) Calcd. for C16H19O6: 307.1187, Found: 307.1193. 
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Ethyl-5,5a-dimethyl-1,3-dioxo-2-phenyl-2,3,5a,6,6a,7-hexahydro-1H,5H-5,7-
ethenocyclopropa[d][1,2,4]triazolo[1,2-a]pyridazine-6-carboxylate (2.40): The 
title compound was prepared according to General Procedure C using o-xylene 
(2.47 mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol), Rh2(TFA)4 (6.6 mg, 
0.01 mmol), and 4-phenyl-1,2,4-triazoline-3,5-dione (44 mg, 0.25 mmol), yielding 
a white solid (31 mg, 9%). Analytical data: 1H NMR (600 MHz, CDCl3) δ (2.40a, 
76%) 7.44 (m, 4H), 7.36 (m, 1H), 6.14 (dd, J = 7.8, 6.0 Hz, 1H), 6.04 (dd, J = 7.8, 1.5 Hz, 1H), 
5.23 (ddd, J = 6.0, 1.5, 1.5 Hz, 1H), 4.17 (q, J = 7.2 Hz, 2H), 2.12 (dd, J = 3.6, 1.5 Hz, 1H), 1.99 
(s, 3H), 1.65 (d, J = 3.6 Hz, 1H), 1.43 (s, 3H), 1.29 (t, J = 7.2 Hz, 3H); (2.40b, 24%) 7.44 (m, 4H), 
7.36 (m, 1H), 6.24 (dd, J = 4.2, 3.6 Hz, 1H), 4.90 (dd, J = 4.2, 3.6 Hz, 1H), 4.17 (q, J = 7.2 Hz, 
2H), 1.65 (m, 5H), 1.50 (s, 3H), 1.301.27 (m, 4H); 13C NMR (150 MHz, CDCl3) δ (2.40a, 76%) 
169.9, 155.7, 155.4, 132.5, 131.3, 129.0, 128.2, 125.7, 124.7, 65.9, 61.1, 61.8, 28.2, 24.0, 22.7, 
19.1, 14.2, 10.1; mp 131132°C; IR (thin film, cm-1) 2981, 2929, 1771, 1715, 1504, 1404, 1223, 
1188; TLC (20% EtOAc/hexanes) Rf = 0.13; HRMS (ESI
+) Calcd. for C20H22N3O4: 368.1605, 
Found: 368.1627.   
Ethyl -9-fluoro-1,3-dioxo-2-phenyl-2,3,5a,6,6a,7-hexahydro-1H,5H-5,7-
ethenocyclopropa[d][1,2,4]triazolo[1,2-a]pyridazine-6-carboxylate (2.41): The 
title compound was prepared according to General Procedure C using 
fluorobenzene (1.88 mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol), Rh2(TFA)4 (6.6 mg, 
0.01 mmol), and 4-phenyl-1,2,4-triazoline-3,5-dione (193 mg, 1.1 mmol). Flash chromatography 
(20% EtOAc/hexanes) provided a white solid (167 mg, 47%). Analytical data: 1H NMR (600 
MHz, CDCl3) δ 7.46 (m, 4H), 7.38 (m, 1H), 5.46 (m, 1H), 5.38 (m, 1H), 5.352 (ddd, J = 8.4, 5.4, 
3.0, Hz, 1H), 4.17 (q, J = 7.2 Hz, 2H), 2.30 (m, 1H), 2.22 (m, 1H), 1.61 (t, J = 2.7 Hz, 1H), 1.28 
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(t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 169.8, 156.4, 156.2 (d, J = 3.3 Hz), 154.2, 
130.9, 129.1, 128.4, 125.3, 98.6 (d, J = 3.5 Hz), 61.4, 54.3 (d, J = 26.7 Hz), 52.7 (d, J = 6.3 Hz), 
23.2, 16.8, 14.9 (d, J = 2.6 Hz), 14.0; mp  132133°C; IR (thin film, cm-1) 3064, 2987, 2932, 
1717, 1663, 1404, 1226, 1165, 1050; TLC (20% EtOAc/hexanes) Rf = 0.16; HRMS (ESI
+) Calcd. 
for C18H17FN3O4: 358.1198, Found: 358.1217.   
Ethyl -9-chloro-1,3-dioxo-2-phenyl-2,3,5a,6,6a,7-hexahydro-1H,5H-5,7-
ethenocyclopropa[d][1,2,4]triazolo[1,2-a]pyridazine-6-carboxylate (2.42): The 
title compound was prepared according to General Procedure C using 
chlorobenzene (2.03 mL, 20 mmol), ethyl diazoacetate (114 mg, 1 mmol), Rh2(TFA)4 (6.6 mg, 
0.01 mmol), and 4-phenyl-1,2,4-triazoline-3,5-dione (193 mg, 1.1 mmol). Flash chromatography 
(20% EtOAc/hexanes) provided a white foam (191 mg, 51%). Analytical data: 1H NMR (600 
MHz, CDCl3) δ 7.46 (m, 4H), 7.39 (m, 1H), 6.13 (dd, J = 6.6, 2.4 Hz, 1H), 5.33 (dd, J = 6.6, 5.8 
Hz, 1H), 5.30 (dd, J = 4.8, 2.4 Hz, 1H), 4.17 (q, J = 7.2 Hz, 2H), 2.31 (ddd, J = 8.1, 4.8, 3.0, Hz, 
1H), 2.23 (ddd, J = 8.1, 4.8, 3.0 Hz, 1H), 1.52 (t, J = 3.0 Hz, 1H), 1.29 (t, J = 7.2 Hz, 1H) ; 13C 
NMR (150 MHz, CDCl3) δ 169.8, 156.4, 156.0, 130.9, 129.1, 128.5, 128.4, 125.3, 120.8, 61.4, 
59.1, 53.5, 23.3, 16.5, 15.3, 14.1; IR (thin film, cm-1) 3065, 2981, 2932, 1772, 1716, 1646, 1505, 
1404, 1224; TLC (20% EtOAc/hexanes) Rf = 0.15; HRMS (ESI
+) Calcd. for C18H17ClN3O4: 
374.0902, Found: 374.0911. 
Ethyl -5-methoxy-1,3-dioxo -2-phenyl- 2,3,6,9- tetrahydro -1H,5H -5,9- etheno 
[1,2,4]triazolo[1,2-a][1,2]diazepine-6-carboxylate (2.43): The title compound was 
prepared according to General Procedure C using anisole (2.17 mL, 20 mmol), ethyl 
diazoacetate (114 mg, 1 mmol), Rh2(TFA)4 (6.6 mg, 0.01 mmol), and 4-phenyl-1,2,4-triazoline-
3,5-dione (53 mg, 0.3 mmol). Flash chromatography (20% EtOAc/hexanes) provided a yellow oil 
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(34 mg, 9%). Analytical data: 1H NMR (600 MHz, CDCl3) δ 7.53 (d, J = 7.9 Hz, 2H), 7.47 (dt, J 
= 7.9, 7.3 Hz, 2H), 7.38 (t, J = 7.3 Hz, 1H), 6.78 (dd, J = 9.6, 7.2 Hz, 1H), 6.34 (d, J = 9.6 Hz, 
1H), 6.21 (ddd, J = 11.1, 7.2, 2.4 Hz, 1H), 5.77 (dd, J = 11.1, 4.4 Hz, 1H), 5.02 (dd, J = 7.2, 7.2 
Hz, 1H), 4.28 (dd, J = 4.4, 2.4 Hz, 1H), 4.16 (q, J = 7.2 Hz, 2H), 3.60 (s, 3H), 1.27 (m, 4H); 13C 
NMR (150 MHz, CDCl3) δ 167.0, 154.4, 150.8, 132.5, 131.2, 131.1, 129.3, 129.0, 128.2, 126.5, 
125.5, 91.2, 61.4, 53.7, 52.0, 50.3, 14.0; IR (thin film, cm-1) 3067, 2981, 2938, 1772, 1715, 1498, 
1409, 1247, 1187; TLC (20% EtOAc/hexanes) Rf = 0.10; HRMS (ESI
+) Calcd. for C19H20N3O5: 
370.1397, Found: 370.1419.   
Further Transformations of DielsAlder Products  
Method to Obtain HPLC Traces of 2.44a,b 
 
Note: The title procedure was required to assay the enantiomeric ratio (er) of the initial 
desymmetrization products 2.44a,b owing to their poor UV activity. The desymmetrization could 
also be performed using benzyl alcohol without any loss in reactivity; however, this product was 
also poorly UV active. Furthermore, it was required to convert the hemiester into the respective 
lactone, since the acid functionality inhibited elution on silica. Due to the conformational rigidity 
of the hemiester, and the intermediates to 2.54, we presume that no loss of enantiomeric purity was 
observed in this sequence.  
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(1S,2S,4R,5R,6R,7S) -3-(ethoxycarbonyl)-7-
(methoxycarbonyl)tricyclo[3.2.2.02,4] non-8-ene-6-carboxylic acid (2.44a/b): 
The anhydride (262 mg, 1 mmol) was added to a flame-dried round-bottomed flask 
containing the cinchona alkaloid (357 mg, 1.1 mmol), and the solid was suspended 
in 1:1 toluene/CCl4 (5 mL for quinidine, 20 mL for quinine). Then methanol (121 
μL, 3 mmol) was added and the mixture was cooled to -55 °C, where it stirred for 60 
h. The mixture was warmed to room temperature and concentrated, and the residue was taken up 
in Et2O (10 mL) and washed with 1 M HCl (3 × 10 mL). The combined aqueous layer was extracted 
with Et2O (2 × 10 mL). Note: the cinchona alkaloid could be recovered from the acidic aqueous 
layer by basifying with Na2CO3 and extracting with Et2O. The combined organic layer was then 
extracted with Na2CO3 (2 × 20 mL). The resultant aqueous layer was then acidified with conc. HCl 
(approx. 10 mL), and the organics were extracted with Et2O (2 × 25 mL), washed with brine, dried 
over MgSO4, filtered, and concentrated, yielding a white solid of good purity: for quinine (2.44a, 
272 mg, 93%), for quinidine (2.44b, 290 mg, 99%). Analytical data: 1H NMR (400 MHz, CDCl3) 
δ 10.16 (br s, 1H), 6.01 (t, J = 6.8 Hz, 1H), 5.93 (t, J = 6.8 Hz, 1H), 4.09 (q, J = 7.2 Hz, 2H), 3.59 
(s, 3H), 3.30 (m, 2H), 3.17 (dd, J = 10.4, 1.6 Hz, 1H), 3.12 (dd, J = 10.4, 2.0 Hz, 1H), 1.67 (m, 
2H), 1.37 (dd, J = 2.8, 2.4 Hz, 1H), 1.24 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 178.2, 
173.0, 172.8, 128.7, 127.8, 60.6, 51.6, 47.4, 47.2, 33.8, 33.3, 20.3, 20.2, 18.4, 14.1; mp 114–116 
°C; []D = (2.44a) +0.5° (c = 5.21, CH2Cl2), (2.44b) -1.4° (c = 11.79, CH2Cl2); IR (thin film, cm-
1) 3446, 2984, 1732, 1717, 1698, 1419, 1280, 1161, 1047; HRMS (ESI-) Calcd. for C15H17O6: 
293.1031, Found: 293.1031.   
89 
 
(3aS,4S,4aS,5aR,6R,6aR)-5-(hydroxymethyl)-3,3a,4,4a,5,5a,6,6a-octahydro-
1H-4,6-ethenocyclopropa[f]isobenzofuran-1-one (2.52): The hemiester 2.44a 
(290 mg, 1 equiv) was added to a flame-dried 25 mL round-bottomed flask under 
nitrogen atmosphere and cooled to 0 °C. A solution of LiEt3BH (1.0 M in THF, 6 
mL, 6 equiv) was then added dropwise over 3 min. After stirred for 15 min at 0 °C, 
the ice bath was removed, and the solution warmed to room temperature while stirred 
for 6 h. The reaction was then carefully quenched with 1 M HCl (10 mL) under nitrogen 
atmosphere, and the mixture stirred for an additional 2 h. The organics were then extracted with 
Et2O (2 × 10 mL), dried over MgSO4, filtered, and concentrated. The crude material was purified 
by column chromatography (40% EtOAc/hexanes), yielding a pungent smelling, white solid (132 
mg, 71%). Analytical data: 1H NMR (600 MHz, CDCl3) δ 5.99 (dd, J = 7.8, 6.6 Hz, 1H), 5.93 (dd, 
J = 7.2, 7.2 Hz, 1H), 4.38 (dd, J = 9.6, 9.0 Hz, 1H), 3.89 (dd, J = 9.6, 4.8 Hz, 1H), 3.51 (dd, J = 
11.4, 6.6 Hz, 1H), 3.45 (dd, J = 11.4, 7.2 Hz, 1H), 3.38 (m, 1H), 3.04 (m, 1H), 2.92 (dd, J = 9.6, 
3.6 Hz, 1H), 2.85 (dddd, J = 9.6, 9.6, 3.6, 3.6 Hz, 1H), 1.04 (ddd, J = 7.2, 3.0, 3.0 Hz, 1H), 0.97–
0.91 (m, 2H); 13C NMR (150 MHz, CDCl3) δ 178.3, 130.8, 128.8, 71.8, 64.0, 45.7, 39.1, 34.5, 
33.1, 20.3, 15.5, 15.4; mp 115117 °C; []D = (2.52a) +43.8° (c = 2.90, CH2Cl2), (2.52b) -53.6° 
(c = 6.27, CH2Cl2); IR (thin film, cm
-1) 3420, 2851, 1748, 1652, 1541, 1396, 1190, 1038; TLC 
(20% EtOAc/hexanes) Rf = 0.05; HRMS (ESI
+) Calcd. for C12H15O3: 207.1016, Found: 207.1021.   
(3aS,4S,4aR,5aS,6R,6aR)- 5- (chloromethyl) - 3,3a,4,4a,5,5a,6,6a - octahydro - 1H 
- 4,6-ethenocyclopropa[f]isobenzofuran-1-one (2.53): Hexachloroacetone (0.6 mL, 
6 equiv) was added to a 25 mL round-bottomed flask with 2 mL CH2Cl2, and the flask 
was cooled to 0 °C. Triphenylphosphine (185 mg, 1.1 equiv) was added, and the mixture stirred 
for 5 min. The intermediate alcohol 2.52 (132 mg, 1 equiv) was added in 3 mL CH2Cl2, and the 
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clear solution stirred for 5 min at 0 °C and 2 h at room temperature. The reaction was concentrated 
and immediately purified by column chromatography (20% EtOAc/hexanes), yielding a white 
solid (107 mg, 74%). Analytical data: 1H NMR (600 MHz, CDCl3) δ 5.96 (dd, J = 7.8, 6.6 Hz, 
1H), 5.92 (dd, J = 7.8, 6.6 Hz, 1H), 4.35 (t, J = 9.6 Hz, 1H), 3.85 (dd, J = 9.6, 4.2 Hz, 1H), 3.45 
(dd, J = 10.8, 7.2 Hz, 1H), 3.38 – 3.32 (m, 2H), 3.04 (m, 1H), 2.88 (dd, J = 9.6, 3.6 Hz, 1H), 2.82 
(m, 1H), 1.13 (m, 1H), 1.06 – 0.99 (m, 2H); 13C NMR (150 MHz, CDCl3) δ 178.0, 130.6, 128.8, 
71.6, 46.8, 45.3, 38.8, 34.3, 33.0, 20.2, 18.1, 18.0; mp 99100 °C; IR (thin film, cm-1) 3050, 2934, 
2867, 1759, 1636, 1377, 1182, 1007; TLC (20% EtOAc/hexanes) Rf = 0.05; HRMS (ESI
+) Calcd. 
for C12H14ClO2: 225.0677, Found: 225.0677.   
(3aS,4S,4aR,5aS,6R,6aR)- 5- (iodomethyl) - 3,3a,4,4a,5,5a,6,6a - octahydro - 1H 
- 4,6-ethenocyclopropa[f]isobenzofuran-1-one (2.45): A 25 mL round-bottomed 
flask was charged with triphenylphosphine (412 mg, 2.05 equiv) and imidazole (261 
mg, 5 equiv). The solids were dissolved in CH2Cl2 (5 mL) and cooled to 0 °C. Iodine 
(389 mg, 2 equiv) was added, and the yellow-orange solution stirred at 0 °C for 10 
min. The intermediate alcohol 2.52 (158 mg, 0.8 mmol) was added in 10 mL of 
CH2Cl2, and the reaction was allowed to gradually warm to room temperature as it stirred for 16 
h. Then the reaction was quenched with saturated Na2S2O3 (8 mL), and the reaction was stirred at 
room temperature for 15 min. The product were then extracted with CH2Cl2 (3 × 10 mL), and 
washed with brine (1 × 20 mL), dried over Na2SO4, filtered, and concentrated, and immediately 
purified by column chromatography (40% EtOAc/hexanes), yielding a white solid (88 mg, 36%). 
Analytical data: 1H NMR (600 MHz, CDCl3) δ 5.96 (dd, J = 7.2, 6.6 Hz, 1H), 5.92 (dd, J = 7.2, 
6.6 Hz, 1H), 4.34 (dd, J = 9.6, 9.0 Hz, 1H), 3.85 (dd, J = 9.6, 4.2 Hz, 1H), 3.36 (m, 1H), 3.13 (dd, 
J = 9.6, 7.2 Hz, 1H), 3.07 – 2.99 (m, 2H), 2.87 (dd, J = 9.6, 3.0 Hz, 1H), 2.08 (dddd, J = 9.6, 9.6, 
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4.2, 4.2 Hz, 1H), 1.08 (m, 2H), 0.97 (m, 1H); 13C NMR (150 MHz, CDCl3) δ 177.9, 130.6, 128.7, 
71.5, 45.1, 38.6, 34.6, 33.3, 23.3, 23.0, 22.3, 9.4; mp 9899 °C; []D = (2.45a) +47.3° (c = 2.00, 
CH2Cl2), (2.45b) -43.0° (c = 4.60, CH2Cl2); IR (thin film, cm
-1) 3054, 2859, 2359, 1756, 1484, 
1437, 1182, 1119, 998, 750; TLC (20% EtOAc/hexanes) Rf = 0.06; HRMS (ESI
+) Calcd. for 
C12H14IO2: 317.0033, Found: 317.0035.   
(3aS,4S,4aR,5aS,6R,6aR)-5-((phenylthio)methyl)-3,3a,4,4a,5,5a,6,6a-
octahydro-1H-4,6-ethenocyclopropa[f]isobenzofuran-1-one (2.54): n-BuLi (2.61 
M in hexanes, 0.36 mL, 2 equiv) was added dropwise to a flame-dried 25 mL round-
bottomed flask containing thiophenol (0.15 mL, 3 equiv) in anhydrous THF cooled 
to 0 °C. After complete addition, the solution was warmed to room temperature, 
where it stirred for 15 min. The alkyl chloride 2.53 (107 mg, 1 equiv) was added with 
4 mL anhydrous THF, and the clear solution stirred until deemed complete by TLC 
(16 h). The reaction was then concentrated and immediately purified by column chromatography 
(20% EtOAc/hexanes), yielding a white solid (61 mg, 59%). The enantiomeric ratio (2.54a: 94:6; 
2.54b, 6:94) was determined by chiral HPLC (column IA, 90:10 hexanes/iPrOH). Analytical data: 
1H NMR (600 MHz, CDCl3) δ 7.35 (m, 2H), 7.29 (m, 2H), 7.21 (m, 1H), 5.94 (t, J = 7.2 Hz, 1H), 
5.88 (t, J = 7.2 Hz, 1H), 4.35 (dd, J = 9.6, 9.0 Hz, 1H), 3.85 (dd, J = 9.6, 4.2 Hz, 1H), 3.32 (m, 
1H), 2.99 (m, 1H), 2.89 – 2.83 (m, 2H), 2.81 – 2.85 (m, 2H), 1.00 (ddd, J = 7.5, 3.0, 3.0 Hz, 1H), 
0.91 (ddd, J = 7.5, 3.6, 3.6 Hz, 1H), 0.87 (dddd, J = 6.6, 6.6, 3.6, 3.0 Hz, 1H); 13C NMR (150 
MHz, CDCl3) δ 178.3, 136.2, 130.6, 130.0, 128.8, 128.7, 126.3, 71.7, 45.5, 38.9, 36.3, 34.6, 33.2, 
18.04, 18.00, 17.5; mp 9697 °C; []D = (2.54a) +22.5° (c = 0.98, CH2Cl2), (2.54b) -21.0° (c = 
0.18, CH2Cl2); IR (thin film, cm
-1) 3053, 2948, 1758, 1647, 1584, 1479, 1377, 1183, 1015; TLC 
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(20% EtOAc/hexanes) Rf = 0.11; HRMS (ESI
+) Calcd. for C18H19O2S: 299.1100, Found: 
299.1110.   
Cyclopropylmethyl Radical-Promoted Ring-Opening of 2.45 
 
9-vinyl-3a,4,7,7a-tetrahydro-4,7-ethanoisobenzofuran-1(3H)-one and 9-vinyl-
3a,4,7,7a-tetrahydro-4,7-ethanoisobenzofuran-3(1H)-one (2.46/2.47): The alkyl 
iodide 2.45 (38 mg, 0.12 mmol) was added to a flame-dried 5 dram vial under nitrogen 
atmosphere. Then the Bu3SnH (0.13 mL, 4 equiv) was added, and the mixture was 
dissolved in anhydrous CH2Cl2 (10 mL). The vial was then subjected to irradiation by 
a Hg lamp/Pyrex filter for 1 h. After 1 h, the lamp was turned off and the reaction was concentrated 
and purified by column chromatography (20% EtOAc/hexanes), yielding a clear oil as a mixture 
of regioisomers (23 mg, >99%).  Analytical data: 1H NMR (600 MHz, CDCl3) δ (2.46, 56%) 6.42 
(dd, J = 7.2, 7.2 Hz, 1H), 6.21 (dd, J = 7.2, 7.2 Hz, 1H), 5.56 (m, 1H), 4.98 (m, 1H), 4.91 (m, 1H), 
4.37 (dd, J = 9.0, 9.0 Hz, 1H), 3.87 (dd, J = 9.6, 4.2 Hz, 1H), 3.11 (m, 1H), 2.84 2.77 (m, 2H), 
2.76 2.68 (m, 1H), 2.38 (m, 1H), 1.91 (ddd, J = 12.6, 9.6, 2.4 Hz, 1H), 1.19 (ddd, J = 13.2, 4.8, 
3.6 Hz, 1H); (2.47, 44%) 6.36 (dd, J = 7.2, 7.2 Hz, 1H), 6.26 (dd, J = 7.2, 7.2 Hz, 1H), 5.56 (m, 
1H), 4.98 (m, 1H), 4.91 (m, 1H), 4.37 (dd, J = 9.0, 9.0 Hz, 1H), 3.87 (dd, J = 9.6, 4.2 Hz, 1H), 
3.07 (m, 1H), 2.87 (dd, J = 10.2, 3.6 Hz, 1H), 2.76 2.68 (m, 2H), 2.45 (m, 1H), 1.83 (ddd, J = 
12.6, 9.6, 2.4 Hz, 1H), 1.15 (ddd, J = 13.2, 5.4, 3.0 Hz, 1H); 13C NMR (150 MHz, CDCl3) δ (2.46, 
56%) 179.1, 143.0, 134.9, 130.7, 113.5, 71.9, 44.1, 40.6, 39.4, 38.5, 32.3, 31.3; (2.47, 44%) 178.9, 
142.8, 133.2, 132.4, 113.6, 72.3, 45.1, 40.3, 37.4, 37.3, 34.0, 31.3; IR (thin film, cm-1) 3048, 2934, 
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2867, 1759, 1636, 1377, 1182, 1007; TLC (20% EtOAc/hexanes) Rf = 0.16; HRMS (ESI
+) Calcd. 
for C12H14NaO2: 213.0886, Found: 213.0890.   
Desymmetrization of bis-Epoxide 2.27 
 
Ethyl -2,5-dihydroxybicyclo[4.1.0]hept-3-ene-7-carboxylate (2.55): The bis-
epoxide 2.27 (250 mg, 1.3 mmol) and Bu3SnH (1.4 mL, 4 equiv) were added to a 
flame-dried 25 mL round-bottomed flask under nitrogen atmosphere and dissolved in anhydrous 
THF (10 mL).  Then the reaction was cooled to 0 °C before the MeMgI (3.0 M in Et2O, 0.53 mL, 
1.25 equiv) was added dropwise over 5 min. After complete addition of MeMgI, the reaction was 
immediately quenched with saturated NH4Cl (5 mL) under nitrogen atmosphere. The product was 
extracted with Et2O (2 × 5 mL), dried over MgSO4, filtered, and concentrated. The crude material 
was purified by column chromatography (50% EtOAc/hexanes  100% EtOAc  90% 
EtOAc/MeOH) yielding a golden oil (221 mg, 87%). Note: the reaction was slow to proceed if run 
in Et2O, and it failed when MeMgBr was used instead. The inclusion of Bu3SnH minimizes THF 
polymerization, although the reaction proceeds without it as an additive. Analytical data: 1H NMR 
(600 MHz, CDCl3) δ 5.87 (br s, 2H), 4.42 (br s, 2H), 4.32 (br s, 2H), 4.14 (q, J = 7.2 Hz, 2H), 2.04 
(d, J = 4.2 Hz, 2H), 1.38 (t, J = 4.2 Hz, 1H), 1.27 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) 
δ 172.8, 128.3, 61.8, 61.0, 25.9, 21.3, 14.2; IR (thin film, cm-1) 3391, 2983, 2905, 1716, 1447, 
1302, 1198, 1013, 801; TLC (20% EtOAc/hexanes) Rf = 0.02; HRMS (ESI
-) Calcd. for 
C10H14NaO4: 221.0784, Found: 221.0789.   
94 
 
Ethyl-2,5-bis((tosylcarbamoyl)oxy)bicyclo[4.1.0]hept-3-ene-7-
carboxylate (2.48): The diol 2.55 (53 mg, 0.26 mmol) was added to a flame-
dried 10 mL round-bottomed flask under nitrogen atmosphere and dissolved 
in anhydrous THF (2.5 mL). The p-toluenesulfonyl isocyanate (81 μL, 2.01 equiv) was then added, 
and the reaction was allowed to stir at room temperature for 8 h. The reaction was then 
concentrated and flushed through a short pad of silica first with 20% EtOAc/hexanes (40 mL) then 
with EtOAc (100 mL). The fractions containing the product were collected and concentrated, 
yielding a white solid (158 mg, >99%). Analytical data: 1H NMR (600 MHz, CDCl3) δ 7.93 (m, 
4H), 7.34 (m, 4H), 5.93 (br s, 2H), 5.42 (m, 2H), 4.13 (q, J = 7.2 Hz, 2H), 2.46 (s, 6H), 1.95 (m, 
2H), 1.43 (t, J = 4.2 Hz, 1H), 1.25 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 171.2, 150.0, 
145.2, 135.3, 129.6, 128.4, 127.4, 66.2, 61.4, 21.7, 21.4, 21.1, 14.1; mp 8789 °C; IR (thin film, 
cm-1) 3248, 2985, 2875, 1716, 1597, 1456, 1353, 1161, 853; TLC (20% EtOAc/hexanes) Rf = 
0.01; HRMS (ESI-) Calcd. for C26H27N2O10S2
-: 591.1113, Found: 591.1160.   
Ethyl -2-oxo-3-tosyl-3,3a,5a,6,6a,6b-hexahydro-2H-cyclopropa[3,4]benzo[1,2-
d]oxazole-6-carboxylate (2.49): A flame-dried 10 mL round-bottomed flask was 
charged with Pd2(dba)3•CHCl3 (10 mg, 0.05 equiv) and tris-(2-furyl)phosphine (5 
mg, 0.1 equiv) in a nitrogen-filled glovebox. The solids were then dissolved in anhydrous THF 
(2.5 mL), and the dark mixture stirred for 1 h. Then the bis-carbamate 2.48 (114 mg, 0.19 mmol) 
was added with anhydrous THF (2.5 mL), and the reaction was allowed to stir at room temperature 
for 16 h. Once the reaction was deemed complete by TLC analysis, the reaction was concentrated 
and immediately subjected to column chromatography (30% EtOAc/hexanes) to yield a white 
foam (55 mg, 76%). Analytical data: 1H NMR (600 MHz, CDCl3) δ 7.96 (d, J = 8.4 Hz, 2H), 7.37 
(d, J = 8.4 Hz, 2H), 6.28 (ddd, J = 7.2, 5.4, 1.8 Hz, 1H), 5.63 (ddd, J = 7.2, 3.6, 1.8 Hz, 1H), 5.14 
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(dd, J = 7.8, 1.5 Hz, 1H), 4.71 (ddd, J = 7.8, 3.6, 1.8 Hz, 1H), 4.16 (q, J = 7.2 Hz, 2H), 2.46 (s, 
3H), 2.28 (ddd, J = 7.8, 4.8, 1.5 Hz, 1H), 2.08 (ddd, J = 7.8, 5.4, 3.6 Hz, 1H), 1.56 (dd, J = 4.8, 
3.6 Hz, 1H), 1.27 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 170.4, 150.7, 145.7, 135.3, 
129.9, 129.1, 128.4, 119.5, 70.4, 61.4, 53.0, 29.7, 21.8, 20.2, 18.6, 14.2; IR (thin film, cm-1) 3058, 
2984, 1780, 1717, 1647, 1366, 1300, 1193, 1015, 814; TLC (20% EtOAc/hexanes) Rf = 0.14; 
HRMS (ESI+) Calcd. for C18H19NNaO6S: 400.0825, Found: 400.0851.   
HPLC traces for 2.54a,b (derived from hemiesters 2.44a,b) 
2.54 (rac): 
peak # RT (min) area (mAU × s) height (mAU) area(%) 
1 14.842 390454.38 18414.06 52.9 
2 16.972 347299.13 17470.47 47.1 
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2.54a (quinine): 
peak # RT (min) area (mAU × s) height (mAU) area(%) 
1 14.857 25553519.61 1041017.51 93.7 
2 17.093 1705684.86 86778.97 6.3 
 
 
2.54b (quinidine): 
peak # RT (min) area (mAU × s) height (mAU) area(%) 
1 14.989 1182560.66 67685.57 6.3 
2 16.905 17686664.05 724177.58 93.7 
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CHAPTER THREE: 
THE DEVELOPMENT OF REGIOISOMERICALLY ENRICHED BUCHNER PRODUCTS FOR USE AS 
CYCLOHEXADIENYL SYNTHETIC INTERMEDIATES
 
3.1 Introduction 
After our initial progress in showcasing norcaradienes (NCDs) as viable dienyl 
intermediates in the generation of highly substituted carbocyclic products (see Chapter Two),1 the 
need for regioisomerically pure NCDs has become ever increasing. Although the kinetic separation 
of regioisomers was feasible in many cases, direct access to single regioisomers would not only 
offer an expedient route to valuable building blocks, but it would also be less wasteful in cases 
where a single regioisomer is desirable. Therefore, we endeavored to develop methods to provide 
such products.  
There are two general methods for direct access to single regioisomeric NCDs: the 
development of a regioselective intermolecular Buchner reaction or an intramolecular Buchner 
reaction. Although there are currently no general methods for regioselective intermolecular 
Buchner reactions, intramolecular reactions have been shown to exhibit high levels of 
regioselectivity in many cases;2 however, there are few examples of downstream applications to 
non-aromatic products.3  This chapter will be divided into two distinct, but related projects: 
discussed first will be our efforts towards the development of the first highly regioselective 
intermolecular Buchner reaction, and the utility of those intermediates in complex carbocycle 
synthesis. The second portion of the chapter will entail a discussion on the intramolecular Buchner 
reaction of benzyl cyanodiazoacetates and the functionalization of the resultant fused tricyclic 
NCDs. The initial investigations into both of these areas offer a firm foundation for the ultimate 
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goal of generating single regioisomers of enantioenriched norcaradienyl intermediates for use in 
downstream functionalization towards complex carbocyclic materials.  
3.2 Background 
3.2.1 Poor Regioselectivity of Buchner Reactions Using Diazoacetates 
As discussed in depth throughout Chapter Two, there currently exists no highly 
regioselective intermolecular Buchner reaction. This is likely a result of the high energy barrier 
for dearomatization, coupled with the reactive carbenoid intermediates required for the 
transformation, providing poor discrimination between various sites of reactivity. Scheme 2-10 
and 2-11 outlined the key stereoelectronic factors that affect the regioselectivity of the Buchner 
reaction, whereby the electronic factors dominated site selectivity in the case of highly activating 
or deactivating groups;1,4 at the same time, steric factors controlled arenes bearing simple aliphatic 
groups. Although the regioselectivity of the Buchner reaction employing simple diazoesters 3.1 
can be partially modulated by varying the steric profile of the ester substituent (Scheme 1a),5 
alteration of the identity of the diazo compound could offer a platform for absolute control over 
the reaction profile, such that the regioselectivity of the reaction could be adequately controlled 
(Scheme 3-1b).  
Scheme 3-1. Controlling the Intermolecular Buchner Reaction through Steric Effects 
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To this end both the steric profile of the carbene and the identity of the catalyst could be 
manipulated to influence the regioselectivity of the transformation. There are a myriad of reports 
in the literature that outline the impact of catalyst variation on reaction outcome. In one related 
example, Davies showed how aryl diazoacetates 3.3 under Rh(II) catalysis are prone to insert into 
allylic C–H bonds to form 3.5, rather than cyclopropane 3.4; however, upon switching the catalyst 
to AgSbF6, the C–H insertion pathway can be significantly suppressed (Scheme 3-2).6 
Scheme 3-2. Divergent Carbenoid Reactivity upon Variation of the Catalyst  
 
3.2.2 Controlling Regio- and Enantioselectivity of Intramolecular Buchner Reactions 
Another common way of rendering the Buchner reaction highly regioselective is through 
the incorporation of a tether. By forcing an intramolecular reaction with an appropriately sized 
tether, the reaction of 3.6 can only occur at a single site (Scheme 3-3a);2,7 however, if the tether is 
too long, as in the case of 3.8 (Scheme 3-3b), this constraint is relaxed and a mixture of 
regioisomeric products 3.9/3.10 can be observed.8 
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Scheme 3-3. Controlling the Intramolecular Buchner Reaction through Appropriately Sized 
Tethers 
 
Aside from diastereoselective intramolecular Buchner reactions, there are examples of 
enantioselective variants.9 Doyle has shown that donor-acceptor diazo compounds 3.11 can 
undergo an enantioselective Buchner reaction generating 3.12, followed by [3,3]-rearrangement to 
3.13 using chiral rhodium carboxylate catalysts; however, isolation of the enantioenriched 
products 3.12 was challenging, due to facile racemization via a zwitterionic intermediate prior to 
Cope rearrangement (Scheme 3-4).10  
Scheme 3-4. Enantioselective Intramolecular Buchner Reaction/[3,3]-Rearrangement 
 
The above examples employing donor-acceptor diazo compounds and/or appropriately-
sized tethers offered insight into direct ways to access regioisomerically pure NCDs. In the next 
section, we detail our efforts into not only gaining access to new regioisomerically pure NCDs, 
but also their utility in the synthesis of stereochemically complex carbocycles.  
  
104 
 
3.3 Results and Discussion 
3.3.1 The Reactivity of Various Diazo Substitution Patterns towards the Buchner Reaction 
After our initial investigations into intermolecular Buchner chemistry with ethyl 
diazoacetate (see Chapter Two),1 we sought to discover conditions for a highly regioselective 
Buchner reaction. Since diazo compounds containing a single electron acceptor (Scheme 3-5a) 
result in poor regioselectivity regardless of identity,5 we began to explore diazo compounds 
bearing other substitution patterns. In our hands, acceptor-acceptor diazo compounds11 (i.e., 
dimethyl diazomalonate) were plagued by lower reactivity than EDA and provided products that 
were prone towards rearomatization (Scheme 3-5b). Davies has pioneered donor-acceptor diazo 
compounds as selective and tunable carbene precursors;12 however, there are few examples of 
using donor-acceptor diazo compounds for Buchner chemistry in the literature (Scheme 3-5c).13 
Scheme 3-5. The Shortcomings of Different Diazo Classes in Intermolecular Buchner Reactions 
 
3.3.2 Iron Porphyrin Catalyzed Buchner Reaction 
The most promising example using donor-acceptor diazo compounds was reported using 
the iron-porphyrin catalyzed decomposition of methyl phenyl diazoacetate 3.3, which provided the 
stable norcaradiene 3.14 from p-xylene as a single regioisomer in modest yield (Scheme 3-6); the 
formation of this product was competitive with benzylic CH insertion.13a,c  
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Scheme 3-6. Fe(TPP)Cl-Catalyzed Intermolecular Buchner Reaction of p-Xylene 
 
With this precedent in mind, we were interested in seeing if this catalyst, or variants thereof 
would promote this reaction for a range of substrates. Especially intriguing about this catalyst class 
is the possibility of substituting a chiral salen ligand for the porphyrin, since they are reported to 
behave analogously in many cases.14 In light of this, we screened a wide variety of conditions, 
varying both the ligand, metal source, and temperature (Table 3-1). Following the conditions 
reported by Mbuvi and Woo (entry 1),13c we successfully isolated a modest yield of the desired 
product 3.14, which existed exclusively as the meso-NCD. Starting with the in situ-generated 
Fe(II) porphyrin provided a modest increase in the yield of 3.14 (entry 2). Although cationic Fe(III) 
resulted in an increased reaction rate, the only product identified was the formal arene C–H 
insertion product 3.16, that would arise from the rearomatization of 3.14. Since iron salen 
complexes provided comparable results to that of Fe(TPP)Cl (entry 5), salen ligands were used in 
the remaining screening, since their synthesis was more modular. Notably, the reaction shut down 
when performed at temperatures lower than 80 °C (entry 6). Copper (II) and cobalt (II) salen 
complexes offered neither an improvement nor a detriment to the iron (II) catalyzed cases (entries 
7-10).  
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Table 3-1. Catalyst Screen for Intermolecular Buchner Reaction of p-Xylenea 
 
entry catalyst temperature (°C) time (h) yield (%)b 3.14:3.15c 
1 Fe(TPP)Cl 80 16 16 2:1 
2 Fe(TPP)Cl/CoCp2 80 16 34 (55)
d 2:1 
3 Fe(TPP)Cl/AgSbF6 80 16 0 (40)
e - 
4 Fe(TPP)Cl/CoCp2/AgSbF6 80 16 34 2:1 
5 Fe(salen)Cl/CoCp2 80 16 38 2:1 
6 Fe(salen)Cl/CoCp2 40 16 0 - 
7 Cu(salen) 80 16 34 2:1 
8 Cu(salen) 40 16 0 - 
9 Cu(salen) 23 16 0 - 
10 Co(salen)/CoCp2 80 16 36 2:1 
11 CoCp2 80 16 42
d 2:1 
12 - 80 16 41d 2:1 
aReactions used 5 mol % catalyst, 100 equiv p-xylene. bYields are isolated yields of 3.14 unless 
otherwise noted. c3.14:3.15 ratio was determined from the crude 1H NMR. dDenotes 1H NMR 
yield. eDenotes 1H NMR yield of the rearomatization byproduct 3.16. 
 
With minimal improvements to the reaction, we then tried to confirm that the catalyst was 
necessary for the transformation. Much to our chagrin, running the reaction at 80 °C in the absence 
of catalyst provided comparable results to the initial hit (entries 11, 12), indicating that the catalyst 
was not needed. It has been well-documented that aryl diazoacetates readily thermolyze at elevated 
temperatures.12b,13e   
3.3.3 Thermolysis of Phenyl Diazoacetates 
In light of this, we found it operationally facile to simply thermolyze the diazo compound, 
providing access to the desired NCD in modest yields and high purity after a single 
recrystallization (Scheme 3-7). Although the thermolysis of 3.3 was limited to p-xylene, the ease 
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of accessing this material prompted us to investigate the utility of this norcaradiene in subsequent 
transformations.  
Scheme 3-7. Thermolysis of Methyl Phenyl Diazoacetate in p-Xylene 
 
3.3.4 Functionalization of Norcaradienes through Cycloaddition Reactions 
To probe its reactivity, NCD 3.14 was reacted with competent dienophiles, such as maleic 
anhydride, providing access to the expected [2.2.2]-bicyclic product in excellent yields (Scheme 
3-8). We were excited about the possibility of expanding the scope of reactive dienophiles. If the 
rate limiting step of this Diels–Alder reaction is generation of the NCD (as opposed to the CHT), 
then having a stable norcaradiene such as 3.14, would allow for the Diels–Alder reactions to 
proceed with less activated dienophiles. Unfortunately, this was not the case, as electron-deficient 
alkenes (i.e., acrolein, methyl acrylate, dimethyl fumarate, etc.) did not engage 3.14.  
Scheme 3-8.  Diels–Alder Reactions of Norcaradiene 3.14  
 
Endoperoxide 3.18 was generated from the rose bengal sensitized singlet oxygen Diels–
Alder reaction with 3.14.15 Notably, this endoperoxide was isolable after silica gel 
chromatography. Reduction of the endoperoxide could be realized upon hydrogenolysis using 
Lindlar’s catalyst, providing the syn-1,4-diol 3.19 in excellent yield.  
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Scheme 3-9.  Access to syn-1,4-Diol 3.19 from meso-Norcaradiene 3.14 
 
3.3.5 Non-Cycloaddition Transformations of Norcaradiene 
Direct, non-cycloaddition methods for functionalizing the norcaradienyl core proved to be 
challenging transformations. Of the multitude that were screened (e.g., hydroboration,16 
hydrogenation,17 epoxidation,18 carbonyl ene,19 etc.) the only conditions that were successful in 
symmetry-breaking diene functionalization were simple dihydroxylations using OsO4,
20 affording 
a mixture of mono-dihydroxylation 3.20 and bis-dihydroxylation 3.21 products. Controlling the 
stoichiometry of NMO succeeded in suppressing the formation of the 3.21, albeit with incomplete 
conversion. Sharpless conditions for asymmetric dihydroxylation21 were unable to promote the 
desymmetrizing transformation, presumably due to the increased steric constraints imposed by the 
chiral ligand.  
Scheme 3-10. Dihydroxylation of meso-Norcaradiene 3.14 
 
The vinyl methyl groups could also be functionalized, as in the case of allylic bromination, 
providing the bis-bromide 3.22. Kornblum oxidation22 of 3.22 allowed access to the bis-aldehyde 
3.23 in good yield, although purification of the bis-aldehyde resulted in low mass recovery. This 
facile two-step route allows for the formal Buchner reaction on an electron-deficient arene. 
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Scheme 3-11. Allylic Bromination and Kornblum Oxidation of meso-Norcaradiene 
 
Rather than focus functionalizations on the diene portion of 3.14, metal hydride reduction 
of the ester provided cycloheptatrienyl methanol. Parikh–Doering oxidation23 of the intermediate 
allowed for formation of the aldehyde 3.24, which was thermally unstable and gradually 
rearranged to the dihydrobenzofuran 3.25.13a This process proceeded slowly at room temperature, 
but was accelerated upon heating to 40 °C. Attempts to extend this methodology to dihydroindoles 
or dihydrobenzothiophenes, were unsuccessful; all attempts at substitution of the primary alcohol 
after initial reduction resulted in styrene products via rearomatization. 
Scheme 3-12.  Dihydrobenzofuran Synthesis from meso-Norcaradiene 
 
3.3.6 Silver(I)-Catalyzed Buchner Reaction 
With the inherent limitations of the thermolysis method of generating norcaradienes, we 
further investigated transition metal catalyzed methods at lower temperatures. Neither Rh(II) 
carboxylates nor Cu(II) complexes were successful at providing meaningful yields of Buchner 
products with aryl diazoacetates; however, upon screening AgSbF6, we were able to observe low 
yields of the desired product 3.14 in high regioselectivity with p-xylene.  
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Scheme 3-13. AgSbF6 Catalyzed Intermolecular Buchner Reaction of p-Xylene 
 
Despite the diminished levels of regioselectivity relative to thermolysis (see Section 3.3.3), 
this initial hit encouraged us to further optimize this transformation, since the reaction could be 
performed at ambient conditions. 
3.3.7 Ligand Screening for the Silver(I) Buchner Reaction 
With the goal of accessing enantioenriched products, we began to screen various chelating 
ligands to probe their effect on the transformation. We began our screening with silver scorpionate 
catalysts since they have been effectively used in cyclopropanation reactions.24 We found that 
electron rich ligands 3.27 completely suppressed the reaction, while electron deficient ligands 3.28 
promoted the reaction, in poor selectivity over benzylic C–H insertion and carbene dimerization 
(Table 3-2). Switching to cyclohexyl diimine catalysts 3.29 showed a similar trend with imines 
bearing electron deficient groups providing higher selectivity for NCD 3.14. While screening these 
ligands, however, we noticed that if the stoichiometry of the ligand was not carefully controlled, 
no conversion of the diazo compound would be observed. We attributed this suppression of 
reactivity to the formation of an inert 18-electron complex with two chelating ligands on silver.  
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Table 3-2. Ligand Screening in Ag(I)-Catalyzed Buchner Reaction of p-Xylene 
 
To avoid the possibility of this inert intermediate, we focused our attention on tridentate 
ligands, which would provide reactive 16-electron silver complexes. Much to our chagrin, using 
the strongly electron-deficient pyridyl ligand 3.30, we were unable to complex the silver. Simple 
pybox ligands 3.31 were able to complex silver; although being electron rich, reactivity was shut 
down. It was not until switching the pyridyl backbone to a furyl group 3.32 that promising results 
were obtained. Using 3.32b, high selectivity over both C–H insertion and dimerization was 
observed, albeit in low isolated yields (20%). Switching the diazo compound to the analogous 4-
nitroaryl diazo acetate, dimerization could be completely suppressed, and a 4:1 3.14:3.15 ratio 
could be obtained, though this iteration required >3 d at 40 °C for complete conversion.  
  
112 
 
3.3.8 AgPF6 Catalyzed Regioselective Intermolecular Buchner Reaction 
Despite the promising levels of chemoselectivity using ligand 3.32b, the extended reaction 
times and inability to impart enantioselectivity using the optimized system prompted us to probe 
the parent reactivity of the Ag(I) Buchner reaction. Over the course of these investigations, we 
discovered inauspicious product instability to the reaction conditions, with complete conversion 
of the NCD to the rearomatized product, which is likely a key factor in the formation of the formal 
arene C–H insertion product 3.16 observed above. Perhaps most striking is that NCD 3.14 was 
stable to both AgPF6 and methyl phenyldiazoacetate 3.3 individually, but not the mixture of the 
two reagents, indicating that the mechanism for rearomatization is not a simple Lewis acid-
promoted cyclopropyl ring opening and rearomatization (Scheme 3-14).  
Scheme 3-14. Norcaradiene Instability to Methyl Phenyldiazoacetate and AgPF6 
 
The mechanism for rearomatization can be rationalized by invoking a single electron 
transfer from the diazo compound 3.3 to Ag(I), resulting in a radical cation intermediate that 
readily releases nitrogen.25 This highly electrophilic intermediate 3.33 then engages the 
norcaradiene to provide radical cation intermediate 3.35, which rapidly rearomatizes. Electron 
transfer and protonation produces the observed arene C–H insertion product 3.16 and regenerates 
Ag(I). Alternatively, a radical chain pathway could be initiated in the same manner, but propagates 
through electron transfer steps from the rearomatized intermediate 3.36 and another equivalent of 
3.14 (Scheme 3-15). A radical pathway to generate carbene 3.34 could also be accessed upon 
treatment of diazo compound 3.3 with other radical initiators (i.e., AIBN/60 °C, Ru(byp)3Cl2/h, 
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SbCl6N(4-Br-C6H4)3); all of which either provided appreciable amounts of NCD 3.14, arene C–H 
insertion 3.16, or carbene dimerization 3.26.  
Scheme 3-15. Plausible Radical Cation Mechanism for Rearomatization of 3.14 
 
Such a treatment of the formation of the arene C–H insertion product 3.16 offers significant 
insight into the trends observed in the ligand screening. By including electron-withdrawing 
substitution on the ligands, the oxidation potential of Ag(I) increases, thereby slowing the rate of 
radical cation formation. Since silver carbenoids are known to selectively cyclopropanate over 
inserting into arene C–H bonds6a (unlike gold carbenes26), all observed arene C–H insertion 
products most likely arise from the mechanism outlined in Scheme 3-15. Therefore, to further 
disfavor this radical cation pathway, the addition of a strongly electron withdrawing substituent on 
the aryl diazoacetate would destabilize radical cation intermediate 3.33 and greatly suppress the 
undesired pathway.  
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In the event, we found that octyl 4-nitrophenyldiazoacetate 3.37 completely avoided the 
formation of the arene C–H insertion product, although heating was required to achieve reasonable 
reaction rates. As shown in Table 3-3, remarkable levels of regioselectivity were observed in many 
cases of aliphatic substituted arenes 3.38a-c; however, for non-methyl substrates, or more electron-
deficient arenes 3.38f-h, the reactivity was significantly retarded. Notably, benzylic C–H insertion 
was not competitive in any case other than p-xylene—even for benzylic positions that are prone 
towards C–H insertion, such as ethyl benzene.13e  
Table 3-3. Substrate Scope of AgPF6-Catalyzed Buchner Reaction of p-Xylene 
 
3.3.9 Efforts towards an Enantioselective Silver Buchner Reaction 
Since we were precluded from using chiral ligands on silver to impart enantioselectivity 
upon the Buchner reaction, we identified two areas that might provide an enantioselective reaction. 
The first of these was based on the chiral anion approach. To this end, chiral phosphoric acid-
derived AgSTRIP was prepared27 and the Buchner reaction of toluene was investigated (Scheme 
3-16).   
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Scheme 3-16. AgSTRIP Catalyzed Enantioselective Buchner Reaction 
 
In the event, we observed an 88:12 er under standard reaction conditions, albeit in low 
isolated yield of 3.38a. The low yield could be explained by the fact that phosphates are more 
coordinating than PF6
-. A strong correlation between the pKa of the counterion and the yield of the 
reaction has been observed.6a Nonetheless such a high initial hit for enantioselectivity could 
provide the foundation for an enantioselective silver Buchner reaction.  
An alternative method that we tested was the union of chiral thiourea catalysis with silver(I) 
catalysis, since hydrogen bonding interactions between thioureas and nitro groups is well-
documented.28 In hopes of the thiourea catalyst affecting the transition state of the Buchner 
reaction, we moved the nitro group to the 2-position in 3.39 so it would be closer to the silver 
catalyst. However, in both the 2-nitro and 4-nitro cases, thiourea 3.41 was found to suppress 
reactivity, possibly through coordination with the silver. Due to these unavoidable detriments to 
reactivity, this path of investigation was abandoned.  
Scheme 3-17. Dual Catalytic Hydrogen Bond Donor/Silver(I) Catalytic System 
  
116 
 
3.3.10 Functionalization of Regioisomerically Enriched Norcaradienes 
Many non-cycloaddition reactions on these intermediate NCDs were infeasible (i.e., 
epoxidation, (3+2)-annulation, carbonyl ene, Tsuji-Trost, etc.); however, treatment with N-
phenylmaleimide on brine provided complete conversion to the desired Diels–Alder product.1 
Unfortunately, it seems that the formation of the Diels–Alder product is reversible, since attempts 
at purifying the [2.2.2]-bicyclic product resulted in quantitative recovery of the NCD 3.38b. In an 
attempt to prevent this retro-Diels–Alder by disfavoring the reverse reaction, the ester was first 
reduced to the primary alcohol 3.42b,29,30 which resulted in the CHT as the sole product. Treatment 
of CHT 3.42b with N-phenylmaleimide resulted in quantitative conversion to the desired Diels–
Alder product 3.43b that was stable to silica gel chromatography.  
Scheme 3-18. Selective Reduction and Diels–Alder of 3.38b 
 
With this proof-of-concept, we have developed the first highly regioselective, metal-
catalyzed intermolecular Buchner reaction. Although at this juncture the scope is limited, all of the 
products exist as stable norcaradienes that are amenable to further functionalization to deliver 
highly substituted cyclohexane cores. Efforts are ongoing in our lab to further exploit this 
reactivity.  
3.3.11 Benefits of an Intramolecular Buchner Reaction 
At this juncture, we transitioned our investigations towards intramolecular Buchner 
reactions. These intermediates offer several advantages over NCDs derived from an intermolecular 
process: (1) The inclusion of a tether strongly enforces high regioselectivity in the transformation; 
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(2) The Buchner reaction generates a quaternary stereocenter, which minimizes the propensity of 
the NCDs to rearomatize; (3) -Chiral benzyl alcohols are easily prepared and readily available, 
allowing for diastereoselective transformations to generate enantioenriched NCDs.  
Scheme 3-19. Benefits of Using an Intramolecular Buchner Reaction  
 
3.3.12 Initial Investigations into an Intramolecular Buchner Reaction 
We began our investigations using simple benzyl diazoacetates 3.44, which have been 
previously reported to undergo intramolecular Buchner reactions.2b Despite this fact, there has 
been little utility of any of these intramolecular Buchner products as non-aromatic intermediates 
for downstream functionalization. Upon screening a variety of commercial Rh(II) and Cu(II) 
catalysts, we observed minimal formation of 3.45. These poorly-yielding reactions coupled with 
instability of 3.44 towards storage prompted abandonment of this route. Dibenzyl diazomalonates 
3.46 were slow to react under the screened conditions, a phenomenon that has been previously 
observed in intramolecular Buchner reactions.31  
Scheme 3-20. Intramolecular Buchner Attempts with Diazoacetates and Malonates 
 
Slowed by reactivity issues for known diazo substitution patterns, we became interested in 
the possibility of including a removable silicon tether between the diazo and aryl moieties. We 
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envisioned two possible locations for silicon incorporation: either directly bound to the acetate or 
included as a silyl enol ether, analogous to the donor-acceptor diazo compounds pioneered by 
Doyle.10,32 Attempts at generating the requisite diazo compounds were complicated by product 
instability. We were unable to append phenyl silanes onto carboxylic acids 3.48, so attempts at 
making the related diazo compounds were not feasible.  
Scheme 3-21. Non-Isolable Silyl Esters 
 
Using Doyle’s conditions,10 and variants thereof to access the desired donor-acceptor diazo 
compound, we were unable to form the silyl enol ether 3.50. It seems that Doyle’s TBS enol ether 
is the only silyl group that tolerates those conditions, as phenyl silanes returned starting material. 
The secondary alcohol resulting from reduction of the diazo ketone was able to be silicon protected 
with both dimethylphenylsilyl chloride and TBDPSCl; however, decomposition of 3.51 resulted 
only in Wolff rearrangement33 to the trivial dicarbonyl 3.52.  
Scheme 3-22. Donor-Acceptor Diazo Compounds for Intramolecular Buchner Reactions 
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3.3.13 Development of an Expedient Route to Cyano Diazoacetates 
At this critical impasse for the continuation of this project, we returned to the work by 
Reisman and the intramolecular Buchner reaction of cyanodiazoacetates she employed in her 
synthesis of salvileucalin B.3,31 Although she reports conventional Regitz diazo transfer to 
cyanoacetates, in our hands we found that such a procedure resulted in severe decomposition of 
the resultant diazo compound. To circumvent this, we developed a multistep route that allowed for 
reliable generation of a series of cyanodiazoacetates. The sequence was initiated by a method 
developed by Fukuyama,34 where bis-tosylhydrazine converted an α-bromoester to α-diazoester 
3.53 under basic conditions. This intermediate was then condensed with an isocyanate, providing 
the free primary amide upon hydrolysis.35 This amide was dehydrated using trichloroacetyl 
chloride, cleanly providing cyano diazoacetate 3.54 in 25-45% yield over the five discrete steps. 
Although the route is longer than conventional methods, this route could be completed in just over 
a day and required only a single chromatographic operation. The 4-OMe substrate was unable to 
be prepared in this manner due to competing generation of quinone methide intermediates through 
elimination of the diazoacetate.  
Scheme 3-23. Expedient Route to Benzyl Cyano Diazoacetates 
 
3.3.14 Substrate Scope of Intramolecular Buchner Reaction of Cyano Diazoacetates 
With a number of diazo compounds in hand, the substrates were screened with typical 
reductive metals for carbene catalysis (i.e., Rh2(OAc)4, Rh2(TFA)4, Cu(hfacac)2, AgPF6, etc.) 
which were all met with discouraging results. Turning our attention to microwave heating, 
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however, provided efficient reactivity using Cu(hfacac)2 as the metal catalyst at 120 °C for 2 min, 
providing NCDs 3.55 in high regioselectivity and diastereoselectivity (Table 3-4). The 
regioselectivity is exclusively controlled by steric effects; this bias is so strong that mesitylene-
derived diazo compound 3.54i (see Experimental Details, section 3.5) was unable to provide any 
meaningful levels of Buchner products, since both ortho-sites were blocked by the flanking methyl 
groups.  
Notably, Rh2(OPiv)4 provided dramatically improved yields in many cases, concomitant 
with improved regioselectivity. This can be attributed to the suppression of Lewis acid assisted 
degradation and isomerization pathways of the initially formed norcaradiene 3.55. 
Table 3-4. Substrate Scope of Intramolecular Buchner Reaction under Microwave Heating  
 
Upon screening various copper sources under the standard microwave conditions, we 
found that cationic Cu(II)(pybox) systems could provide the desired NCD, albeit in lower yields 
than Cu(hfacac)2. Despite this exciting possibility of an enantioselective transformation, we were 
unable to assay the product by HPLC. Fused norcaradienes are known to undergo reversible ring-
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opening,10 concomitant with racemization; we are attributing the poor performance on the HPLC 
to rapid enantiomerization, resulting in a single peak on the HPLC trace. Therefore, although it 
may not be feasible to perform this Buchner reaction asymmetrically, it may be possible to perform 
a dynamic kinetic resolution (DKR) in subsequent manipulation of the NCDs (vide infra).  
Along these lines, the poor regioselectivity in the case of 3.55d can also be explained by 
this ring-opening pathway. Since the mesitylene-derived analogue 3.54i failed to react (vide 
supra), it is reasonable to conclude that direct cyclopropanation of the fully-substituted site was 
unlikely to occur. Instead, initial formation of 3.55da is kinetically favorable, followed by either 
a thermal or Lewis acid-promoted ring opening and closure event results in the regioisomeric 
scrambling (Scheme 3-24). 
Scheme 3-24. Erosion of Regioselectivity via Zwitterionic Intermediates 
 
3.3.15 Further Functionalization of Fused Norcaradienes 
Having accessed a number of regioisomerically enriched norcaradienes, we turned our 
attention to functionalizing them to access complex carbocyclic products. As expected, Diels–
Alder cycloaddition with N-benzylmaleimide smoothly provided the [2.2.2]-bicyclic product in 
high conversion to a single diastereomer of 3.56b, with the maleimide approach anti- to the nitrile, 
although diminished yields were observed upon isolation (Scheme 3-25).  
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Scheme 3-25. Diels–Alder Cycloaddition of 3.55b and N-Benzylmaleimide 
 
To probe the possibility of a DKR of 3.55b via an achiral zwitterionic intermediate, 3.55b 
was treated with an N-chiral maleimide in brine at room temperature. Gratifyingly, the Diels–Alder 
product 3.57b/b′ was obtained in 1.8:1 dr (although the absolute configuration of the respective 
diastereomers was not definitively identified) at both partial and complete conversion, indicating 
that this result was not due to a simple kinetic resolution, but rather the desired racemization 
pathway was operative (Scheme 3-26). Further exploitation of this facile racemization is 
warranted.  
Scheme 3-26. Dynamic Kinetic Resolution of Fused Norcaradiene 3.55b 
 
Gratifyingly, we were also able to develop an efficient non-cycloaddition transformation 
of NCD 3.55b. Treatment of 3.55b with in situ-generated DMDO36 provided a single diastereomer 
of the epoxide 3.58b in excellent yield. Notably, the DMDO approached anti- to the nitrile, 
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signifying that the nitrile imposes a significant steric obstacle to the facial approach of 
electrophiles (Scheme 3-27). Efforts to extend this methodology to enantioselective epoxidations 
are ongoing.  
Scheme 3-27. DMDO Epoxidation of Fused Norcaradiene 3.55b 
 
3.4 Conclusions 
We have performed initial investigations into methods to generate highly regioselective 
Buchner products. Silver(I) decomposition of electron deficient aryl diazoacetates provides the 
first example of a highly regioselective intermolecular Buchner reaction; however, this reaction is 
complicated by possible radical cation-initiated side reactions. Thermolysis of phenyl 
diazoacetates in p-xylene provided a single regioisomer of product and this intermediate was 
amenable to a number of complexity-building transformations.  
A new method for the generation of cyanodiazoacetates has been developed, providing 
synthetically useful yields while requiring minimal purification. Intramolecular Buchner reactions 
can be efficiently performed using these benzyl cyanodiazoacetates under copper(II) catalysis and 
microwave irradiation to provide single regioisomers, favoring functionalization at the least 
sterically encumbered site. DMDO oxidation of the resultant norcaradiene provided a single 
diastereomer of product in high yield, signifying that these intermediates can be used to rapidly 
generate complex carbocycles without requiring cycloaddition transformations. Efforts to further 
expand the scope of downstream transformations and to generate the carbocyclic products 
asymmetrically through a DKR mechanism are currently underway.    
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3.5 Experimental Details 
Methods 
Proton and carbon magnetic resonance spectra (1H NMR and 13C NMR) were recorded on 
either a Bruker model DRX 400 or 600 spectrometer (1H NMR at 400 or 600 MHz and 13C NMR 
at 100 or 150 MHz) with solvent resonance as the internal standard (1H NMR: CDCl3 at 7.28 ppm 
and 13C NMR: CDCl3 at 77.0 ppm). 
1H NMR data are reported as follows: chemical shift, 
multiplicity (abbreviations: s = singlet, br s = broad singlet, d = doublet, dd = doublet of doublets,  
dq = doublet of quartets, t = triplet, and m = multiplet), coupling constant (Hz) and integration. 
Melting points (mp) were determined using a Thomas Hoover Capillary Melting Point Apparatus 
and are uncorrected. Infrared (IR) spectra were obtained using a Jasco 260 Plus Fourier Transform 
Infrared Spectrometer. High resolution mass spectrometry (HRMS) was performed using a 
Thermo Scientific LTQ FT Ultra mass spectrometer S2 with direct infusion in either the positive 
or negative ion mode. Samples were prepared in HPLC grade methanol. All reported masses 
obtained in the positive ion mode correspond to the protonated molecular ion (M+H) unless 
otherwise noted, and all reported masses obtained in the negative ion mode correspond to the 
deprotonated molecular ion (M–H), unless otherwise noted. High performance liquid 
chromatography (HPLC) was performed on a Perkin Elmer Flexar® HPLC system equipped with 
a Chiracel IA column. Samples were eluted with HPLC grade hexanes with the indicated 
percentage of iPrOH with an oven temperature of 40 °C. Microwave reactions were performed 
using a 300 W CEM Discover System with internal temperature monitoring via infrared sensing, 
in sealed 10 mL pressure vessels with a maximum ramp time of 2 min. Reactions performed “on 
water” were run in either conventional round-bottomed flasks or 1 or 5 dram vials with rapid 
agitation, either by vigorous manual shaking, or stirring (>900 rpm); we noticed no noticeable 
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difference in the two methods. Thin layer chromatography (TLC) was performed on Sorbtech 
plastic-backed 0.20 mm silica gel 60 plates. Visualization was accomplished with UV light and 
either an aqueous ceric ammonium molybdate (CAM) or potassium permanganate (KMnO4) 
solution, followed by heating. Flash chromatography was performed under positive air pressure 
using Siliaflash-P60 silica gel (40-63 μm) purchased from Silicycle. Unless otherwise specified, 
all crude materials were introduced to the chromatography column after dissolution in the specified 
eluent (plus a few drops dichloromethane, if required). Yields, regioisomeric ratios (rr’s) and 
diastereomeric ratios (dr’s) are reported herein for a specific experiment and as a result may differ 
slightly from those found in the tables, which are averages of at least two experiments. 
 
Materials 
Nitrogen was dried by passage through anhydrous calcium sulfate with 3% cobalt chloride 
as indicator (commercial Drierite). Diazo compounds 3.3, 3.37, and 3.39 were prepared via slight 
modifications to known procedures.6,12 Caution: While we experienced no difficulties in handling 
the diazo compounds reported herein, care must be taken at all times when handling diazo 
compounds, as they are known to be explosive, especially upon heating during distillation. Simple 
acceptor diazo compounds, such as benzyl diazoacetate should be stored away from light, and cold 
to prevent decomposition. The following ligands were all prepared according to known 
procedures: salen,14,37 scorpionate 3.27/3.28,38 cyclohexyldiimine 3.29,39 2,6-pyridyl diimine 
3.30,40 pybox 3.31,41 2,5-furyl diimine 3.32.42 The preparation of the carbene dimer 3.26 has been 
reported.43 Diazo 3.51 was prepared via a modification of a known procedure.44 Anhydrous 
Cu(hfacac)2 was prepared from the commercial hydrate according to a known procedure, and was 
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stored under anhydrous conditions.45 All other reagents and solvents were purchased from 
commercial sources and used as received. 
General Procedure A for the Fe(TPP)Cl Promoted Buchner Reaction of p-Xylene 
 
To a flame-dried 1 dram vial in a nitrogen-filled glovebox was added Fe(TPP)Cl (2.8 mg, 
0.004 mmol). The diazo compound 3.3 (35 mg, 0.2 mmol) was then transferred to the vial using 
p-xylene (2 mL, 16 mmol) via syringe. The vial was then placed in an oil bath preheated to 80 °C. 
After stirring at that temperature for 16 h, the reaction was removed from heat and allowed to cool 
to room temperature. The crude reaction mixture was flushed through a short pad of silica to 
remove the iron salts, and concentrated by rotary evaporation. The ratio between 3.14, 3.15, and 
3.16 was then determined from the crude 1H NMR. Isolation of 3.14 could be accomplished either 
through column chromatography using 20% EtOAc/hexanes as eluent, or by recrystallization from 
10% EtOAc/hexanes.  
General Procedure B for the Thermolysis of 3.3 in p-Xylene 
 
The p-xylene (270 mL, 2.18 mol) was added to a 500 mL round-bottomed flask with an 
attached addition funnel and heated to 120 °C under nitrogen atmosphere. Then the diazo 
compound 3.3 (19.2 g, 109 mmol) was diluted with 100 mL p-xylene and added dropwise over 3 
h. The orange solution stirred at that temperature for 20 h. Upon completion of the reaction, the 
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solution had turned yellow, and the reaction was cooled to room temperature and concentrated. 
Note: the excess p-xylene could be easily recovered by distillation. The crude residue was 
triturated with 10% EtOAc/hexanes, and the resultant white solid was collected by filtration and 
dried in vacuo, providing a white solid (9.21 g, 33%). 
 Methyl 2,5-dimethyl-7-phenylbicyclo[4.1.0]hepta-2,4-diene-7-carboxylate 
(3.14): The product was prepared according to either General Procedure A or B, 
yielding a white solid. Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.21 (m, 
3H), 6.98 (m, 2H), 5.49 (s, 2H), 3.67 (s, 3H), 2.96 (s, 2H), 2.10 (s, 6H); 13C NMR (150 MHz, 
CDCl3) δ 177.5, 132.9, 131.8, 130.4, 127.3, 126.9, 122.0, 52.9, 41.2, 26.0, 23.7. 
Methyl 2-phenyl-3-(p-tolyl)propanoate (3.15): The product was prepared 
according to either General Procedure A or B, yielding a clear oil. Analytical data: 
1H NMR (400 MHz, CDCl3) δ 7.35–6.95 (m, 5H), 3.85 (dd, J = 8.8, 6.8 Hz, 1H), 
3.62 (s, 3H), 3.40 (dd, J = 13.8, 8.8 Hz, 1H), 3.00 (dd, J = 13.8, 6.8 Hz, 1H), 2.13 (s, 3H). 
Methyl 2-(2,5-dimethylphenyl)-2-phenylacetate (3.16): The product was 
prepared according to either General Procedure A or B, yielding a clear oil. 
Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.40–4.22 (m, 6H), 7.10–6.99 (m, 
2H), 5.22 (s, 1H), 3.78 (s, 3H), 2.32 (s, 3H), 2.26 (s, 3H). 
Transformations of meso-Norcaradiene 3.14 
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Methyl (3aR,4S,4aS,5aR,6R)-4,6-dimethyl-1,3-dioxo-5-phenyl-
3,3a,4,4a,5,5a,6,6a-octahydro-1H-4,6-ethenocyclopropa[f]isobenzofuran-5-
carboxylate (3.17): Norcaradiene 3.14 (10 mg, 0.04 mmol) and maleic anhydride 
(7.7 mg, 0.08 mmol) were combined in a 1 dram vial, dissolved in 0.5 mL C6H6 and heated to 
reflux for 20 h, at which point the reaction was cooled to room temperature and concentrated. The 
residue was subjected to column chromatography using 10% EtOAc/hexanes as eluent, yielding 
an off white solid (12 mg, 88%). Analytical data: 1H NMR (600 MHz, CDCl3) δ 7.26 (m, 2H), 
7.21 (m, 1H), 7.01 (m, 2H), 5.01 (s, 2H), 3.57 (s, 3H), 3.15 (s, 2H), 2.05 (s, 2H), 1.83 (s, 6H); 13C 
NMR (150 MHz, CDCl3) δ 173.5, 169.9, 135.7, 133.6, 130.8, 128.4, 126.9, 53.0, 52.5, 39.7, 38.6, 
37.0, 22.2.  
 
Methyl -1,5-dimethyl-3-phenyl-6,7-dioxatricyclo[3.2.2.02,4]non-8-ene-3-
carboxylate (3.18): The norcaradiene 3.14 (896 mg, 3.52 mmol) and rose bengal 
(36 mg, 0.035mmol) were added to a 10 mL round bottomed flask and dissolved in 
40 mL CCl4/2 mL MeOH, and cooled to 0 °C. A steady stream of O2 was then bubbled through 
the solution, and the pink mixture was irradiated with a medium pressure Hg lamp for 20 h. After 
completion, the lamp was turned off and the reaction was concentrated by rotary evaporation. The 
crude material was purified by column chromatography using 10%20% EtOAc/hexanes as 
eluent, yielding a pinkish white solid of good purity (850 mg, 84%). Analytical data: 1H NMR 
(600 MHz, CDCl3) δ 7.30–7.25 (m, 2H), 7.25–7.21 (m, 1H), 6.93 (m, 2H), 5.35 (s, 2H), 3.61(s, 
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3H), 2.43 (s, 2H), 1.65 (s, 6H). 13C NMR (150 MHz, CDCl3) δ 173.3, 135.2, 132.1, 131.0, 128.4, 
127.0, 77.1, 53.0, 35.7, 29.4, 22.1. 
Methyl -2,5-dihydroxy-2,5-dimethyl-7-phenylbicyclo[4.1.0]hept-3-ene-7-
carboxylate (3.19): The endoperoxide 3.18 (10 mg, 0.035 mmol) and Lindlar’s 
catalyst (1 mg) were combined in a 1 dram vial that was purged with N2. Then the 
vial was charged with 1 mL EtOAc and was purged with H2. The reaction stirred under H2 for 40 
min. After completion, the reaction was first purged with N2, then filtered through a short pad of 
Celite and concentrated, yielding a white solid of good purity (9 mg, 90%). Analytical data: 1H 
NMR (400 MHz, CDCl3) δ 7.19 (m, 3H), 7.12 (m, 2H), 5.31 (s, 2H), 3.56 (s, 3H), 2.39 (s, 2H), 
1.61 (s, 3H). LRMS (ESI+) Calcd. for C17H20NaO4: 311.13, Found: 311.2. 
 
Methyl -4,5-dihydroxy-2,5-dimethyl-7-phenylbicyclo[4.1.0]hept-2-ene-7-
carboxylate (3.20): The norcaradiene 3.14 (10 mg, 0.04 mmol) and N-
morpholine oxide (4.6 mg, 0.04 mmol) were combined in a 1 dram vial with 1 mL acetone/0.1 mL 
water. Then a 3% w/w aqueous solution of OsO4 (2.5 μL, 0.4 μmol) was added and the yellow 
solution stirred at room temperature for 16 h. The organics were then extracted with EtOAc (3 × 
1 mL), and the combined organic layer was dried over Na2SO4, filtered, and concentrated, yielding 
3.20 (40%, 1H NMR yield). Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.47–7.21 (m, 4H), 
7.04 (m, 1H), 5.11 (s, 1H), 3.63 (s, 3H), 2.88 (s, 1H), 2.58 (d, J = 8.8 Hz, 1H), 2.42 (s, 1H), 2.37–
2.25 (m, 2H), 2.11 (br s, 3H), 1.55 (s, 3H). 
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Methyl -2,5-bis(bromomethyl)-7-phenylbicyclo[4.1.0]hepta-2,4-diene-7-
carboxylate (3.22): To a 50 mL round-bottomed flask was added 3.14 (254 mg, 
1 mmol) and N-bromosuccinimide (358 mg, 2.01 mmol). A reflux condenser was 
then attached, and the mixture was then dissolved in 20 mL CCl4, purged with N2, and heated to 
reflux for 16 h. The reaction was then cooled to room temperature and concentrated. The residue 
was then purified by column chromatography using 10% EtOAc/hexanes as eluent, yielding a 
white solid (259 mg, 63%). Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.21 (m, 3H), 7.16 (m, 
2H), 5.87 (s, 2H), 4.36 (d, J = 10.4 Hz, 2H), 4.29 (d, J = 10.4 Hz, 2H), 3.71 (s, 3H), 3.36 (s, 2H). 
Methyl -2,5-diformyl-7-phenylbicyclo[4.1.0]hepta-2,4-diene-7-carboxylate 
(3.23): The bis-bromide 3.22 (250 mg, 0.61 mmol) was added to 25 mL round-
bottomed flask and diluted with 3 mL DMSO and 3 mL CH2Cl2 and cooled to 0 
°C. Then the trimethylamine N-oxide (810 mg, 7.3 mmol) was added, and the ice bath was 
removed. The reaction was allowed to stir at room temperature for 2 h. Then the reaction was 
quenched with water (3 mL) and the organics were extracted with CH2Cl2 (2 × 3 mL). The 
combined organic layer was washed with water (5 mL) and brine (5 mL), dried over Na2SO4, 
filtered, and concentrated. The crude material (70% by 1H NMR) was purified by column 
chromatography using 20%50% EtOAc/hexanes as eluent, yielding a yellow solid (18 mg, 
11%). Analytical data: 1H NMR (400 MHz, CDCl3) δ 9.81 (s, 2H), 7.16 (m, 3H), 6.79 (s, 2H), 
6.75 (m, 2H), 3.71 (s, 3H), 3.65 (s, 2H). 
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 (3,6-Dimethyl-1-phenylcyclohepta-2,4,6-trien-1-yl)methanol (3.58): To a flame-
dried 25 mL round-bottomed flask under nitrogen atmosphere was added 3.14 (254 
mg, 1 mmol) with 4 mL anhydrous THF. After cooling to 0 °C, the LiAlH4 (2 M in 
THF, 1 mL, 2 mmol) was added slowly, and the reaction stirred at that temperature for 30 min. 
The reaction was then quenched with careful, sequential addition of 0.1 mL water, 0.1 mL 10% 
KOH, and 0.3 mL water. The ice bath was then removed and the reaction stirred at room 
temperature for 30 min. The mixture was then diluted with Et2O, and copious MgSO4 was added, 
and the slurry was filtered through Celite and concentrated, yielding the cycloheptatrienyl 
methanol in excellent purity. Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.37–7.07 (m, 5H), 
5.79 (s, 2H), 4.18 (s, 2H), 4.00 (br s, 2H), 2.02 (s, 6H). 
 5,7a-Dimethyl-3-phenyl-3a,7a-dihydrobenzofuran (3.25): The clear oily 
residue was then taken up in 10 mL CH2Cl2/DMSO (4:1), and treated with Et3N 
(0.7 mL, 5 mmol). Meanwhile, a 2 mL DMSO solution of the SO3•pyridine (480 
mg, 3 mmol) was prepared, and allowed to stir for 15 min prior to careful addition to the reaction 
mixture. After stirring at room temperature for 16 h, the reaction was quenched with water (10 
mL) and diluted with CH2Cl2 (10 mL). The organics were separated, and washed with water (3 × 
10 mL) and brine (10 mL), dried over Na2SO4, filtered, and concentrated, providing a mixture of 
3.24 and 3.25. The isomerization was completed upon gentle heating (40 °C) for 6 h. Analytical 
data: 1H NMR (400 MHz, CDCl3) δ 7.35–7.00 (m, 5H), 6.86 (d, J = 2.4 Hz, 1H), 5.93 (d, J = 9.8 
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Hz, 1H), 5.79 (d, J = 9.8 Hz, 1H), 5.68 (br s, 1H), 3.82 (br s, 1H), 1.76 (dd, J = 2.0, 2.0 Hz, 3H), 
1.50 (s, 3H). 
General Procedure C for the Silver(I) Catalyzed Intermolecular Buchner Reaction 
 
To a flame-dried 1 dram vial in a nitrogen filled glovebox was added either AgSbF6 or 
AgPF6 (0.05 equiv), then 0.5 mL anhydrous DCE and the arene (20 equiv) were added via syringe, 
and the vial was placed in an oil bath preheated to 45 °C, while excluded from light. A 1 mL 
solution of the diazo compounds (1 equiv) in anhydrous DCE was then added via syringe pump 
over 20 h. After complete addition, the reaction was allowed to stir for an additional hour before 
cooling to room temperature and concentration by rotary evaporation. The regioisomeric ratio was 
then determined from the crude 1H NMR. The dearomatized products were then isolated after silica 
gel chromatography. 
Octyl 4-methyl-1-(4-nitrophenyl)cyclohepta-2,4,6-triene-1-
carboxylate (3.38a): The product was prepared according to either 
General Procedure C using toluene (0.21 mL, 2 mmol), octyl 4-
nitrophenyl diazoacetate 3.37 (32 mg, 0.1 mmol), AgSbF6 (1.7 mg, 0.005 mmol), and was purified 
using 5% EtOAc/hexanes yielding a yellow oil (21 mg, 56%). Analytical data: 1H NMR (400 
MHz, CDCl3) δ 8.03 (d, J = 8.8 Hz, 2H), 7.31 (d, J = 8.8 Hz, 2H), 6.23 (m, 1H), 6.02 (m, 1H), 
5.77 (d, J = 8.0 Hz, 1H), 4.07 (t, J = 6.4 Hz, 2H), 3.95 (m, 2H), 2.38 (s, 3H), 1.55–1.10 (m, 12H), 
0.90 (t, J = 7.2 Hz, 3H). 
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3.38a (racemic, using AgSbF6): 
peak # RT (min) area (mAU × s) height (mAU) area(%) 
1 15.634 2142781.65 35192.04 54.1 
2 17.103 1820328.46 48431.79 45.9 
 
 
3.38a (chiral, using AgSTRIP): 
peak # RT (min) area (mAU × s) height (mAU) area(%) 
1 14.321 4684159.27 180167.29 88.0 
2 16.871 642460.12 78388.29 12.0 
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Octyl 2,5-dimethyl-7-(4-nitrophenyl)bicyclo[4.1.0]hepta-2,4-diene-7-
carboxylate (3.38b): The product was prepared according to either General 
Procedure C using p-xylene (2.5 mL, 20 mmol), octyl 4-nitrophenyl 
diazoacetate 3.37 (319 mg, 1 mmol), AgSbF6 (17 mg, 0.05 mmol), and was purified using 5% 
EtOAc/hexanes yielding a yellow oil (114 mg, 29%). Analytical data: 1H NMR (600 MHz, CDCl3) 
δ 8.05 (d, J = 9.0 Hz, 2H), 7.11 (d, J = 9.0 Hz, 2H), 5.48 (s, 2H), 4.06 (t, J = 6.6 Hz, 2H), 3.00 (s, 
2H), 2.10 (s, 6H), 1.46 (m, 2H), 1.31–1.11 (m, 10H), 0.88 (t, J = 7.2 Hz, 3H). 13C NMR (150 
MHz, CDCl3) δ 175.3, 146.6, 140.8, 132.6, 130.1, 122.5, 122.2, 65.9, 41.0, 31.6, 29.0, 28.9, 28.3, 
25.6, 23.6, 22.5, 14.0. 
Octyl 2,4-dimethyl-7-(4-nitrophenyl)bicyclo[4.1.0]hepta-2,4-diene-7-
carboxylate (3.38c): The product was prepared according to either 
General Procedure C using m-xylene (2.5 mL, 20 mmol), octyl 4-
nitrophenyl diazoacetate 3.37 (319 mg, 1 mmol), AgSbF6 (17 mg, 0.05 mmol), and was purified 
using 5% EtOAc/hexanes yielding a yellow oil (235 mg, 59%). Analytical data: 1H NMR (400 
MHz, CDCl3) δ 8.06 (d, J = 8.8 Hz, 2H), 7.21 (d, J = 8.8 Hz, 2H), 5.80 (d, J = 6.4 Hz, 1H), 5.44 
(dd, J = 6.4, 5.6 Hz, 1H), 4.07 (t, J = 6.4 Hz, 2H), 3.24 (dd, J = 8.4, 5.6 Hz, 1H), 3.09 (d, J = 8.4 
Hz, 1H), 2.11 (s, 3H), 1.52 (s, 3H), 1.51 (m, 2H), 1.40–1.15 (m, 10H), 0.91 (t, J = 7.2 Hz, 3H). 
Octyl 2,3-dimethyl-7-(4-nitrophenyl)bicyclo[4.1.0]hepta-2,4-diene-7-
carboxylate (3.38d): The product was prepared according to either 
General Procedure C using o-xylene (2.5 mL, 20 mmol), octyl 4-
nitrophenyl diazoacetate 3.37 (319 mg, 1 mmol), AgSbF6 (17 mg, 0.05 
mmol), and was purified using 5% EtOAc/hexanes yielding a yellow oil 
(232 mg, 58%, 59:41 rr). Analytical data: 1H NMR (600 MHz, CDCl3) δ 
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(3.38da, 59%) 8.04 (d, J = 9.0 Hz, 2H), 7.16 (d, J = 9.0 Hz, 2H), 6.01 (dd, J = 9.3, 5.4 Hz, 1H), 
5.60 (d, J = 9.3 Hz, 1H), 4.04 (m, 2H), 3.25 (dd, J = 9.0, 5.4 Hz, 1H), 3.13 (d, J = 8.0 Hz, 1H), 
2.08 (s, 3H), 1.52 (s, 3H), 1.51–1.1 (m, 12H), 0.88 (t, J = 7.2 Hz, 3H); (3.38db, 41%) 8.18 (d, J = 
9.0 Hz, 2H), 7.25 (d, J = 9.0 Hz, 2H), 5.92 (t, J = 3.0 Hz, 2H), 4.16 (t, J = 6.9 Hz, 2H), 3.22 (dd, 
J = 3.6, 2.4 Hz, 2H), 2.25 (s, 6H); 1.63 (m, 2H), 1.32–1.11 (m, 10H), 0.88 (t, J = 7.2 Hz, 3H). 13C 
NMR (150 MHz, CDCl3) δ (combined 3.38a and 3.38b) 175.1, 174.9, 135.3, 134.2, 133.4, 130.8, 
130.0, 129.50, 129.48, 126.6, 125.6, 123.5, 122.1, 121.8, 121.23, 121.20, 65.8, 65.7, 65.6, 56.4, 
31.63, 31.58, 29.1, 29.03, 29.00, 28.9, 28.4, 28.30, 28.27, 25.7, 25.6, 22.54, 22.52, 20.2, 19.8, 
19.31, 19.25, 18.1, 14.00, 13.99. 
Octyl 1-(4-nitrophenyl)-1a,7b-dihydro-1H-
cyclopropa[a]naphthalene-1-carboxylate (3.38e): The product was 
prepared according to either General Procedure C using naphthalene (128 
mg, 1 mmol), octyl 4-nitrophenyl diazoacetate 3.37 (32 mg, 0.1 mmol), AgSbF6 (1.7 mg, 0.005 
mmol), and was purified using 5% EtOAc/hexanes yielding a yellow oil (33 mg, 78%). Analytical 
data: 1H NMR (400 MHz, CDCl3) δ 7.86 (d, J = 8.4 Hz, 2H), 7.57 (d, J = 7.6 Hz, 1H), 7.32 (m, 
1H), 7.15 (m, 1H), 6.97 (br d, 8.4 Hz, 2H), 6.82 (d, J = 7.6 Hz, 1H), 6.20 (m, 2H), 4.09 (m, 2H), 
3.69 (d, J = 8.8 Hz, 1H), 3.23 (ddd, J = 8.8, 2.8, 2.8 Hz, 1H), 1.50 (m, 2H), 1.35–1.11 (m, 10H), 
0.89 (t, J = 7.2 Hz, 3H). 
Subsequent Transformations of 3.38b 
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 5-(Hydroxymethyl)-4,6-dimethyl-5-(4-nitrophenyl)-2-phenyl-
4,4a,5,5a,6,6a-hexahydro-4,6-ethenocyclopropa[f]isoindole-
1,3(2H,3aH)-dione (3.43):The Buchner intermediate 3.38b (38 mg, 0.12 
mmol) was placed in a flame-dried 25 mL round-bottomed flask under 
nitrogen atmosphere and dissolved in 10 mL anhydrous THF and cooled to 0 °C. Then the 
trimethyl borate (1.3 μL, 0.012 mmol) was added, followed by slow addition of LiBH4 (1 M in 
THF, 0.3 mL, 0.3 mmol). After complete addition, the reaction stirred at that temperature for 30 
min. The reaction was quenched by dropwise addition of 0.03 mL water, 0.03 10% KOH, and 0.1 
mL water. Then the reaction was warmed to room temperature and stirred for 30 min. MgSO4 was 
then added, and the reaction was filtered over Celite and concentrated, yielding the intermediate 
3.42b. The residue was then treated with N-phenylmaleimide (22.8 mg, 0.13 mmol) and dissolved 
in 10 mL MeOH, and the reaction stirred at room temperature for 16 h. Upon completion, the 
reaction was concentrated by rotary evaporation, and the resultant material was purified by column 
chromatography (50%100% EtOAc/hexanes), yielding a white solid. Analytical data: 1H NMR 
(400 MHz, CDCl3) δ 8.07 (m, 2H), 7.36–7.25 (m, 3H), 7.21 (m, 2H), 6.98 (m, 2H), 5.01 (s, 2H), 
3.34 (s, 2H), 2.93 (s, 2H), 1.78 (s, 6H), 1.50 (s, 2H). 
General Procedure D for the Synthesis of Benzyl Cyanodiazoacetates 
 
A 100 mL round-bottomed flask was charged with NaHCO3 (3 equiv) and the benzyl 
alcohol (20 mmol, 1 equiv). The reagents were suspended in 15 mL MeCN and cooled to 0 °C. 
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Then the bromoacetyl bromide (1.5 equiv) was added slowly, and the reaction stirred at that 
temperature for 45 min. The reaction was then carefully quenched with water. After the gas 
evolution subsided, the organics were extracted with CH2Cl2 (2 × 10 mL), washed with NaHCO3 
(2 × 10 mL), and brine (15 mL), dried over Na2SO4, filtered, and concentrated, yielding a clear, 
colorless oil of the α-bromoester. 
The bis-tosylhydrazine (1.5 equiv) was then added to the 250 mL round-bottomed flask 
containing the bromoester, and the reaction vessel was purged with nitrogen while cooling to 0 °C, 
then 40 mL degassed THF was added. Then the DBU (4 equiv) was added slowly over 5 min, and 
the reaction stirred at that temperature for 40 min. Then the reaction was quenched with aqueous 
NaHCO3 (50 mL), and the reaction was allowed to stir at room temperature for 30 min. Note: 
allowing the reaction to stir with NaHCO3 was important to isolate the diazo compound cleanly 
without a column. After stirring for 30 min, the solid was removed by filtration through Celite, 
and the filtrate was transferred to a separatory funnel containing H2O/Et2O (100 mL ea). The 
organics were collected, and the aqueous layer was further extracted with Et2O (100 mL). The 
combined organic layer was washed with NaHCO3 (100 mL), and brine (100 mL), dried over 
MgSO4, filtered, and concentrated by rotary evaporation. After ensuring all of the THF had been 
removed, the residue was then triturated with Et2O, and filtered through a short pad of 3:1 
Celite/silica and concentrated, yielding the diazo compound 3.53 in good purity.  
The diazo compound 3.53 was then added to a flame-dried 100 mL round-bottomed flask 
under nitrogen atmosphere with 20 mL anhydrous Et2O and cooled to -78 °C. The isocyanate (1 
equiv) was then added slowly over 30 min as a 10 mL solution in Et2O. After complete addition, 
the reaction was maintained at -78 °C for 3 h. Then the reaction was warmed to room temperature 
and concentrated by rotary evaporation. The residue was then taken up in EtOH (50 mL), and 
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water (15 mL) was then added forcefully to the solution, and the reaction was allowed to stand at 
room temperature overnight. Note: if upon standing, there is only a white solid, then the amide 
intermediate did not crystallize. If there is a yellow-colored solid, then that is the diazo compound. 
If the diazo compound solidified, then it can be isolated by filtration and washed with cold EtOH; 
otherwise, the ethanolic solution can be diluted with copious amounts of water (100 mL) and 
extracted with Et2O (2 × 50 mL), dried over MgSO4, filtered, and concentrated, yielding the diazo 
amide.  
The amide was then transferred to a flame-dried 250 mL round-bottomed flask under 
nitrogen atmosphere with 40 mL anhydrous CH2Cl2 and cooled to 0 °C, followed by anhydrous 
Et3N (3 equiv). Then the trichloroacetyl chloride (3.3 equiv) was added slowly. After stirring for 
5 min, the reaction was carefully quenched with aqueous NaHCO3 (50 mL). After gas evolution 
subsided, the reaction was transferred to a separatory funnel and the organics were collected. The 
aqueous layer was further extracted with CH2Cl2 (50 mL). The combined organic layer was then 
washed with NaHCO3 (50 mL), water (50 mL), and brine (50 mL), dried over Na2SO4, filtered, 
and concentrated. The orange residue was purified by column chromatography, yielding the 
desired product.  
Note: This reaction sequence was performed without discrete isolation and characterization 
of the intermediates. Included below are representative 1H NMR spectra of the intermediates 
towards 3.54b, and the final cyanodiazoacetates 3.54a-i. 
4-Methylbenzyl 2-bromoacetate (3.59b): The title compound was 
prepared according to General Procedure D using 4-methylbenzyl alcohol 
(6.11 g, 50 mmol), sodium bicarbonate (12.6 g, 150 mmol), bromoacetyl bromide (6.5 mL, 75 
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mmol), yielding a clear, colorless oil. Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.29 (d, J = 
8.0 Hz, 2H), 7.20 (d, J = 8.0 Hz, 2H), 5.18 (s, 2H), 3.88 (s, 2H), 2.38 (s, 3H). 
4-Methylbenzyl 2-diazoacetate (3.53b): The title compound was prepared 
according to General Procedure D using 3.59b (11.5 g, 50 mmol) bis-
tosylhydrazine (25.5 g, 75 mmol), 1,8-diazabicyclo[5.4.0]undec-7-ene (30 mL, 200 mmol), 
yielding a bright red oil. Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.31 (d, J = 8.0 Hz, 2H), 
7.22 (d, J = 8.0 Hz, 2H), 5.20 (s, 2H), 4.83 (br s, 1H), 2.40 (s, 3H). 
4-Methylbenzyl 3-amino-2-diazo-3-oxopropanoate (3.60b): The title 
compound was prepared according to General Procedure D using 3.53b 
(8.26 g, 43.4 mmol) chlorosulfonyl isocyanate (3.8 mL, 43.4 mmol), yielding a pale yellow solid. 
Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.78 (br s, 1H), 7.28 (s, 2H), 7.22 (s, 2H), 5.87 (br 
s, 1H), 5.25 (s, 2H), 2.39 (s, 3H). 
4-Methylbenzyl 2-cyano-2-diazoacetate (3.54b): The title compound 
was prepared according to General Procedure D using 3.60b (3.20 g, 13.7 
mmol) triethylamine (5.8 mL, 41.2 mmol) and trichloroacetyl chloride (5.1 mL, 45.3 mmol), 
yielding a yellow solid (1.96 g, 34%, 5 steps). Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.30 
(d, J = 8.0 Hz, 2H), 7.22 (d, J = 8.0 Hz, 2H), 5.28 (s, 2H), 2.39 (s, 3H). 
Benzyl 2-cyano-2-diazoacetate (3.54a): The title compound was prepared 
according to General Procedure D using benzyl alcohol (2.1 mL, 20 mmol), 
sodium bicarbonate (5.04 g, 60 mmol), bromoacetyl bromide (2.6 mL, 30 mmol), bis-
tosylhydrazine (10.2 g, 30 mmol),  1,8-diazabicyclo[5.4.0]undec-7-ene (12 mL, 80 mmol), 
chlorosulfonyl isocyanate (1.7 mL, 20 mmol), triethylamine (8.4 mL, 60 mmol) and trichloroacetyl 
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chloride (7.4 mL, 66 mmol), yielding a red oil (1.19 g, 30%, 5 steps). Analytical data: 1H NMR 
(400 MHz, CDCl3) δ 7.40 (s, 5H), 5.33 (s, 2H). 
3-Methylbenzyl 2-cyano-2-diazoacetate (3.54c): The title compound 
was prepared according to General Procedure D using 3-methylbenzyl 
alcohol (1.2 mL, 10 mmol), sodium bicarbonate (2.52 g, 30 mmol), bromoacetyl bromide (1.3 mL, 
15 mmol), bis-tosylhydrazine (5.1 g, 15 mmol),  1,8-diazabicyclo[5.4.0]undec-7-ene (6 mL, 40 
mmol), chlorosulfonyl isocyanate (0.87 mL, 10 mmol), triethylamine (4.2 mL, 30 mmol) and 
trichloroacetyl chloride (3.7 mL, 33 mmol), yielding a yellow oil (653 mg, 30%, 5 steps).  
Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.30 (m, 1H), 7.20 (m, 3H), 5.29 (s, 2H), 2.39 (s, 
3H). 
2-Methylbenzyl 2-cyano-2-diazoacetate (3.54d): The title compound was 
prepared according to General Procedure D using 2-methylbenzyl alcohol 
(1.22 g, 10 mmol), sodium bicarbonate (2.52 g, 30 mmol bromoacetyl bromide (1.3 mL, 15 mmol), 
bis-tosylhydrazine (5.1 g, 15 mmol),  1,8-diazabicyclo[5.4.0]undec-7-ene (6 mL, 40 mmol), 
chlorosulfonyl isocyanate (0.87 mL, 10 mmol), triethylamine (4.2 mL, 30 mmol) and 
trichloroacetyl chloride (3.7 mL, 33 mmol), yielding a yellow solid (223 mg, 10%, 5 steps).  
Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.32 (m, 2H), 7.24 (m, 2H), 5.36 (s, 2H), 2.40 (s, 
3H). 
4-(tert-Butyl)benzyl 2-cyano-2-diazoacetate (3.54e): The title 
compound was prepared according to General Procedure D using 4-tert-
butylbenzyl alcohol (1.77 mL, 10 mmol), sodium bicarbonate (2.52 g, 30 mmol bromoacetyl 
bromide (1.3 mL, 15 mmol), bis-tosylhydrazine (5.1 g, 15 mmol),  1,8-diazabicyclo[5.4.0]undec-
7-ene (6 mL, 40 mmol), chlorosulfonyl isocyanate (0.87 mL, 10 mmol), triethylamine (4.2 mL, 30 
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mmol) and trichloroacetyl chloride (3.7 mL, 33 mmol), yielding a yellow oil (333 mg, 13%, 5 
steps).  Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.43 (d, J = 8.4 Hz, 2H), 7.34 (d, J = 8.4 
Hz, 2H), 5.29 (s, 2H), 1.35 (s, 9H). 
3,4-Dimethylbenzyl 2-cyano-2-diazoacetate (3.54f): The title compound 
was prepared according to General Procedure D using 3,4-dimethylbenzyl 
alcohol (2.72 g, 20 mmol), sodium bicarbonate (5.04 g, 60 mmol), bromoacetyl bromide (2.6 mL, 
30 mmol), bis-tosylhydrazine (10.2 g, 30 mmol),  1,8-diazabicyclo[5.4.0]undec-7-ene (12 mL, 80 
mmol), chlorosulfonyl isocyanate (1.7 mL, 20 mmol), triethylamine (8.4 mL, 60 mmol) and 
trichloroacetyl chloride (7.4 mL, 66 mmol), yielding a red oil (1.56 g, 34%, 5 steps).  Analytical 
data: 1H NMR (400 MHz, CDCl3) δ 7.15 (m, 3H), 5.26 (s, 2H), 2.30 (s, 6H). 
4-Chlorobenzyl 2-cyano-2-diazoacetate (3.54g): The title compound was 
prepared according to General Procedure D using 4-chlorobenzyl alcohol 
(1.43 g, 10 mmol), sodium bicarbonate (2.52 g, 30 mmol bromoacetyl bromide (1.3 mL, 15 mmol), 
bis-tosylhydrazine (5.1 g, 15 mmol),  1,8-diazabicyclo[5.4.0]undec-7-ene (6 mL, 40 mmol), 
chlorosulfonyl isocyanate (0.87 mL, 10 mmol), triethylamine (4.2 mL, 30 mmol) and 
trichloroacetyl chloride (3.7 mL, 33 mmol), yielding a yellow oil (177 mg, 8%, 5 steps).  Analytical 
data: 1H NMR (400 MHz, CDCl3) δ 7.39 (m, 2H), 7.34 (m, 2H), 5.28 (s, 2H). 
3-Methoxybenzyl 2-cyano-2-diazoacetate (3.54h): The title compound 
was prepared according to General Procedure D using 3-methoxybenzyl 
alcohol (3.21 g, 23.2 mmol), sodium bicarbonate (5.86 g, 70 mmol), bromoacetyl bromide (3.0 
mL, 35 mmol), bis-tosylhydrazine (11.9 g, 35 mmol),  1,8-diazabicyclo[5.4.0]undec-7-ene (14 mL, 
93 mmol), chlorosulfonyl isocyanate (2.0 mL, 23.2 mmol), triethylamine (9.7 mL, 70 mmol) and 
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trichloroacetyl chloride (8.6 mL, 77 mmol), yielding a yellow oil (2.36 g, 44%, 5 steps). Analytical 
data: 1H NMR (400 MHz, CDCl3) δ 7.30 (m, 1H), 7.00–6.85 (m, 3H), 5.29 (s, 2H), 3.84 (s, 3H). 
2,4,6-Trimethylbenzyl 2-cyano-2-diazoacetate (3.54i): The title 
compound was prepared according to General Procedure D using 2,4,6-
trimethylbenzyl alcohol (3.00 g, 20 mmol), sodium bicarbonate (5.04 g, 60 mmol), bromoacetyl 
bromide (2.6 mL, 30 mmol), bis-tosylhydrazine (10.2 g, 30 mmol),  1,8-diazabicyclo[5.4.0]undec-
7-ene (12 mL, 80 mmol), chlorosulfonyl isocyanate (1.7 mL, 20 mmol), triethylamine (8.4 mL, 60 
mmol) and trichloroacetyl chloride (7.4 mL, 66 mmol), yielding a red oil (1.12 g, 23%, 5 steps). 
Analytical data: 1H NMR (400 MHz, CDCl3) δ 6.91 (s, 2H), 5.42 (s, 2H), 2.39 (s, 6H), 2.31 (s, 
3H). 
General Procedure E for the Intramolecular Buchner Reaction of Cyano Diazoacetates 
 
To a flame-dried 10 mL microwave reaction vessel in a nitrogen-filled glovebox was added 
anhydrous Cu(hfacac)2 (0.2 equiv). The diazo compound (1 equiv) was then transferred with 
anhydrous DCE (0.1 M) via syringe. The reaction was then heated to 120 °C under microwave 
irradiation (2 min ramp, 5 min hold). After completion, the brown solution was cooled to room 
temperature, stirred with silica gel, and filtered over Celite and concentrated. The solid brown 
residue was then purified by either trituration with Et2O or column chromatography, yielding the 
desired product in good purity.  
 3-Oxo-1H,3H-benzo[1,3]cyclopropa[1,2-c]furan-3a(3bH)-carbonitrile  (3.55a): 
The title compound was prepared according to General Procedure E using benzyl 2-
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cyano-2-diazoacetate 3.54a (81 mg, 0.4 mmol) and Cu(hfacac)2 (38 mg, 0.08 mmol), and was 
purified using 10% EtOAc/hexanes as eluent, yielding a clear oil (27 mg, 39%). Analytical data: 
1H NMR (400 MHz, CDCl3) δ 6.67 (br s, 2H), 6.50 (br s, 1H), 6.38 (br s, 1H), 4.99 (br s, 1H), 
4.72 (br s, 1H), 4.14 (br s, 1H). 
 5-Methyl-3-oxo-1H,3H-benzo[1,3]cyclopropa[1,2-c]furan-3a(3bH)-
carbonitrile (3.55b): The title compound was prepared according to General 
Procedure E using 4-methylbenzyl 2-cyano-2-diazoacetate 3.54b (430 mg, 2 mmol) and 
Cu(hfacac)2 (191 mg, 0.4 mmol), and was purified by trituration with Et2O, yielding an off-white 
solid (118 mg, 32%). Analytical data: 1H NMR (400 MHz, CDCl3) δ 6.43 (d, J = 9.2 Hz, 1H), 
6.20 (d, J = 9.2 Hz, 1H), 6.10 (d, J = 6.0 Hz, 1H), 4.75 (d, J = 10.4 Hz, 1H), 4.49 (d, J = 10.4 Hz, 
1H), 3.53 (d, J = 6.0 Hz, 1H), 2.08 (s, 3H). 
 6-Methyl-3-oxo-1H,3H-benzo[1,3]cyclopropa[1,2-c]furan-3a(3bH)-
carbonitrile  (3.55c): The title compound was prepared according to General 
Procedure E using 3-methylbenzyl 2-cyano-2-diazoacetate 3.54c (22 mg, 0.1 mmol) and 
Cu(hfacac)2 (9.6 mg, 0.02 mmol), and was purified using 20%40% EtOAc/hexanes as eluent, 
yielding a white solid (3 mg, 16%). Analytical data: 1H NMR (400 MHz, CDCl3) δ 6.50 (br s, 
1H), 6.37 (br s, 1H), 6.13 (d, J = 6.8 Hz, 1H), 4.77 (d, J = 9.0 Hz, 1H), 4.50 (d, J = 9.0 Hz, 1H), 
3.30 (br s, 1H), 2.16 (s, 3H). 
 7-Methyl-3-oxo-1H,3H-benzo[1,3]cyclopropa[1,2-c]furan-3a(3bH)-
carbonitrile  (3.55d): The title compound was prepared according to General 
Procedure E using 2-methylbenzyl 2-cyano-2-diazoacetate 3.54d (mg, mmol) and 
Cu(hfacac)2 (mg, mmol), and was purified using 20%40% EtOAc/hexanes as 
eluent, yielding a brown oil (12 mg, 32%). Analytical data: 1H NMR (600 MHz, CDCl3, 3.55da, 
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77%) δ 6.63 (dd, J = 9.0, 7.5 Hz, 1H), 6.54 (d, J = 9.0 Hz, 1H), 6.36 (d, J = 7.5 Hz, 1H), 5.02 (d, 
J = 12.0 Hz, 1H), 4.71 (d, J = 12.0 Hz, 1H), 4.39 (br s, 1H), 2.04 (s, 3H); (3.55db, 23%) 6.72 (m, 
2H), 6.32 (m, 1H), 5.96 (br s, 1H), 5.10 (dd, J = 12.6, 1.5 Hz, 1H), 4.82 (dd, J = 12.6 Hz, 1.2 Hz, 
1H), 1.93 (s, 3H). 13C NMR (150 MHz, CDCl3) δ 170.4, 129.9, 129.5, 129.4, 127.5, 126.7, 120.7, 
69.9, 69.6, 19.1, 18.9. 
 5-tert-Butyl-3-oxo-1H,3H-benzo[1,3]cyclopropa[1,2-c]furan-3a(3bH)-
carbonitrile  (3.55e): The title compound was prepared according to General 
Procedure E using 4-tert-butylbenzyl 2-cyano-2-diazoacetate 3.54e (26 mg, 0.1 mmol) and 
Cu(hfacac)2 (9.6 mg, 0.02 mmol), and was purified using 10% EtOAc/hexanes as eluent, yielding 
a white solid (10 mg, 44%). Analytical data: 1H NMR (400 MHz, CDCl3) δ 6.73 (br s, 1H), 6.39–
6.20 (m, 2H), 4.79 (br s, 1H), 4.49 (br s, 1H), 3.47 (br s, 1H), 1.21 (s, 9H). 
4,5-Dimethyl-3-oxo-1H,3H-benzo[1,3]cyclopropa[1,2-c]furan-3a(3bH)-
carbonitrile  (3.55f): The title compound was prepared according to General 
Procedure E using 3,4-dimethylbenzyl 2-cyano-2-diazoacetate 3.54e (46 mg, 0.2 
mmol) and Rh2(OPiv)4 (1.2 mg, 0.002 mmol), and was purified using 20% 
EtOAc/hexanes as eluent, yielding a clear oil as a 1:0.43 mixture of regioisomers (31 mg, 77%). 
Analytical data: 1H NMR (400 MHz, CDCl3) δ (3.55fa, 70%) 6.38 (d, J = 9.2 Hz, 1H), 6.02 (d, J 
= 9.2 Hz, 1H), 4.63 (d, J = 10.0 Hz, 1H), 4.36 (d, J = 10.0 Hz, 1H), 3.07 (br s, 1H), 2.07 (s, 3H), 
2.00 (s, 3H); (3.55fb, 30%) 6.08 (m, 1H), 5.93 (br s, 1H), 4.57 (d, J = 9.6 Hz, 1H), 4.33 (d, J = 9.6 
Hz, 1H), 3.12 (d, J = 5.2 Hz, 1H), 2.05–2.01 (m, 6H). 
 5-Chloro-3-oxo-1H,3H-benzo[1,3]cyclopropa[1,2-c]furan-3a(3bH)-
carbonitrile  (3.55g): The title compound was prepared according to General 
Procedure E using 4-chlorobenzyl 2-cyano-2-diazoacetate 3.54g (47 mg, 0.2 mmol) and 
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Cu(hfacac)2 (19 mg, 0.04 mmol), and was purified using 10% EtOAc/hexanes as eluent, yielding 
a brown solid (23 mg, 55%). Analytical data: 1H NMR (400 MHz, CDCl3) δ 6.72 (d, J = 6.0 Hz, 
1H), 6.47 (d, J = 4.8 Hz, 1H), 6.35 (d, J = 6.0 Hz, 1H), 4.92 (d, J = 8.0 Hz, 1H), 4.67 (d, J = 8.0 
Hz, 1H), 4.11 (br s, 1H). 
 6-Methoxy-3-oxo-1H,3H-benzo[1,3]cyclopropa[1,2-c]furan-3a(3bH)-
carbonitrile  (3.55h): The title compound was prepared according to General 
Procedure E using 3-methoxybenzyl 2-cyano-2-diazoacetate 3.54g (23 mg, 0.1 
mmol) and Rh2(OPiv)4 (0.6 mg, 0.001 mmol). Analytical data: 1H NMR (400 MHz, CDCl3) δ 6.38 
(dd, J = 10.0, 1.2 Hz, 1H), 6.26 (dd, J = 10.0, 4.4 Hz, 1H), 3.95 (s, 3H). 
Subsequent Transformations of 3.55b 
 
 6-Benzyl-10-methyl-3,5,7-trioxo-3b,4,4a,5,6,7,7a,8-octahydro-1H-4,8-
ethenofuro[3',4':1,3]cyclopropa[1,2-f]isoindole-3a(3H)-carbonitrile 
(3.56b): In a 1 dram vial were combined 3.55b (9.4 mg, 0.05 mmol) and N-
benzylmaleimide (28 mg, 0.15 mmol) in DMSO (1 mL). The reaction was allowed to stir at room 
temperature for 3 d before the reaction was partitioned between EtOAc (1 mL) and water (1 mL). 
The aqueous layer was then extracted with EtOAc (4 × 1 mL). The combined organic layer was 
then washed with water (2 × 2 mL) and brine (1 × 2 mL), dried over Na2SO4, filtered, and 
concentrated. The solid residue was then triturated with Et2O (2 mL), and the supernatant was 
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removed by suction. The solid was then washed with Et2O (3 × 2 mL), and the residual solvent 
was removed in vacuo, providing a white solid in good purity as a single diastereomer (14 mg, 
75%). Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.33 (m, 5H), 5.61 (dq, J = 5.2, 1.6 Hz, 1H), 
4.63 (d, J = 14.0 Hz, 1H), 4.54 (d, J = 14.0 Hz, 1H), 4.48 (d, J = 8.8 Hz, 1H), 4.30 (d, J = 8.8 Hz, 
1H), 3.64–3.58 (m, 2H), 3.14 (dd, J = 8.0, 3.2 Hz, 1H), 3.06 (dd, J = 7.6, 3.2 Hz, 1H), 1.98 (d, J = 
4.0 Hz, 1H), 1.52 (d, J = 1.6 Hz, 3H).  
 
In a 1 dram vial were combined 3.55b (9.4 mg, 0.05 mmol) and (R)-N-(1-phenylethyl)-
maleimide (15.1 mg, 0.075 mmol). The mixture was then suspended in brine (1 mL) and the 
mixture was rapidly stirred for 16 h. After the reaction was complete by TLC, the organics were 
extracted with EtOAc (5 × 1 mL), dried over Na2SO4, filtered, and concentrated. The resultant 
solid was triturated with Et2O, and washed with Et2O (3 × 1 mL), yielding a white solid (16 mg, 
81%, 1.8:1 dr). Analytical data: 1H NMR (400 MHz, CDCl3) δ 7.33 (m, 5H), 5.70 (m, 0.34H, 
minor), 5.62 (m, 0.64 H, major), 5.33 (m, 1H), 4.50 (m, 1H), 4.30 (m, 1H), 3.64 (m, 1H), 3.57 (m, 
1H), 3.10 (m, 1H), 3.02 (m, 1H), 1.99 (m, 1H), 1.74 (m, 4.92H), 1.43 (br s, 1.02H, minor). 
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 6a-Methyl-2-oxo-1a,6a-dihydro-2H,4H-
oxireno[2'',3'':3',4']benzo[1',2':1,3] cyclopropa[1,2-c]furan-1c(1bH)-
carbonitrile (3.58b): The norcaradiene 3.55b (10 mg, 0.05 mmol) and sodium bicarbonate (22 
mg, 0.27 mmol) were added to a 1 dram vial and dissolved in 1:1 acetone/water (1 mL) and cooled 
to 0 °C. Then Oxone® (164 mg, 0.27 mmol) was added in one portion, and the reaction was 
allowed to gradually warm to room temperature over 22 h. Then the reaction was quenched with 
Na2S2O3 (1 mL), extracted with CH2Cl2 (1 mL), dried over Na2SO4, filtered, and concentrated, 
yielding a clear oil in good purity as a single diastereomer (9 mg, 90%). Analytical data: 1H NMR 
(400 MHz, CDCl3) δ 6.09 (d, J = 5.8 Hz, 1H), 5.87 (d, J = 5.8 Hz, 1H), 4.44 (d, J = 9.8 Hz, 1H), 
4.36 (d, J = 9.8 Hz, 1H), 3.56 (d, J = 2.0 Hz, 1H), 2.74 (d, J = 2.0 Hz, 1H), 1.50 (s, 3H). 
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